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ABSTRACT OF DISSERTATION 
 
SURFACE-INITIATED POLYMERIZATION FOR THE RAPID SORTING OF 
RARE CANCER CELLS 
 
Cancer metastasis directly accounts for an estimated 90% of all cancer related 
deaths and is correlated with the presence of malignant tumor cells in systemic 
circulation. This observed relationship has prompted efforts to develop a fluid biopsy, 
with the goal of detecting these rare cells in patient peripheral blood as surrogate markers 
for metastatic disease as a partial replacement or supplement to invasive tissue biopsies. 
Numerous platforms have been designed, yet these have generally failed to support a 
reliable fluid biopsy assay due to poor performance parameters such as low throughput, 
low purity of enriched antigen positive cells, and insufficiently low detection thresholds 
to detect poor expressed surface markers of target cell populations. This work describes 
the development of a rapid cell sorting technology called Antigen Specific Lysis (ASL) 
based on photo-crosslinked polymer film encapsulation to isolate tumor cells in 
suspension. 
In the first study, we characterize the chemical and structural properties of the 
surface-initiated polymer films formed directly on mammalian cell surfaces. Coated cell 
populations are shown to remain highly viable after coating formation. Biomolecular 
transport is examined though film coatings on cellular substrates using fluorescent, time-
resolved confocal microscopy and diffusivity estimates are generated for these materials. 
In the next study, a lysis-based cell isolation platform is described in which marker 
positive cells can be specifically coated in a heterogeneous cell suspension. Anionic 
surfactants lyse virtually 100% of uncoated cells while fully encapsulated cells remain 
protected, and are then easily collected by centrifugation. We report that purified cells are 
released from polymeric coatings to yield viable and functional populations. We monitor 
cell response throughout the isolation process by multiple techniques, and report cell 
viability >80% after the sorting process. Lastly, we examine the response of process yield 
on the level of photoinitiator loading on target cell populations. Streptavidin-
fluorochrome loading was quantitatively assessed on a panel of markers, both epithelial 
and mesenchymal, on representative model breast and lung cancer cells. We report that 
ASL is fundamentally capable of achieving 50-60% yield which is promising for fluid 
biopsy applications. Finally, both EpCAM and metastatic targeting strategies are then 
compared to covalently biotinylated samples to inform future robust targeting strategies.  
 
KEYWORDS: cancer, cell sorting, photopolymerization, thin films, surface coatings, cell 
encapsulation  
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1 
Chapter 1: Introduction 
Tumor metastasis plays a central role in the often fatal nature of cancer, and 
directly accounts for an estimated 90% of all cancer related deaths [3, 4]. Although the 
exact signaling cues and underlying mechanisms that drive the metastatic process remain 
an area of intense research, the link between metastasis and the presence of circulating 
tumor cells (CTCs) in peripheral blood has long been observed. Many have reported that 
the detection of high numbers of CTCs in cancer patients is correlated with poorer 
prognosis, particularly in breast, prostate and colorectal cancer types [5-9]. 
These findings have prompted much effort in developing technologies to detect, 
isolate, and characterize these CTCs in patient peripheral blood samples for clinical use 
as a “fluid biopsy”, with the hope of establishing a reliable prognostic indicator. Ideally, 
this isolation modality could be implemented in a treatment regimen as a supplement or 
partial replacement for a traditional tissue biopsy. This would allow almost continual 
supervision of progression and response to treatment, while minimizing the trauma and 
bodily stress of a tissue biopsy. For decades, strategies have focused on simple 
enumeration of the rare epithelial-like cell in the bloodstream, and have shown limited 
success as a reliable, predictive assay. Critically, the poor performance in both sensitivity 
and specificity of CTC isolation strategies has prevented their incorporation into standard 
therapy practices and has not led to measurable improvements in clinical outcomes [10]. 
This has been due, in part, to the reliance of these isolation technologies on detecting 
cells based on the definitive epithelial marker, EpCAM, and the assumption that the 
tumor cell phenotype is static and unalterable [11-13]. Emerging evidence suggests there 
exists vastly complex biochemical signaling between tumor cells and their evolving 
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microenvironment that provoke and sustain metastasis [14]. This heterotypic signaling 
causes a certain subset of tumor primary cells to shed their epithelial phenotype and gain 
more stem-like properties that allow them to be particularly well suited for the 
subsequent phases of metastasis – migration, invasion, intravasation, circulation, and 
extravasation [1].  
This process, known as epithelial-mesenchymal-transition (EMT), has been 
shown to causes a reversible and dynamic shift in the tumor cell phenotype as epithelial 
markers are downregulated, suggesting that CTC detection strategies based on 
recognition of epithelial markers may not “see” a large proportion of these highly 
metastatic stem-like CTCs [4, 15, 16]. We submit that mesenchymal cells represent 
significant false negative events in current detection approaches, contributing to poor 
assay sensitivity, specificity, and ultimately utility. Further, while this phenomenon has 
been well described in vitro and at the tumor primary, little is known about the marker 
expression profile of a CTC during transit in the bloodstream largely because currently 
available CTC isolation technologies are incapable of isolating these populations with the 
purity and quantity needed for analysis. 
This dissertation focuses on the development of polymer thin film cell coatings to 
rapidly sort marker-positive cancer cells via lysis based negative depletion of all marker-
negative cells. Here, we demonstrate that primary antibodies bind specifically to cancer 
cell surface markers, which through subsequent biotin/avidin interactions then direct the 
site-specific binding of visible-spectrum photoinitiator species. Irradiation in the presence 
of monomer and coinitiator is shown to crosslink a nanothin film around marker-positive 
cells that specifically protects and stabilizes these cells during surfactant lysis. Chapter 2 
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presents a more detailed background of cancer biology relevant to circulating tumor cells, 
and an overview of the current technologies designed to isolate and detect these rare 
cells. In Chapter 3, a background of the polymer materials is introduced as well as the 
specific photochemistry reactions utilized in this work. In chapters 4 through 7, the main 
projects of this work are presented. First, the chemical, structural, and selective 
permeability properties of our thin film materials on cell substrates are investigated. Next, 
a UV-photodegradable functionality is designed to allow for release of target cells after 
isolation, and sorting from heterogeneous cell suspensions confirms the specificity of our 
method. Due to the variability often seen in cancer phenotypes, we then offer a 
quantitative and comparative analysis of a panel of markers implicated in metastasis. 
Commonly studied breast and lung cancer lines are examined to provide reference and 
guidance as to the quantity, and moreover density, of cancer markers available for 
targeting. Lastly, we relate photoinitiator binding density to the yield of cells delivered 
and determine a loading threshold for isolation. 
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1.1 Specific Objectives 
The overall objective of this work was to design and implement surface-initiated polymer 
coatings for protective isolation during lysis-based negative depletion. The specific 
objectives of the four experimental chapters presented in this dissertation are shown 
below: 
1. Characterization of Molecular Transport in Ultrathin Hydrogel Coatings on 
Cellular Substrates for Engineered Selective Permeability 
a. Demonstrate successful and specific cell surface film coating 
b. Analyze and describe the chemical and structural properties of polymer 
coatings 
c. Investigate the cell toxicity effects of coating formation  
d. Develop Fickian model and determine macromolecular diffusivity within 
PEGDA film coatings 
2. Design and Development of Protective Polymer Coatings for Rapid High-Purity 
Cancer Cell Isolation 
a. Synthesize UV-degradable macromers and confirm structure 
b. Demonstrate marker specific cell sorting in binary mixtures 
c. Determine sorted cell purity after ASL sorting 
d. Determine cell viability and capacity for proliferation of sorted 
populations 
3. Quantitative Investigation of Surface Receptor Expression Density For The 
Isolation of Tumor Cells 
a. Identify cancer-associated markers implicated in metastasis for analysis 
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b. Describe non-small lung cancer and breast cancer cell morphology and 
calculate diameter. 
c. Determine specific fluorescent probe loading for all marker targeting 
scenarios on cancer lines and normal human peripheral blood cells 
d. Calculate loading densities for all marker targeting scenarios 
4. The Role of Surface Receptor Density in Surface-Initiated Polymerizations for 
Cancer Cell Isolation 
a. Determine effect on isolated cell yield of incrementally varied 
photoinitiator loading on A549 cells covalently tagged with sulfo-NHS-
biotin  
b. Compare isolation yield of covalent biotinylation to populations targeted 
via primary antibodies binding epithelial and stem markers 
c. Investigate gelation response in analogous protein microarrays 
d. Determine lower threshold photoinitiator loading density required for 
protective coating isolation 
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Chapter 2: Relationship of CTC Isolation Technologies to Metastatic Cancer 
Biology 
2.1 Introduction 
Recent evidence suggests a subpopulation of primary tumor cells acquire stem-
like properties that permit the dissemination from the primary into the surrounding 
stroma and sets the stage for metastatic spread. In contrast, current CTC isolation 
methodologies are based on detecting cells based on the antigenic profiles found in the 
original primary, which are largely epithelial. This disconnect highlights the need for a 
greater appreciation of the biological drivers of metastasis in designing CTC detection 
technologies. This chapter focuses on metastatic cancer biology that determines CTC 
phenotype and provides perspective in light of the currently available CTC isolation 
technologies. 
2.2 Role of Epithelial-Mesenchymal Transitions in Metastatic Cancer 
Numerous studies have reported epithelial-mesenchymal transitions are a 
facilitator and driver of metastatic activity [17]. Recently, several underlying signaling 
networks have been revealed to be extremely intricate, and eventually generate a 
heterogeneous composition of cell phenotypes in the stromal environment and at distant 
metastases. Further, EMT is highly active at both the primary invasive front and during 
blood bourne metastasis where intervening treatment is perhaps most crucial for disease 
management [1, 18]. These findings have highlighted the need for greater appreciation of 
the biology in designing cell isolation methodology.  
During tumor formation in a primary carcinoma, oncogenic changes in epithelial 
cells lead to excessive proliferation, as well as angiogenesis and cell recruitment to fuel 
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rapid growth [19]. During this initial stage of tumorigenesis, the malignant cells are 
thought to retain much of their epithelial characteristics, including cell-cell junctions, 
apical-basal polarity, and lack of motility [14]. However, as recruitment cytokines 
emanate from the primary, the stromal environment begins to evolve and diversify with 
the accumulation of support cells such as mesenchymal stem cells, endothelial 
progenitors, and macrophages [20, 21]. This complex signaling landscape is believed to 
play a prominent role in sparking aggressive and robust EMT programs in a certain 
subset of primary cells that drive the subsequent stages of cancer progression [22]. 
Growth factors exchanged at the tumor-stroma interface such as PDGF, EGF, HGF, and 
TGF-β have been shown to initiate pathways that induce transcription factors implicated 
in EMT [1, 23, 24]. Notably, induction of Snail, Slug, ZEB1/2, Twist, and the Wnt/β-
catenin pathway previously associated with wound healing and embryogenesis models 
have all more recently been implicated in this cancer progression process [25, 26]. 
Epithelial surface proteins, particularly those involved in attachment to ECM are cell-
junctions, are downregulated such E-cadherin, αβ-integrins, and EpCAM [27]. The 
marker E-cadherin especially has been widely studied in this context, and the functional 
loss of this epithelial marker has become a hallmark of the EMT program. Accompanying 
the repression of attachment proteins, mesenchymal traits begin to appear such as 
restructuring of the cytoskeleton to favor a more motile and invasive cell, as well as 
enhanced resistance to apoptosis, and loss of polarity [28]. Other stem-like molecular 
features also appear such as matrix metalloprotease and N-cadherin expression that 
allows for degradation of ECM and basement membranes and increased capacity for 
migration necessary to enter the vasculature [27]. 
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Not surprisingly, evidence shows these stem-like tumor cells are highly enriched 
at the invasive front of many primary carcinomas as depicted in Figure 2.1. Further, 
these cells may even lead the way for intravasation of many other tumor cell phenotypes 
arising from the same primary that otherwise may not have had the required invasive 
attributes to accomplish the feat on their own [26, 29].  
While we hypothesize that the mesenchymal transitioned tumor cells are the most 
relevant and potent for disease progression, this could perhaps reconcile the observed link 
between the detection of epithelial-like cells in circulation of metastatic patients and poor 
prognosis in several current CTC isolation technologies. Largely, once tumor cells spill 
into the bloodstream, little is known about the exact mechanisms that determine their 
phenotype while in free circulation. Some evidence supports that a CTC is never truly 
autonomous, but EMT signaling in the primary does stabilize the mesenchymal state for 
transit such that it constitutively remains until signals favoring an epithelial phenotype 
reverses the cell back to a more epithelial state, ostensibly at a secondary and distant site 
(i.e. metastatic focus) [15, 30]. Further complicating the characterization of these stem-
like CTCs, the Stott group recently managed to collect a small number of CTCs from 
several metastatic breast cancer patients, and immunostained for both epithelial and 
mesenchymal markers. The results suggest these cells as highly variable from patient to 
patient, and even shows variable phenotypes within the same peripheral blood sample 
[31]. Many cells expressed significant levels of both epithelial and mesenchymal 
markers, suggesting an EMT phenotype in reality falls more on a continuum between the 
two extremes. Collectively, these findings relating EMT to surface expression on CTCs 
point toward the need for an isolation methodology capable of yielding viable and 
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functional cells for further analysis to elucidate the mechanisms that shift or sustain CTC 
phenotypes. 
2.3 Current CTC Isolation Technologies 
Given the significant progress made in revealing the underlying biological drivers 
governing metastasis, the isolation technology community has been compelled to reassess 
the fundamental bases and performance characteristics that will be needed to deliver a 
reliable CTC sorting approach [32-35]. While some groups have had moderate success is 
isolating CTCs based on physical properties such as size and membrane rigidity [36], the 
most promising approaches by far have isolated CTCs based on recognition of surface 
antigens. However, translating these for clinical use has remained challenging due to poor 
sensitivity and biological specificity, largely because they target epithelial antigens. 
Moreover, many assay protocols require fixation and often take an entire day of 
processing, which precludes further functional analysis of these multipotent EMT cells 
[9]. In the following sections, the current most common isolation methodologies will be 
detailed, with context given to the particular challenges of metastatic tumor cell targeting. 
2.3.1 Magnetic-Activated Cell Sorting 
Magnetically-activated cell sorting, or MACS, relies on tagging antigen-positive 
populations with magnetic particles by standard immunolabeling protocols [37].  
Antibodies are conjugated to magnetic particles and incubated with a cell mixture where 
they bind to a particular surface marker of interest [38]. Magnetic sorting can achieve its 
highest throughput in a semi-batch mode, where after immunolabeling a cell mixture is 
passed through a magnetized disposable column. The sensitized antigen positive cells are 
retained by the column with varying affinity while all other cell populations not 
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sensitized by immunomagnetic labeling pass through the column readily and are 
discarded. The magnetic field is removed, and through subsequent rinsing steps the 
antigen-positive cells are removed and collected from the column [39]. The main 
advantages of MACS is in its high throughput capabilities and little sterilization 
requirements because the column is typically single-use. In evaluating the efficacy of 
MACS in circulating tumor cell detection applications, even advanced MACS systems 
only achieve ~50-75% purity [34] , which is insufficient given the extreme rarity at which 
CTCs exist in circulation (~1 per million).   
2.3.2 Fluorescence-Activated Cell Sorting 
Fluorescence-activated cell sorting (FACS) has existed as a concept for cell 
analysis for several decades and is based on labeling antigen-positive cells with 
fluorophores conjugated to antibodies. Flow cytometry is used to measure the cell 
fluorescence due to antibody binding, size, and granularity, and thresholding is imposed 
to collect target cells based on marker expression [40]. Purities attained by FACS are 
often greater than 99%, but because microfluidics are used to hydrodynamically focus 
individual cells during sorting, this high purity comes at the cost of extremely slow 
sorting rates [41, 42]. Additionally, FACS has the capability of analyzing several 
fluorescent signals simultaneously with multiple-laser configurations, representing a key 
advantage in analyzing complex protein interactions. Flow sorters are also prohibitively 
costly (~$500,000) to many laboratories, and require lengthy sterilization procedures to 
flush contaminates from fluidic lines, and peristaltic pumps need to be routinely 
calibrated to ensure measurement accuracy.  In all, due to its reliance on microfluidics, 
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FACS inherently cannot provide rapid and cost effective sorting for large-scale CTC 
detection and isolation. 
2.3.3 CellSearch System 
To date, only one CTC isolation technology is clinically validated by the FDA 
called CellSearch, designed by Veridex (Raritan, NJ), which involves enrichment with 
immunomagnetic beads against EpCAM followed by immunofluorescent labeling and 
analysis to further confirm the epithelial phenotype (DAPI+, CK+, CD45-) of the 
enriched population. Staining with DAPI ensures the detected event is a nucleated cell, 
while staining for cytoplasmic cytokeratins is a secondary measure for an epithelial cell. 
Finally, positive detection also requires the cell event to be negative for the leukocyte-
common antigen CD45. Using this definition of a CTC, it was established that a count of 
≥5 of cells per 7.5ml peripheral blood that met the thresholding criteria correlated with a 
statistically significant drop in prognosis in breast, prostate, and colon cancers [8, 9]. 
CellSearch systems have been the most commonly employed CTC isolation and 
enumeration methods, however have not incorporated into standard treatment regimens 
because of widely reported low sensitivity resulting in considerable false negatives in 
metastatic patients as well as low purity of isolated cells. As detailed above, it is 
suspected that the poor performance of CellSearch is due to variability in antigen 
expression from EMT processes, such that the most metastatic cells have little to no 
epithelial expression and therefore go unnoticed as false negatives when employing the 
CellSearch platform [4, 12]. Further, the FDA validated CellSearch protocol requires 
fixation and permeabilization of the cell samples, which presumably improves 
consistency and reproducibility, yet does not yield viable and functional cells post-
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processing. We hypothesize that the isolation of biologically functional CTCs for 
downstream characterizations is critical for linking the observed EMT processes with the 
ultimate fate of a CTC, and for developing a fluid biopsy approach with greater 
prognostic capacity. 
2.3.4 Microfluidic Approaches 
More recently, groups have worked toward designing CTC isolation methods 
capable of delivering viable cells that use microfluidic channels to separate and capture 
CTCs [35]. For metastatic breast cancer, cell suspensions are flowed into microfluidic 
devices containing reservoirs that feature arrays of micro-posts covalently functionalized 
with antibodies cocktails – typically a combination of EpCAM, HER2, and EGFR [43-
45]. These antigen-selective methods have exhibited moderate purity and capture 
efficiency. Later generations of these devices have begun to appreciate the dynamic and 
seemingly unpredictable nature of CTC phenotypes, and take a more unbiased and 
agnostic approach to enrichment by negatively depleting CD45+ cells by magnetic 
separation in microfluidic channels to yield cells unmolested by sorting methodology 
[46]. While these creative approaches have yielded intriguing results that will 
undoubtedly instruct future generations of isolation technology, they suffer critically 
from low throughput at approximately 3 mL processed per hour [45]. Microfluidic 
channels inherently introduce high levels of shear forces that prevent the increase of fluid 
flow rates to practical levels, and require the need for careful optimization so fluid shear 
does not exceed the electrostatic force of antibody capture. These constraints ultimately 
result in an assay that would require a day or more to isolate a population of CTCs 
sufficient for immediate characterization. 
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2.4 Conclusions and Perspectives 
Here, the biology of cancer metastasis has been discussed, as well as the 
limitations of current CTC isolation approaches. In the context of sorting rare stem-like 
populations, these cells purportedly exist in a dedifferentiated state that can respond to a 
multitude of lineage-specific, directing stimuli [47]. Therefore, we submit that not only 
does a CTC sorting method need to yield functional cells, perform with high specificity 
and purity, but also be a high-throughput and rapid technique to successfully isolate these 
stem-like populations for analysis. 
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Figure 2.1: Schematic depicting invasion of mesenchymal-transitioned cells leaving the 
primary tumor site. From Kalluri & Weinberg (2009) [1]. 
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Chapter 3: Hydrogel Polymerization Approaches to Cellular Encapsulation and 
Surface Modification 
3.1 Introduction 
In the past several decades, the use of synthetically derived polymeric materials 
has revolutionized the field of medicine, particularly for targeted therapy and tissue 
regeneration. Hydrogel polymers allow remarkable versatility; they can be tailored to 
possess a wide array of functional characteristics that make them well suited as a medium 
in biomedical settings [48, 49]. This chapter will focus on the polymerization of 
hydrogels as a scaffold for cell encapsulation. First, the chemical and structural 
characteristics of hydrogels will be introduced in the context of cell encapsulation. 
Microencapsulation strategies will be discussed with perspective on the effect of 
encapsulation environment on permeability and mass transfer to the cell surface. Next, 
photoinitiated free radical polymerization will be examined as a route to hydrogel 
formation, with particular emphasis on the eosin Y photoinitiation system, which is used 
throughout this dissertation. Lastly, we will examine surface initiated polymer-based 
amplification as a method to form nanometer-scale hydrogel films specifically at sites of 
protein expression. 
3.2 Hydrogel Properties  
 Synthetic hydrogels have long been studied for the protection of biological 
species in vivo [50]. Hydrogels for cell encapsulation are typically covalently crosslinked 
[51]. The most definitive property of hydrogels is the ability to absorb water and swell 
and remain stable and water-insoluble, often to several fold greater sizes that the 
dehydrated states [52]. This swelling occurs due to hydrogen bonding and electrostatic 
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interactions between water and the crosslinked structure, such that water is 
thermodynamically favored to infiltrate the porous material. In applications in aqueous 
cell media settings, oxygenated water and other small molecules can readily permeate to 
and from the cell surface while the cell itself stays protected and occluded for large 
molecular structures. This allows cells to remain encapsulated for long periods of time 
while retaining high viability [53, 54].  
 One particularly advantageous capability is the polymerization of hydrogel 
materials directly around cells from a monomeric precursor solution. This allows one to 
carefully tune and tailor the properties of the eventual 3D material. Scaffold geometry 
and material thickness is an important design consideration and can be modified 
depending on the polymerization method employed. Mechanical properties can also be 
tuned with the monomer chemical composition and concentration. Crosslinked hydrogels 
consist of a porous mesh structure with void space between crosslinks, which allows for 
significant movement and flexing under mechanical strain. Many groups have shown that 
the mechanical performance of hydrogel is predictably controlled to mimic that of 
biologically derived tissue depending on the monomer, crosslinking density, and 
molecular weight between crosslinks (MWBC) [55-57]. Hydrogels can been designed to 
resemble a variety of complex tissues at a wide range of length scales from extracellular 
matrices, to individual cells, to whole organs [58, 59].  
These parameters (monomer concentration, crosslinking density, MWBC, mesh 
size) are also significant determinants of the permeability of hydrogel scaffolds. For 
homogenously crosslinked hydrogels, smaller MWBC and mesh size or higher 
crosslinking density will generally result in lower permeability [60-62]. Tailoring the 
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selective permeability of hydrogel encapsulation environments is critical for many 
applications. Selectivity based on sized can prevent large macromolecules such as host 
antibodies and immune cells from penetrating the hydrogel architecture while allowing 
smaller growth factors to freely penetrate. Cruise et al. has shown in bulk crosslinked 
PEG-diacrylate membranes that PEG-diacrylate with MWBC of 2kDa, vitamin B12 (1.2 
kDa) was able to permeate the material while globular proteins such as myoglobin 
(16.7kDa) and larger showed no detectable diffusion [60]. Membranes composed of 
20kDa PEG-diacrylate, however, readily allowed both vitamin B12 and myoglobin, 
showing the effect of MWBC on the membrane permeability. Reinhart et al. developed a 
model for swollen polyvinyl alcohol hydrogels that relates solute diffusivity to these 
structural parameters for several biomolecular permeants, which further suggests the 
direct positive correlation between MWBC and diffusivity [63, 64]. Increasing the cross-
linking density, by either increasing the monomeric concentration in solution, longer 
polymerization reaction times, or increased reaction kinetics, can also reduce the 
permeability of hydrogel membranes. More complete crosslinking (i.e. unreacted pendant 
monomer ends) reduces the mobility and access of solutes as they navigate through the 
material via passive diffusion. 
3.3 Hydrogel Chemical Composition 
 Many monomer chemistries have been explored for hydrogel cell encapsulation 
and are selected with consideration to each particular application [65]. Both naturally-
derived and synthetic polymers have been investigated. Naturally-derived hydrogel 
materials typically offer innate compatibility with the encapsulated cells of interest as 
they are often derived from ECM scaffolds that would surround these cells 
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physiologically. They include materials composed of collagen, gelatin, fibrin, and 
chitosan typically covalently modified with vinyl moieties to allow for radical 
polymerization [66]. While these materials have shown successful application in tissue 
engineering to encapsulate chondrocytes [67], cardiomyocytes [68], and mesenchymal 
stem cells [69] among many others, they are often impractical to utilize due to their 
heterogeneous and complex nature. Gelation kinetics, mechanical performance, and 
diffusivity are often difficult to predict and control for these materials. Alternatively, 
synthetic monomeric compounds are typically more monodisperse and predictable and 
offer high control over gelation rates and consistent mechanical performance. Synthetic 
materials that have been utilized for cell encapsulation include polyethylene glycol 
(PEG), polycaprolactone (PCL), polyvinyl alcohol (PVA), poly lactic acid (PLA), and 
poly lactic-co-glycolic acid (PLGA) [70]. Of these, PEG has been by far the most widely 
investigated material for encapsulation. PEG macromers are typically functionalized with 
acrylate groups to enable radical polymerization in solution, and are typically water 
soluble. PEG hydrogels also show high structural and chemical stability [71]. While the 
ester bond within acrylate backbones of PEG hydrogels is susceptible to hydrolytic 
degradation, this occurs at very slow rates. Further, PEG has been widely shown to be 
biocompatible in vivo and exhibit low encapsulated cell toxicity [53]. Many acrylated 
PEG macromers with excellent monodispersity are also commercially available, 
providing a convenient medium with which to design and scale up many cell 
encapsulation technologies with predictable gelation kinetics and mechanical properties.  
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3.4 Microencapsulation and Hydrogel Geometry Effects on Mass Transfer  
 While macroscale cell-laden hydrogel scaffolds have advanced numerous 
applications in tissue engineering and regenerative medicine , many researchers have 
recognized the potential advantages of microengineered hydrogel architectures in certain 
applications [51, 72-74]. Microencapsulation is the strategy to coat individual cells or 
small groups of cells with porous scaffold material with thicknesses typically a few 
hundred micron or less. Minimizing the coating thickness, and thus the diffusion length, 
would improve the transport of low-molecular weight nutrients and cellular waste 
components while still preventing large immune molecules from reaching the cell 
surface. Because of the increased surface area to hydrogel volume ratio, the overall mass 
flow rate can increase per cell. In the field of islet encapsulation for insulin therapy, 
Canaple et al. showed an improvement in diffusion leading to increased long term 
viability and cellular function for islets encapsulated in 400 μm thick coatings as 
compared to 1000 μm [75]. Further, for coatings designed to be degradable 
(enzymatically or photocleavage), the volume of material to be degraded is minimized.  
 Several methodologies have been investigated for hydrogel cell 
microencapsulation. Mumaw et al. encapsulated small groups of mesenchymal stem cells 
in PEG-diacrylate (10kDa) by oil-aqueous phase microemulsion and subsequent UV-
range photopolymerization for bone grafting therapy [76]. Microcapsules were 
approximately 100 μm in diameter, and showed high long term viability and cell 
proliferation. Photolithographic techniques can also be useful in forming microstructures 
with high spatial resolution. Koh et al. showed PEG microstructures could be patterned 
down to 50 μm containing as few as one 3T3 murine fibroblast per structure [77]. Flow 
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microfluidics and combined lithographic techniques have also been explored that can 
generate well defined and gradient microencapsulation geometric shape on the order of 
tens to hundreds of microns in thickness [78, 79]. Cruise et al. showed the capability of 
encapsulating individual porcine islets with visible-light photopolymerization of PEG-
diacrylate coatings after soaking cells in eosin Y (type II photoinitiator) solution [54, 80]. 
This technique allowed for thicknesses down to a few hundred microns, and showed long 
term cell survival and insulin secretion in vivo after xenograft transplantation.  
3.5 Approaches to Photoinitiated Polymerization of Hydrogels 
One of the most commonly employed methods of forming hydrogels for cell 
encapsulation is through radical photopolymerization. This method offers many practical 
advantages for hydrogel formation over other types of polymerization. 
Photopolymerization allows for rapid and predictable gelation from an aqueous monomer 
precursor solution at room temperature, often at buffered, pH balanced conditions [81, 
82]. Initiating light can typically be delivered uniformly throughout hydrogel systems 
creating highly homogenous materials. Further, by controlling where and when light is 
exposed, one has excellent spatial and temporal control over the reaction, allowing for 
complex material geometries or crosslinking gradients to be engineered into hydrogel 
systems if desired. Both visible and UV spectrum range photoinitiated systems have been 
described, where light sensitive compounds are excited to generate radicals to crosslink 
the hydrogels from the precursor solution. Water-soluble monomer units are often vinyl 
or acrylate functionalized, enabling this free radical polymerization process [70]. In the 
following sections, two types of photoinitiator compounds (type-I and type-II) will be 
introduced that have been utilized for hydrogel formation. 
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3.5.1 Type-I Photoinitiators 
Type-I photoinitiation involves the photoinduced cleavage of initiators to produce 
free radical reaction products, which then propagate crosslinking of monomers in 
solution. While these polymerizations are complex reactive processes, a typical 
mechanism can be written for type-I photopolymerization as shown in Scheme 3.1. 
During the initial phase of the polymerization, the reaction rate and double bond 
conversion increase as radicals are generated at a rate such that reaction dominates the 
process and monomer crosslinking propagates. Once the gel point is reached, diffusion 
begins to control the process as radical mobility is decreased leading to termination of 
radicals as nearby monomer ends react. These photocleavage type initiators are 
commonly employed in dental resins and simple tissue engineering scaffolds, where rapid 
gelation and homogenous crosslinking is desired [2]. Widely employed type-I 
photoinitiators for polymerization include the acetophenone and hydroxyalkylphenones 
chemical families, mostly sensitized with irradiation light below 400 nm [70]. One 
particular concern for hydrogel cell encapsulation is water solubility and cell cytotoxicity. 
Because these compounds are mostly comprised of alkyl groups and aromatic rings, they 
typically display limited water solubility making implementation in cellular systems 
difficult. Of type-I photoinitiators, lithium acylphosphinate (LAP), 2-hydroxy-1-[4-
(hydroxyethoxy)phenyl]-2-methyl-1-propanone (Irgacure 2959), 2,2-dimethoxy-2-
phenylacetophenone (Irgacure 651), and 1-hydroxycyclohexyl-1-phenyl ketone (Irgacure 
184) have commonly been employed for hydrogel formation [81, 83]. Williams et al. 
formed cell-laden hydrogel systems with the listed Irgacure compounds in a comparative 
toxicity study and showed that all were generally significantly cytotoxic, with Irgacure 
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2959 showing moderate cell compatibility for a limited number of cell lines [84]. Another 
practical concern is that these compounds are generally unable to achieve regeneration 
after cleavage and must be used at relatively high concentrations, hindering their 
application to coating individual cell surfaces by interfacial polymerization. 
3.5.2 Type-II Photoinitiators 
In type-II polymerization, often referred to as dye photosensitizer systems, 
photosensitive compounds absorb irradiation light energy, enter an excited state and 
abstract a hydrogen molecule from a nearby donor coinitiator which then initiates 
crosslinking of monomer acrylic groups. Scheme 3.2 shows a typical reaction mechanism 
for this process: 
While this system requires a more complex two-component initiation step, the 
propagation and termination steps occur similarly as to type-I systems. Common type-II 
photoinitiators include benzophenone, camphorquinone, xanthene derivatives, and 
thioxanthones [70, 85, 86]. For cell encapsulation, hydrogen donor coinitiators have 
typically been tertiary amines. Several xanthene derivatives absorb in visible range, 
affording the use of more cell compatibility lamp outputs than the typical UV range 
lamps [83]. Of these, eosin Y and fluorescein have been commonly investigated as type-
II initiators and absorb around 450-550 nm [87]. The eosin system in particular shows 
sufficiently fast gelation and excellent cytocompatibility for cell encapsulation utilized in 
tandem with tertiary amine coinitiators [80]. 
3.5.3 Eosin Y Photoinitiation System 
As this dissertation utilizes primarily eosin Y as a type-II photoinitiator, this 
section will expound on the previous work with this specific system. Eosin Y has been 
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used with a tertiary amine coinitiator triethanolamine (TEA) to form crosslinked hydrogel 
networks in aqueous media [88-90]. In our studies, an isothiocyanate group is coupled to 
eosin to form eosin-5-isothiocyanate (EITC), which negligibly affects the absorbance 
properties. A plot of extinction coefficient dependency on wavelength for EITC is shown 
in Figure 3.1. In eosin/TEA systems, eosin is irradiated by visible green light typically in 
the range of 500-550 nm, corresponding to the shown range of absorptivity. Eosin 
molecules are excited to a triplet state, which is quenched by the tertiary amine TEA 
which acts as a hydrogen donor. Proton transfer occurs, which yields a protonated eosin 
radical and a neutral α-aminoalkyl radical. This amine radical then acts to initiate 
polymerization of nearby carbon double bonds [87, 91]. 
Encinas et al. has demonstrated the rate of eosin/TEA system in the 
polymerization of acrylamide in water is largely unaffected by pH changes in the range of 
3 to 10 [87]. Further, this work showed the efficiency of photoinitiation at 20mM TEA of 
approximately 45-55% of triplets quenched to form active amine radicals, which is well 
correlated with trends in the initial polymerization rates of other xanthene dyes. Avens et 
al. presented evidence of a cyclic photoinitiator regeneration mechanism that enables 
eosin to overcome high concentrations of polymerization inhibitors in the reaction 
environment, whereas the cleavage-type photoinitiator Irgacure-2959 was completely 
inhibited in this setting [86]. These data suggested many dye photosensitizer systems 
benefit from cyclic regeneration to achieve overall improved polymerization efficiency. 
Kizilel et al. demonstrated the eosin/TEA system in surface-mediated polymerization, 
where eosin molecules where covalently functionalized on glass substrates, and surface 
grafted thin films of PEG-diacrylate were analyzed both chemically and visually by 
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microscopy [85]. Here, as commonly employed with similar systems, 1-vinyl-2-
pyrrolidinone is included in the monomer formulation as a polymerization accelerator. 
The performance and significant parameters of the surface-mediated eosin system was 
also investigated by Avens et al. for both PEG-diacrylate and acrylamide formulations 
[92]. At eosin functionalization densities greater than 200 molecules/μm2, the acrylamide 
system generated films >600 μm and the PEG-diacrylate system generated films of 
approximately 150 μm. It should be noted that acrylamides have shown to be highly toxic 
in cell environments whereas PEG-diacrylate is generally non-toxic. This work also 
showed the phenomenon of a lower photoinitiator surface density threshold for this 
interfacial system, below which radical generation was no sufficient to crosslink any 
detectable film.  
3.6 Surface-Mediated vs. Bulk Polymerized Hydrogels 
Differences arise between bulk and surface-mediated polymerization settings in 
both design considerations and the eventual hydrogel structure. A bulk crosslinked 
system refers to polymerizations in which photoinitiator is dissolved and distributed 
indiscriminately throughout the precursor solution, and upon irradiation the 
polymerization reaction proceeds uniformly throughout the gelling material irrespective 
of location. In surface-mediated or interfacial polymerization, photoinitiator molecules 
are adsorbed to a surface or interface, and remain localized at this surface throughout the 
reaction. Type-II photosensitizers are often employed in applications for surface-
mediated hydrogel systems and can leverage cyclic regeneration and achieve appreciable 
polymerization efficiencies, whereas cleavage-type compounds can only generate an 
amount of radicals on the same order as the initially adsorbed surface density of 
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molecules. Competing diffusive-reactive phenomena play a large role in the overall 
polymerization performance of surface-mediated systems, as coinitiator molecules in the 
immediate vicinity of the photoreactive surface are radicalized [93]. These free radicals 
are able to diffuse away from the reactive surface, so radical generation must be 
sufficient to overcome diffusion of radicals to reach the gel point for a continuously 
interlinked polymer network to form. While bulk crosslinked systems typically display 
homogenous crosslinking density, this phenomenon in surface-mediated systems leads to 
a gradient, with crosslinking density decreasing at increasing distance from the reactive 
surface as shown in Figure 3.2. As the gel point is first reached near the photoinitiator-
primed surface, radical mobility falls significantly and leads to overall decreasing free 
radical concentration a further outward distances, leading to the gradient in crosslinking 
density. This is an important consideration in hydrogel structure design, particularly in 
applications where permeability is a critical parameter as the hydrogel mesh size cannot 
be assumed to be constant through the entire material. 
3.7 Polymer-Based Amplification 
 The work in this dissertation leverages the efficiency of the eosin 
photopolymerization system to generate polymer thin films specifically at sites of protein 
recognition by adapting the recently described technology of polymer-based 
amplification (PBA), as shown in Figure 3.3 [94]. PBA was developed as an inexpensive 
diagnostic platform to generate an easily detectable signal prompted by recognition of 
biomolecules at extremely low concentrations on printed microarrays. Other signal 
amplification approaches such as tyramide-signal amplification are highly sensitive to 
variations in enzyme activity and preparation conditions that often lead to inconsistent 
26 
results and high nonspecific signal. In contrast, PBA has shown to generate predictable 
signal responses with high signal-to-noise [95]. Specific antibodies or anti-sequence 
oligonucleotides are contacted with microarrays printed with analyte solution. 
Photoinitiators, typically eosin or fluorescein, are covalently labeled directly on these 
molecules or on secondary biorecognition molecules that bind to analyte. 
Photopolymerization is then initiated in the presence of acrylic monomer and tertiary 
amine coinitiator to generate a crosslinked polymer response at sites of analyte 
presentation. PBA has been shown to generate polymer films in response to as low as 
zeptomolar analyte concentrations in seconds to minutes [96]. Applications have been 
developed that utilize initiating visible range light from broad spectrum mercury lamps, 
collimated LEDs, and lasers. Monomer formulations studied for use in PBA include 
acrylamide/bisacrylamide and polyethylene glycol diacrylate, both including 1-vinyl-2-
pyrrolidinone as an accelerator [92]. Because this reaction has been shown to be inhibited 
by oxygen, printed chips or slides are typically purged with inert gas (nitrogen or argon) 
during photopolymerization to remove oxygen from the reacting system. For 
visualization of analyte recognition, polymer films are either colorimetrically stained 
post-polymerization or loaded fluorescent imaging nanoparticles that are physically 
entangled in the film crosslinking during initial photopolymerization. Notably, the signal 
intensity of loaded fluorescent nanoparticles has been shown to trend linearly with film 
thickness in PBA applications [97].  
 PBA has been adapted as a diagnostic platform to detect several types of analytes. 
Hansen et al. (2007) showed a PEG diacrylate film response to detect a short 
oligonucleotide sequences [98]. Hansen et al. (2009) then progressed DNA detection with 
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the specific detection of KRAS sequence variants [99]. Antibody based detection has also 
been investigated, where biotin-α-goat IgG is printed on glass array chips [95]. Eosin-
labeled streptavidin then bonds to sites of biotin functionalization and initiates 
fluorescent PBA with visible light and monomer. Here, fluorescent PBA is shown to 
achieve 100-fold greater signal-to-noise than samples stained with traditional fluorescent 
probe approaches. Fluorescent PBA has also been previously demonstrated for enhanced 
histochemical staining on fixed mammalian cells [100]. Nuclear pore complex, vimentin, 
and von-Willebrand factor proteins are targeted with primary antibodies in permeabilized 
lung fibroblasts, which direct streptavidin-eosin binding and fluorescent PEG-diacrylate 
film formation. PBA is shown to provide enhanced signal-to-noise immunostaining 
compared to parallel stained samples with streptavidin-FITC and tyramide signal 
amplification approaches.  
3.8 Conclusions 
Hydrogels offer a cell compatible material for covalent microencapsulation. By 
dispersing cells in a monomer precursor solution, hydrogel can be formed by 
photopolymerization in situ around individual cells. Further, by tuning the molecular 
weight of monomeric units and crosslinking conditions, hydrogel materials can be 
engineered to act as size selective, semi-permeable membranes that occlude large 
biomolecules while allowing free passage of small compounds. Lastly, eosin-mediated 
polymer-based amplification provides an efficient and convenient approach to forming 
nanothin films specifically at sites of surface protein expression. 
  
28 
I    2R• 
 R• + M    M• 
 Mn• + M    Mn+1• 
 Mn• + Mm•    P 
Scheme 3.1: General mechanism for Type-1 (photocleavage) polymerization. Adapted 
from Ifkovits & Burdick, 2007 [2]. 
 
I    I* 
 I* + R    I+• + R• 
 R• + M    M• 
 Mn• + M    Mn+1• 
Mn• + Mm•    P 
Scheme 3.2: General mechanism for Type-II photopolymerization. 
29 
 
Figure 3.1: Plot of extinction coefficient dependency on wavelength of eosin 
isothiocyanate in water. Calculated from UV-Vis absorbance spectra. 
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Figure 3.2: Comparison of crosslinking density and mesh size for bulk and surface-
mediated polymerization schemes. 
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Figure 3.3: General schematic of fluorescent polymer-based amplification. 
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Chapter 4: Characterization of Molecular Transport in Ultrathin Hydrogel 
Coatings on Cellular Substrates for Engineered Selective Permeability 
This work studies a surface-initiated, nanoscale hydrogel coating on mammalian 
cells for tunable, size-selective permeability. Coatings composed of PEG diacrylate of 
molecular weight 575 Da and 3500 Da were studied by tracking the transport of 
fluorescently-labeled dextrans across the coatings. The molecular weight of dextran at 
which the transport is blocked by these coatings are consistent with cutoff values in 
analogous bulk PEG materials. Additionally, the diffusion constants of 4 kDa dextrans 
across PEG 575 coatings was lower than across PEG 3500 coatings and these trends and 
magnitudes agree with bulk scale models. Further, this study supports the adaptability of 
this coating strategy for a lysis-based isolation methodology, where antigen presenting 
cells are coated with ultra-thin films which impart protection during exposure to SDS 
micelles. The data suggest these hydrogel coatings will be fundamentally capable of 
excluding SDS micelles that are several orders of magnitude larger than the dextran 
molecules shown to be excluded. The chapter presented here is adapted with minor 
modifications from work previously published: 
Jacob L. Lilly, Gabriela Romero, Wejie Xu, Hainsworth Y. Shin, Brad J. Berron. 
Characterization of Molecular Transport in Ultrathin Hydrogel Coatings for 
Cellular Immunoprotection. Biomacromolecules. 27;16(2):541-9, 2015. 
4.1 Introduction 
Synthetic hydrogels have long been studied for the protection of biological 
species [53, 66]. Hydrogel architectures have been designed for use in applications 
ranging from drug delivery particles and scaffolds to large tissue grafts for implantation 
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[101-103]. For cell replacement therapies, exogenous cells have been encapsulated in 
hydrogels to physically prevent the host’s antibodies from recognizing the foreign cells 
while allowing the free transport of water and nutrients throughout the porous mesh [50, 
70]. This strikes a careful balance between the transport of the unwanted high molecular 
weight materials and the beneficial low molecular weight materials. The size selectivity 
of the hydrogel is a property of the polymer mesh structure, where large molecular 
weight materials do not penetrate appreciably into the hydrogel.  
We seek to encapsulate mammalian cells in suspension by the 
photopolymerization of ultra-thin hydrogel films for designed semi-permeable barriers to 
prevent large molecules from reaching the encapsulated cell surface. Our approach is 
based on surface-mediated polymerization of nanoscale films (Figure 4.1), where 
photoinitiator is grafted to the outside of a cell in extremely low concentrations [95]. In 
these conditions, the photoinitiator content is reaction limiting, and the subsequent 
growth of polymer is restricted to a thin film at the cell surface [104]. Upon introduction 
of a monomer precursor solution containing triethanolamine (coinitiator), the initiator-
primed cells are exposed to green light, and a free-radical, interfacial polymerization 
process results [85]. We expect this technique will be capable of completely coating cells 
for size selective control of materials to the cell surface. Prior calculations on 100 µm and 
1 mm thick analogues of these materials describe a mesh size of 2-5 nm which prohibits 
IgG diffusion, yet readily permits diffusion of low MW materials [60, 105]. Critically, 
the diffusion properties of these ultra-thin films on cells have yet to be measured. 
This chapter directly studies the chemical, physical, and transport properties of 
nanoscale hydrogel films on a cellular surface. For experimental simplicity, we examined 
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coatings on the surface of Jurkat cells, an immortalized, robust, and easily cultured T 
lymphoma cancer cell line. The chemistry of the coatings was directly analyzed with 
Raman microscopy showing shifts consistent with the localization of PEG coatings on the 
cell’s surface. The coatings were imaged by scanning electron microscopy, supporting a 
surface morphology distinct from native cells and consistent with control samples of 
surface-initiated polymer thin films.  
While structure and chemical characterizations provide valuable insight to the 
film properties, the most definitive measure of an encapsulation technique is the 
capability to exclude large biomolecules from penetrating the coating while allowing the 
free transport of low molecular weight nutrients to retain high viability. Extrapolation of 
transport properties of a bulk hydrogel to thin film geometries is commonplace, yet 
fundamentally assumes identical and uniform cross-linking in the film [60]. For the 
surface-mediated, free radical polymerizations employed here, a gradient of double bond 
conversion arises during the photoreaction yielding a film with non-uniform 
microstructure [93]. To this end, we measured these transport properties directly on a 
coated cellular substrate for measurement of film properties directly on biological 
supports without any extrapolation of bulk transport properties. Our findings support the 
current practice of extrapolating bulk hydrogel transport properties to nanoscale coatings, 
where minimal differences were observed between our diffusion constants and those of 
the analogous bulk materials. These findings support the potential use of ultra-thin 
coatings, such as those presented here, for tunable, size-selective membranes effectively 
halting transport of large molecular weight materials above the critical values observed in 
bulk hydrogel systems.  
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4.2. Materials and Methods 
4.2.1 Materials 
A Jurkat cell line (clone E6.1) was purchased from ATCC. RPMI-1640 with L-
glutamine and Dulbecco’s Modified Eagle’s Medium were both purchased from Corning 
Cellgro, and supplemented with fetal bovine serum (Gibco) and Streptomycin/Penicillin 
solution (Thermo Scientific). Deionized and ultra-filtered water was purchased from 
Fisher Scientific. Eosin-5-isothiocyanate, poly(ethylene glycol) diacrylate (Mn=575), 1-
vinyl-2-pyrrolidinone, poly-L-lysine (PLL), bovine serum albumin, HEPES-KOH buffer 
solution, potassium acetate, magnesium acetate, and fluorescein isothiocyanate-dextran 
(FD) with MW of 4, 10, and 20kDa were purchased from Sigma-Aldrich. Poly(ethylene 
glycol) diacrylate was passed over a MEHQ removal column twice prior to use. 
Phosphate buffered saline 10X solution, nile red carboxyl-terminated 20 nm Fluosphere 
nanoparticles (NPs), and calcein AM were purchased from Life Technologies. 
Biotinylated monoclonal mouse IgG anti-human CD45 was from BD Pharminogen, 
monoclonal mouse IgG anti-human nuclear pore complex was from Covance, 
biotinylated goat IgG anti-mouse IgG was purchased from Vector Labs. Lyophilized 
streptavidin, biotinylated bovine serum albumin and 4',6-diamidino-2-phenylindole 
(DAPI) were purchased from Thermo Scientific. Poly(ethylene glycol) diacrylate (Mn = 
3500) was purchased from Jenkem Technology. Triethanolamine and Triton X-100 were 
purchased from Acros. Paraformaldehyde (16%, EM grade) was purchased from Electron 
Microscopy Sciences. Sucrose was obtained from MP Biomedical. Calcein/ethidium 
homodimer-1 Cytotoxicity kit was purchased from Life Technologies. 
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4.2.2 Preparation of Polymer Encapsulated Cells in Suspension 
The T lymphoma Jurkat cell lineage was cultured in RPMI-1640 supplemented 
with 10% fetal bovine serum (FBS) and 1% streptomycin/penicillin at 37 °C and 5% 
CO2. The cell culture was maintained at approximately 0.5-1x10
6 cells/ml. A sample of 
1.5 x 106 Jurkats was washed once with phosphate buffered saline (PBS) supplemented 
with 3% FBS (PBS/FBS). Between each rinsing step, the cells were pelleted by 
centrifugation at 300xg and 4°C for 5 minutes. The pellet was resuspended in 20 μL 
biotinylated mouse anti-human CD45 in 100 μL PBS/FBS per 106 cells, gently vortexed 
and incubated at 4°C for 40 minutes. Then, the pellet was resuspended in 25 μg/mL 
streptavidin-eosin isothiocyanate (SA-EITC) in PBS/FBS, gently vortexed and incubated 
for 30 minutes at 4°C. The SA-EITC was synthesized and purified according to a 
previously reported protocol [98]. After incubation and rinsing with PBS/FBS, the cells 
were dispersed in 300 μL of a monomer precursor solution consisting of 420 mM 
poly(ethylene glycol) diacrylate (Mn = 575) (PEGDA 575), 21 mM triethanolamine 
(TEA), 35 mM 1-vinyl-2-pyrrolidinone (VP) in PBS. In fluorescent imaging studies, 0.05 
wt % nile red 20 nanometer fluorescent NPs were also included in the precursor solution. 
Just before introduction to cells, the monomer solution was bubbled with ultra-pure N2 
for approximately 5 minutes to remove oxygen (polymerization inhibitor). The 
monomer/cell solution was gently vortexed and then pipetted onto a standard microscope 
slide in a Chip-clip chamber well (Whatman). The Chip-clip was then placed in a clear 
plastic bag and purged with ultra-pure N2 for 5 minutes. Then, a photopolymerization 
reaction was initiated with an LED lamp emitting collimated 530 nm light, adjusted to an 
intensity of 30 mW/cm2 for 10 minutes. (See Appendix A-1 for example of general 
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photopolymerization setup) The Chip-clip was then removed from the purged bag and the 
cells were removed from the slide with a shearing stream of PBS and washed two times 
to remove any unreacted monomer solution species and free nanoparticles.  
4.2.3 Raman Microscopy Analysis 
To probe the surface chemistry of coated cells, first a PEGDA coated Jurkat cell 
sample was prepared as described, except that Jurkats were fixed in 1% 
paraformaldehyde for 10 minutes and rinsed three times in PBS, and then incubated in 
PBS + 3% FBS for 30 minutes before primary antibody incubation. After rinsing the 
coated cells, the supernatant was removed and the cell pellet was pipetted onto a clean 
microscope slide and allowed to dry for 2 h. For a native cell control, 106 cells were 
centrifuged and rinsed once with cold PBS and then fixed in 1% paraformaldehyde for 10 
minutes. The cells were then rinsed 3 times in cold PBS. After the final rinse, the 
supernatant was removed and the pellet was gently pipetted onto a clean microscope 
slide. A bulk polymer control was prepared by first reacting 25 μg/mL SA-EITC in PBS 
on an epoxy-functionalized slide inserted in to a Chip-Clip for 1 hour. After rinsing, 300 
μL of monomer solution was pipetted into the Chip-Clip well. The Chip-Clip slide was 
purged and irradiated with an LED lamp for 10 minutes, emitting 530 nm light at an 
intensity of 30 mW/cm2. The slide was then washed with deionized water and allowed to 
dry overnight. The samples were analyzed using a Thermo Scientific DXR Raman 
microscope. The 532 nm laser and 100X objective were used for all spectral 
measurements. The pinhole aperture was set to 25 μm, corresponding to a focal spot of 
approximately 1 μm diameter. Spectra were recorded between 300 and 3600 cm-1 at a 5 
cm-1 spectral resolution. The system was calibrated to the spectral line of crystalline 
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silicon at 520.7 cm-1. For a spectral measurement, the microscope was focused on the 
surface of a sample and at least 8 scans at each spot were used to reduce the spectral 
noise.  
4.2.4 Scanning Electron Microscopy 
For SEM analyses, a control Jurkat sample was fixed in 1% paraformaldehyde for 
10 minutes, rinsed twice in PBS, and placed on a PLL coated microscopy slide for 
electrostatic attachment. A coated sample was prepared with paraformaldehyde fixed 
cells, as before. Samples were dried overnight before analysis. The sample slides were 
then coated in gold/platinum by standard techniques and micrographs were taken with a 
Hitachi S-4300 scanning electron microscope (Hitachi, Japan). The working distance was 
set at 15 mm with an accelerating voltage of 5.0 kV. 
4.2.5 Viability Assays  
Cellular viability was measured by a calcein assay. Cells were rinsed once with 
PBS, then the cell pellet was resuspended in cold PBS 1X with 50 nM calcein AM and 
incubated at room temperature protected from light for 15 minutes. After incubation, the 
cells were loaded into a BD Accuri C6 flow cytometer (Becton Dickinson), and run was 
performed at a medium fluidics rate to a total event count of 100,000.  
4.2.6 Surface-Initiated Polymer Microarrays 
Epoxy-functionalized microscopy slides 25 x 75 mm (CEL-1) were rinsed once 
with ethanol and dried with ultra-pure N2. Serial dilutions of biotinylated bovine serum 
albumin (bBSA) from 0.11 to 1000 μg/mL were prepared in PBS plus one negative 
control with 0 mg/mL bBSA (12 solutions total). bBSA solutions were then loaded into a 
96 well plate and printed on the epoxy slides with an Affymetrix 417 Arrayer and 
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allowed to dry overnight. Two replicate spots were printed for each biotin concentration 
in an array, as shown in Appendix A-4. A biotin-functionalized slide was loaded into a 
Whatman Chip-Clip, rinsed once with PBS supplemented with 0.1% BSA (PBSA) for 2 
minutes, and then incubated with PBSA for 1 hr. After blocking, a 25 μg/mL SA-EITC 
solution in PBSA was incubated in the array well for 30 minutes. The slide was then 
rinsed once with PBSA for 2 minutes, then twice with PBS for 2 minutes each. For this 
study, three polymerization conditions were investigated that mimicked live cell 
encapsulation (Condition 1) and conditions used to coat fibroblast nuclei (Conditions 2 & 
3). For live cell encapsulation, the monomer solution (1) consisted of: 420 mM PEGDA 
575, 21 mM TEA, 35 mM VP, 0.05 wt% nile red NPs in PBS. For PEGDA-575 thin 
films around nuclei (2), the monomer solution was: 420 mM PEGDA 575, 210 mM TEA, 
35 mM VP, 0.05 wt% nile red NPs in deionized water. For PEGDA 3500 thin films (3): 
25 wt% PEGDA-3500, 210 mM TEA, 35 mM VP, 0.05 wt% nile red NPs in deionized 
water. Before polymerization, the solution was bubbled for 5 mins with ultra-pure N2. 
After rinsing a slide, 300 μL of the corresponding monomer solution was pipetted into 
the Chip-Clip array well, and placed in a clear plastic bag and purged with N2 for 5 
minutes. The photoinitiation conditions were as follows: (1) 530 nm, 30 mW/cm2, 10 
minutes; (2) 530 nm, 10.5 mW/cm2, 20 minutes; (3) 530 nm, 10.5 mW/cm2, 20 minutes. 
After photopolymerization, the slides were rinsed twice with deionized water before 
imaging. After drying overnight, profilometry measurements were performed on each 
array set with a Dektak 6M profilometer to prevent scratching of the film, scan settings 
were maintained at 4200 micron for 120 s, with a stylus force of 1 mg.  
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4.2.7 Preparation of Encapsulated Subcellular Species by Polymer-Based 
Amplification 
Human dermal fibroblasts were cultured to ~80% confluency in DMEM 
supplemented with 10% FBS and 1% penicillin/streptomycin at 37 °C and 5% CO2. Cells 
were trypsinized, centrifuged, and seeded onto 35 mm cover glass-bottom culture dishes 
(Mat-tek) in media. For encapsulation of nuclei, a recently published protocol was 
adapted [104]. Cell dishes were washed twice with cold PBS, and then fixed with 1% 
paraformaldehyde in PBS for 10 minutes. Cells were then washed 3 more times with cold 
PBS. The fixed cells were then permeabilized with 0.01% Triton X-100 in PBS for 7 
minutes, and washed 3 times with PBS. A blocking solution consisting of 2 mL of PBSA 
with 2% FBS was pipetted into the dishes and incubated for 30 minutes at 4°C. Cells 
were then immersed in a primary antibody solution of 1:1000 monoclonal mouse IgG 
anti-human NPC in PBSA for 40 minutes at 4°C, followed by a secondary antibody 
incubation of 1:400 biotinylated goat IgG anti-mouse IgG in PBSA for 40 minutes at 
4°C. Cells were rinsed 3 times with PBSA, and then incubated with SA-EITC (25 μg/mL) 
in PBSA for 30 min at 4°C. The cells were then washed 2 times with PBS and once with 
deionized water. Two monomer solutions were prepared for polymer films of PEGDA-
575 (420 mM PEGDA-575, 210 mM TEA, 35 mM VP, 0.05 wt% nile red NPs in 
deionized water) and PEGDA-3500 (25 wt% PEGDA-3500, 210 mM TEA, 35 mM VP, 
0.05 wt% nile red NPs in deionized water). For each monomer molecular weight, 915 μL 
of monomer solution was pipetted into a petri dish, and placed in a nitrogen-purged bag 
as before. An LED lamp emitting green light (530 nm, 10.5 mW/cm2) was placed over 
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the dish and the reaction was allowed to proceed for 20 minutes. The dishes were then 
washed 3 times with deionized water.  
4.2.8 Time-Dependent Confocal Microscopy Analysis of Diffusion 
To probe macromolecular permeation through films formed by polymer-based 
amplification, varying sizes of FITC-labeled dextrans (FD) (4kDa, 10kDa, 20kDa) were 
prepared in transport buffer adapted from Mohr et al, consisting of 20mM HEPES-KOH 
pH 7.4, 120 mM potassium acetate, 5mM magnesium acetate, and 250mM sucrose [106]. 
Solutions of 10 kDa and 20 kDa FD were prepared at 15 μM, however, the 4 kDa FD 
required a higher concentration of 45 μM for quantifiable fluorescence signal. Human 
dermal fibroblast cell samples were washed twice with transport buffer. Diffusion 
kinetics were analyzed with a Leica AOBS/TCS SP5 confocal microscope (Leica 
Microsystems, Wetzlar, Germany) equipped with a HyD photon-counting hybrid 
detector. A 63x oil objective and an argon laser were used at 30% power. Just before a 
confocal diffusion study, transport buffer was removed from a glass bottom petri dish and 
it was loaded onto the microscope stage. The focus was adjusted and centered (z-
direction) inside a coated nucleus. An automated timed scan was initiated, with an image 
taken every 1.5 seconds. After approximately 3-4 scans, 100 μL of FD solution was 
pipetted directly onto the scanning region and the automated scanning program was 
allowed to run for at least 160 seconds. For statistical significance analysis Student’s t-
test was calculated for all samples and in all the cases the p value obtained was lower 
than 0.0001. 
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4.3. Results and Discussion 
4.3.1 Encapsulating Live Cells in Suspension by Surface Protein Recognition 
The purpose of this study was to characterize the structure and permeability of 
nanothin hydrogel coatings formed directly on cellular surfaces. These films are formed 
by interfacial polymerization by binding the type-II photoinitiator eosin to surface marker 
sites that enables excellent spatial control of polymer formation and ultra-thin coatings to 
control molecular transport. (See Appendix A-5 for more details on protein specificity of 
polymer formation) Photoinitiated systems are convenient for cell encapsulation, owing 
to the delivery of uniform initiation energy to the system, rapid gelation, excellent 
viability, and the ease of scale-up to large cell populations [70, 107, 108]. For our 
suspension study we chose the T lymphoma Jurkat cell line because it is a robust 
immortalized lineage with a high growth rate and abundant expression of CD45, an 
antigen that is well understood and commonly targeted. The experimentally optimized 
conditions of 21 mM TEA, a 10 minute reaction time, and an initiation light intensity of 
30 mW/cm2 was used to encapsulate Jurkats with a crosslinked PEGDA film, shown in 
Figure 4.2. To monitor film formation by microscopy and flow cytometry, fluorescent 
NPs (nile red, 20nm, Fluospheres) were also introduced in the monomer mixture, and 
have been shown to be physically entangled in the surface-initiated films in a similar 
system [97]. High cell viability was preserved near 90% approximately 1 hour after 
encapsulation, as measured by a flow cytometric calcein assay (Figure 4.3). Further, 
cytometry experiments of coated cells showing low ethidium homodimer-1 fluorescence 
compared to dead controls also suggest high viability of Jurkats through the coating 
process. While longer time points are critical to the ultimate application of cell 
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transplantation, this level of initial viability is consistent with that of similar eosin 
photoinitiated PEGDA encapsulation systems with high long term cell viability [76, 80, 
90]. 
4.3.2 Characterizing Film Surface Chemistry and Morphology 
We used Raman microscopy to characterize the surface chemistry of the hydrogel 
coating. Spectra were collected at the surface of an uncoated Jurkat, the surface of a 
coated Jurkat, and at the surface of bulk cross-linked PEGDA-575 film (Figure 4.4). The 
three spectra revealed the different chemical nature at the surface of each sample. We 
expect the coated cells Raman spectrum to be the result of the superposition of both, 
native cells and polymer film spectra. The coated Jurkat spectrum shows a peak at 2850 
cm-1 associated with the symmetric stretching of CH2 groups from the lipid-rich cellular 
organelles (lipid bodies) present in native Jurkats, but also displays signals from bulk 
PEGDA at 2880 cm-1 and 2950 cm-1 corresponding to CH2 and CH3 vibrations, 
respectively [109]. The presence of peaks associated with both the native cell and the 
bulk polymer control in the polymer coated cell spectra further supports the presence of a 
PEG-diacrylate coating observed at the cell surface by fluorescent labeling (Figure 4.1 
and Figure 4.2). 
 Scanning electron microscopy was also used to analyze the surface morphology 
of a polymer coated cell. A scanning electron micrograph of a paraformaldehyde-fixed 
native Jurkat exhibits a smooth, flattened morphology (Figure 4.5.a), while a PEGDA-
encapsulated, fixed Jurkat cell (Figure 4.5.b) possesses a similar size as the uncoated cell 
with a rough surface. The similarity in size between the coated and uncoated cells 
supports our hypothesis that thin films on the order of nanometers thick and do not 
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appear to alter the resulting coated cell size. The surface texture of coated cells is also 
different from that of an uncoated cell and appears to have a rough yet consistent 
topology. A magnified view of the coated cell surface (Figure 4.5.c) indicates a surface 
texture similar to that of a surface-initiated PEG-diacrylate film (Figure 4.5.d). While 
some variation in coating thickness is expected in surface mediated polymerization on the 
order of tens of nanometers, the surface features in Figure 4.5.c are more consistent with 
the underlying membrane folds common to Jurkats and other leukocytes [110]. Critically, 
SEM observation clearly supports that coatings are uniform and complete across the 
cell’s surface, without observable gaps or apparent changes in thickness. Further, the 
covalent PEG crosslinking that forms these films is highly stable and to limit any 
opportunity for cells to shed the films in the transplantation environment [111]. 
4.3.3 Estimation of Film Thickness 
The overall goal of this work is to determine the size-dependent transport 
properties of nanoscale hydrogels, and to relate them to the established bulk hydrogel 
transport properties. For accurate scaling of nanoscale barrier films to bulk materials, it is 
essential to attain an estimate of the coating thickness. The estimation of coating 
thickness is particularly challenging at thicknesses below direct optical observation. 
Measurement of coating thicknesses less than ~300 nm is typically accomplished by 
ellipsometry, atomic force microscopy, profilometry, or electron microscopy. When 
dealing with a poorly reproducible and non-uniform biological surfaces, it is difficult to 
obtain accurate baseline data for thickness measurement by ellipsometry, atomic force 
microscopy, and profilometry. Further, the solvent-dependent nature of hydrogel 
thickness makes any measurement in a TEM embedding medium impossible to correlate 
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without further understanding the solvent’s influence on the hydrogel thickness. As a 
result, we estimated the thickness based on the fluorescent intensity of the polymer film 
on a biological substrate by correlation to the fluorescent intensity of an easily measured 
polymer film grown on a smooth glass substrate.  
Biotinylated bovine serum albumin (bBSA) microarrays were prepared with 
biotin concentrations between 0 and 1000 μg/ml bBSA, where these surfaces were meant 
to replicate the chemical environment of the biotin-functionalized surface after a cell 
surface is labeled with biotinylated antibodies. These surfaces were treated with 
photopolymerization conditions that were identical to cellular coating procedures. As 
expected, polymer thickness increased with printed bBSA concentration, as more eosin 
molecules were bound to the array surface which increased radical formation during 
photoinitiation (Figure 4.6). From image analysis, it was determined that each a.u. of 
fluorescence intensity corresponded to 4.0 nm of thickness for the fluorescent 
nanoparticle loaded PEGDA-575 hydrogel coatings (Table 4.1). The slope is comparable 
for the PEGDA-3500 coatings (6.1 nm/a.u.), which suggests that the monomer size does 
not have a significant impact on fluorescence per polymer volume, and that the PEGDA-
3500 films displayed reduced fluorescence simply because of lower polymer thickness. 
Using this correlation, the fluorescent signal from nanoparticle-loaded coatings on cell 
structures can be measured to then calculate a film thickness estimate. To obtain a 
thickness estimate for the coatings used later to study transport kinetics, the fluorescent 
signal from nanoparticle-loaded PEGDA-575 and PEGDA-3500 films encapsulating 
dermal fibroblast nuclei was measured by epifluorescent microscopy similarly to the 
microarray samples described above. To account for the signal contribution from the 
46 
upper and lower layers of the spherical nuclei, the signal was divided by two to get a 
representative estimate for the film coating. The thickness of PEGDA-575 and PEGDA-
3500 coatings was then estimated to be 158±16 nm 200±42, respectively (Table 4.1). 
These estimates agree well with previous work with eosin-mediated growth of PEGDA 
thin films and are used later for mass transfer modeling of the films in this work [92, 95]. 
4.3.4 Assessing Permeation Across Hydrogel Thin Films 
To assess the transport kinetics of nanoscale hydrogel coatings on cellular 
substrates, we use time dependent confocal microscopy to measure the transport of 
fluorescently-labeled macromolecules across hydrogel membranes. There are several 
advantages for studying diffusion through hydrogel coatings on adherent nuclei instead of 
an encapsulated whole-cell in suspension. First, using nuclei offer a substrate that is 
surface-anchored by cellular scaffolding without any further need for attachment factors 
that could potentially alter cellular geometry or bias the import kinetics. Nuclei are also 
much more rigidly spherical than other cellular species, including blood cells, that tend to 
flatten when attached to a surface, which allows for more accuracy when collecting 
confocal fluorescence data inside of the nucleus. Finally, the nuclear envelope can be 
extensively permeabilized (with Triton X-100) without complete loss of structure unlike 
most cell membranes, providing a scaffold for film coatings to be studied with minimal 
influence on diffusion kinetics.  
Numerous groups have used this time-dependent confocal microscopy technique 
to study macromolecular permeation kinetics through nuclear pores of permeabilized 
cells, yet the focus has been mechanistic and on the biological cues to passive or active 
diffusion of different molecules [106, 112, 113]. We modify this established assay by 
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first forming a PEGDA thin film coating around a nucleus of a permeabilized cell with 
techniques described here and in prior work [104], and measuring passive diffusion of 
large fluorescent biomolecules through the film by sampling the fluorescence signal (i.e. 
concentration) inside the nucleus over time. 
To establish that permeabilized fibroblast nuclei represented negligible resistance 
to mass transfer across the nuclear envelope, control samples were fixed and 
permeabilized with 0.1% Triton X-100. Solutions of fluorescein and various sizes (4, 10, 
and 20 kDa) of FD were prepared in transport buffer, and the accumulation of fluorescent 
material in nuclei was monitored by confocal microscopy (Figure 4.7). To account for 
differences in absolute fluorescence between permeants, the fluorescent signal was 
normalized by dividing the signal inside the nucleus by the signal outside the cell. For all 
of the permeants studied, diffusion was virtually immediate into the permeabilized 
control nuclei (>90% equilibrium concentration in nucleus at 3s). 
In the uncoated permeation control study with 4 kDa FD, there is a clear affinity 
of the FD for nuclear material seen in Figure 4.7.a. The higher fluorescence of the 
nucleus versus the cytoplasm and surrounding regions at long timescales acts against the 
expected concentration gradient at the nuclear membrane and is contrary to the expected 
diffusive behavior. Further, the dynamics of the increase of fluorescence inside the 
nucleus after 40 s is linear, rather than the first order decay expected in a diffusive 
process. Importantly, the rate of this affinity process is less (0.2 change in relative 
fluorescence over 160 s) than the diffusive behavior (~1.2 change in relative fluorescence 
over 3 s).  
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PEGDA (Mn 575 and 3500) coatings incorporating red NPs were grown on the 
nuclear membrane by immunochemically localizing eosin to sites of nuclear pore 
complex expression (Figure 4.7.b, 4.7.c), as described previously [97, 104]. Permeant 
solutions were prepared as in the uncoated control experiments, and Figure 6 shows a 
representative images at t=3 s and t=160 s after introduction of the fluorescent permeant 
to the slide. For the PEGDA-575 coatings, fluorescein showed an immediate increase to a 
high Fin/Fout as the relatively small molecule readily permeated the film. However, the 
largest molecules investigated of 10 kDa and 20 kDa FD both showed essentially zero 
increase in Fin/Fout during the entire ~170 s experiment, suggesting that both molecules 
were completely excluded from the diffusing through the film. This exclusion of 10 kDa 
FD indicates the PEGDA-575 coatings have a polymer mesh size smaller than 3.7 nm 
(the hydrodynamic diameter of a 10kDa dextran) [114]. The trial of 4 kDa FD diffusion 
showed a Fin/Fout signal that increased, supporting that the mesh size of the PEGDA-575 
film is larger than 1.3 nm (the hydrodynamic diameter of a 4kDa dextran). This 1.3 – 3.7 
nm mesh size is in agreement with a previous estimate of 2.0 – 5.0 nm for bulk PEGDA-
575 with the same mass fraction of monomer in water [97]. This prediction also agrees 
well with the unimpeded diffusion of the fluorescein dye observed in PEGDA-575 
coatings, a clear demonstration of molecular weight cutoff behavior in this coating. 
In diffusion trials for PEGDA-3500, we hypothesized that because the molecular 
weight between crosslinks was larger, the film would be more permissive to molecular 
diffusion. For the largest biomolecules of 10 and 20 kDa, the PEGDA-3500 film showed 
virtually no increase in Fin/Fout during the entire trial, demonstrating dextrans of 
hydrodynamic diameter of > 3.7 nm are excluded by the PEGDA-3500 coatings. The 4 
49 
kDa dextran (diameter ~1.3 nm) does permeate through the coating, indicating the 
PEGDA 3500 coatings also have a mesh size between 1.3 and 3.7 nm. This estimate 
agrees closely with the 2.2-2.7 nm mesh size reported for micron thick PEGDA-4000 
coatings studied previously by Cruise, Scharp, and Hubbell [60]. To further support the 
molecular weight cutoff behavior of these interfacial coatings, a trial of just fluorescein 
showed that the film allowed instantaneous diffusion of the small molecule.  
While the absolute cutoff behavior of the PEGDA-575 and PEGDA-3500 yields 
an identical range of mesh size, the PEGDA-3500 film permitted the diffusion of 4 kDa 
FD at a faster rate than PEGDA-575 (difference in Figure 6 slopes of over the first 10 s 
are statistically significant with p = 1.76x10-25). The faster transport across the PEGDA-
3500 coating suggests a larger mesh size when compared to a PEGDA-575 coating. This 
fundamentally agrees with bulk scale expectations, where a larger diacrylate will yield a 
larger molecular weight between crosslinks, and faster diffusion than a smaller diacrylate 
at an identical mass fraction. It is also observed that the PEGDA-575 or PEGDA-3500 
coating did not alter the apparent affinity of the 4 kDa FD for nuclear material observed 
in the uncoated control studies. At long time scales (t>90 s), there is an increase in 
fluorescence in the nucleus which appears linear and does not follow the expected rate 
decay of a diffusively driven process. 
4.3.5 Estimation of Film Diffusion Coefficients 
 While these time-resolved images provide quantitative information about the size 
exclusion properties of the films, the completeness of substrate coating, and the 
molecular weight cut off for permeants, we also sought to extend our findings to estimate 
the diffusion coefficients. Because bulk photopolymerization proceeds through 
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drastically different initiation conditions than a typical surface-initiated system, the 
crosslinking profiles generated are inherently different [115]. Further, polymer 
diffusivities are typically measured with polymer geometries that are several micrometers 
thick when hydrated, which is a much larger length scale than the thin films generated in 
this work [60, 116]. Thus, direct measurement of diffusivities of films on cellular 
substrates would result in a more representative characterization of transport in the 
cellular microenvironment. 
The diffusion constants for 4kDa FD through PEGDA coatings (D575 and D3500) 
were the only analyzed, owing to clear change in nuclear fluorescence over an 
experimentally-accessible time scale. In addition to permeation data, a coating thickness 
was estimated (Table 4.1) using the relationship between film thickness and fluorescence 
summarized in Figure 4.6. The coating thickness for the model was further expanded to 
include a lower and bound approximately 50 nm above and below the calculated 
estimates from our microarray study of film thicknesses to account for potential error in 
our coating thickness estimate. Thus, a range was defined to be 100 to 200 nm for 
PEGDA-575 film modeling and 150 to 250 nm for PEGDA-3500 film modeling. Coating 
surface area and nuclear volume were calculated from confocal scans of the nucleus prior 
to the assay. The nonlinear fluorescence increase during the first 15 s of the polymer 
coated samples with 4 kDa FD appeared to be first order, and the fluorescence change in 
this region is used to estimate passive diffusion across the polymer coatings. In all 4 kDa 
FD samples, there was a consistent linear increase in nuclear fluorescence, and this non-
diffusive behavior is attributed to an affinity of the dextran for the nuclear material. The 
contribution from 4 kDa FD nuclear affinity was estimated to be 0.03 a.u. per 15 s time 
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span. This contribution is <10% of the overall increase during the initial 15 s analyzed 
and was not included in the model. This omission potentially introduces a small error in 
the estimated diffusion constant, and future studies would benefit from identifying a low 
affinity fluorescent probe in this molecular weight range. 
Using these data, Fick’s Second law was numerically integrated, and diffusion 
constants were fit to the data for each condition. Figure 4.8 shows plots representing a 
model fit for the estimated film thickness studied for each monomer length. For the lower 
and upper bounds of thicknesses modeled for PEGDA-575 (100-200 nm), the diffusivity 
of 4kDa FD through the film was calculated as D575 = 9.5x10
-10 – 2.0x10-9 cm2/s 
Similarly, a diffusivity was fit to the Fin/Fout data for the PEGDA-3500 film at 150-
250nm, and was calculated to be D3500 = 5.9 – 9.8x10
-9 cm2/s. These findings agree with 
the expected higher diffusivity for the PEGDA-3500 film when compared to the PEGDA-
575 film, owing to a higher molecular weight between crosslinks [117]. 
Remarkably, the magnitudes of the diffusion constants for these hydrogel thin 
films on fibroblast nuclei are consistent with that of bulk materials of similar macromer 
molecular weights reported in literature. The most direct literature comparison is in 
Cuchiara et al., where 3 and 10 kDa dextrans diffuse through PEGDA-6000 at a 10% 
w/v, and the diffusivities were reported to be on the order of 10-7 and 10-9 cm2/s, 
respectively [116]. Further, our diffusion results also follow the expected trend of 
increasing diffusivity with increasing PEGDA length. Cruise et al. reported an increase in 
diffusivity as the molecular weight of the PEGDA monomer increased from 2kDa to 20 
kDa for vitamin B-12 (~1.3kDa) permeation across the PEGDA hydrogels [60]. These 
diffusivities were on the order of 10-7 and 10-8 cm2/s for the diffusion of a permeant 
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molecule considerably smaller than the 4 kDa FD studied here (Figure 4.8). This 
observed agreement in diffusivity between thin film and bulk polymer materials suggest 
that permeant diffusivity is largely decoupled from substrate encapsulation geometry. As 
such, we expect the permeability analysis performed here on adherent fibroblast nuclei to 
extend well to outer cell surfaces with minimal difference in diffusivities. 
4.4 Conclusions 
In this work we have demonstrated the encapsulation of both whole cell and sub-
cellular species by photopolymerization of PEGDA films. By SEM and Raman 
microscopy we have shown that complete and conformal films are targeted to cell 
surfaces, and the coating surface is consistent in morphology to a surface-initiated PEG 
diacrylate film. This technique is applicable to both adherent and suspended cell 
configurations. By flow cytometric calcein assays we have shown that encapsulated cells 
retain viability of ~90%. Time-dependent, photon-counting CSLM analysis demonstrates 
that large 10- and 20 kDa fluorescein-functionalized dextran molecules are completely 
excluded by films formed from both PEGDA-575 and PEGDA-3500 monomers, and 
provides a polymer mesh size estimate of 1.3 - 3.7 nm. Microarray studies suggested 
these films were 100 - 200 nm in thickness, which is consistent with previously reported 
data on glass substrates [92]. Diffusion coefficients of 4 kDa FD permeation through 
films calculated from a model of Fick’s second law were in good agreement with 
reported trends and magnitudes in bulk crosslink hydrogel materials of similar precursor 
monomer units. Notably, our results support that the technique described here can 
encapsulate cells with biocompatible hydrogel coatings that achieve similar size selective 
permeability behavior as previously studied cell encapsulation strategies, but with 
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drastically lower thicknesses and minimal synthetic material. Further, these data suggest 
that this surface initiated coating strategy will be capable of completely excluding SDS 
surfactant micelles in ASL isolation, where micelles should be larger than the polymer 
coating mesh size above the critical micellar concentration at ambient conditions [118]. 
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Table 4.1: Comparison of fluorescent signal for nanoparticle-loaded films encapsulating 
dermal fibroblast nuclei. 
Monomer 
(Mn) 
Fluorescence 
Intensity From 
Top and Bottom 
(a.u.) 
Fluorescence 
Intensity From 
Top (a.u.) 
Intensity to 
Thickness 
Conversion 
(nm/a.u.) 
Film Thickness 
Estimate (nm) 
PEGDA (575) 71.9±8.2 35.9±4.1 4.0 158±16
PEGDA (3500) 63.8±13.8 31.9±6.9 6.1 200±42
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Figure 4.1: (a) Schematic of antigen-specific coating process to form nanothin films on 
the surface of individual cells. (b) Fluorescent image of PEGDA encapsulated Jurkats by 
recognition of CD45 antibody. Red fluorescence is from nile red 20 nm fluosphere 
nanoparticles physically entangled in the polymer film. Scale bar = 20 micron. 
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Figure 4.2: (a) Fluorescent image of PEGDA-575 encapsulated Jurkat cells. Red 
fluorescence is from 20 nm nile red fluorescent nanoparticles loaded in film (0.05 wt%) 
(b) Bright field phase image of PEGDA-575 encapsulated Jurkats. Scale bar = 50 μm. 
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Figure 4.3: Flow cytometry analysis of coated cell viability by esterase activity. The live 
control represents calcein stained Jurkat cells from culture and the dead control were 
polymer coated cells incubated with 70% ethanol for 5 minutes before calcein staining. 
Image inset shows a representative micrograph of calcein AM (green) and ethidium 
homodimer-1 (red) staining of coated Jurkats. Student t-test for live control and polymer 
coated populations yielded p=0.125, and for polymer coated and dead control populations 
yielded p=6x10-8. Scale bar represents 100 μm. 
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Figure 4.4: Confocal Raman microscopy surface analysis. Spectral comparison of 
surface of native Jurkat, coated Jurkat, and bulk cross-linked PEG diacrylate (Mn 575). 
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Figure 4.5: Scanning electron microscopy analysis of uncoated and coated cell surface 
morphology. (a) Surface morphology of a native and uncoated Jurkat cell. (b) Surface 
morphology of a PEG diacrylate coated Jurkat. (c) Higher magnification of coating 
morphology. (d) Surface of an interfacial PEG diacrylate film formed on glass. 
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Figure 4.6: Plot of microarray spot thickness vs. spot fluorescence for different monomer 
molecular weights. 
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Figure 4.7: Quantification of molecular diffusion through nanoscale coatings. Image 
summary at t=3 s and t=160 s of passive macromolecular diffusion and time-dependent 
analysis of fluorescent signal from free fluorescein and FITC-Dextrans through (a) 
permeabilized dermal fibroblast nucleus controls, (b) PEGDA-575 and (c) PEGDA-3500 
coated nuclei. Fin signal was from the inner domain of nuclei and Fout was the signal of 
the FITC-dextran solution outside the cell. Error bars are shown only on every other time 
point on plotted data for clarity. 
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Figure 4.8: Analysis of diffusivity of 4 kDa FITC-labeled dextrans through nanoscale 
coatings on cellular substrates. Permeation data was fitted with a time-dependent Fickian 
diffusion model to calculate diffusion constants for lower and upper bounds of film 
thicknesses for both PEGDA-575 and PEGDA-3500 films. (a) Model fit and calculated 
diffusivity for diffusion of 4 kDa FITC-dextran though a PEGDA-575 film of an 
estimated thickness of 150 nm. (b) Model fit and calculated diffusivity of 4 kDa FITC-
dextran through a PEGDA-3500 film of an estimated thickness of 200 nm. Initial 
concentration and time parameters were adjusted to a reference point of zero for model 
curve fitting. 
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Chapter 5: Design and Development of Protective Polymer Coatings for Rapid 
High-Purity Cancer Cell Isolation 
In this chapter, we demonstrate the use of targeted, protective polymer coatings on 
cells for the rapid enrichment of cancer cells. Antigen-positive cells are coated with a 
biocompatible hydrogel which protects the cells, while uncoated cells are immediately 
lysed. The polymer coating is later removed through orthogonal photochemistry. The 
isolate yields viable cells which proliferate at rates comparable to control cells. Minority 
cell populations are enriched from erythrocyte-depleted blood to >99% purity, while the 
entire batch process requires one hour and <$2,000 in equipment. Batch scale-up is only 
contingent on irradiation area for the coating photopolymerization, as surfactant based 
lysis can be easily achieved on any scale. The information presented here is adapted with 
minor modifications from previously published work. Jacob L. Lilly worked 
collaboratively with Gabriela Romero as a primary contributor to protocol and assay 
development, experimentation, and data preparation. 
Gabriela Romero, Jacob L. Lilly, Nathan S. Abraham, Hainsworth Y. Shin, 
Vivek Balasubramaniam, Tadahide Izumi, Brad J. Berron. Protective Polymer 
Coatings for High-Throughput, High-Purity Cellular Isolation. ACS Applied 
Materials & Interfaces. Aug 7;7(32):17598-602, 2015. 
5.1 Introduction 
From the first observation of tumor cells in the peripheral blood of cancer 
patients,  researchers have sought to develop a “fluid biopsy” in which patient-derived 
peripheral blood could be analyzed for circulating tumor cells (CTCs) with the goal of 
providing diagnostic and prognostic information with a minimally invasive procedure. 
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While the observed presence of tumor cells in circulation has been correlated with 
metastatic progression [6-8, 119], the current clinical utility of fluid biopsies remains 
questionable due to a lack of reliability and versatility to detect heterogeneous cancer cell 
types [4, 12]. 
Recent evidence suggests that multiple, distinct populations can arise from a 
single tumor primary with drastically variable phenotypes [1, 15, 17]. While the 
mechanisms that give rise to these populations remains an area of intense research, it has 
been proposed that metastatic cells can be generally categorized as either: 1) primary 
epithelial tumor cells spilling into circulation through leaky vasculature and 2) primary 
tumor cells that have lost their epithelial nature and have actively migrated into the 
peripheral blood in a mesenchymal state. Once in systemic circulation, little is known 
about the biological functionality that leads to colonization of metastatic foci at distant 
sites. Practically, functional characterization of CTCs has been encumbered by the 
extreme rarity at which they seen of ~1 per 106. Further, many CTC isolation methods 
currently available require fixation and intracellular staining to determine epithelial 
identity, which prevents further examination of behavior and functionality after sorting. 
In order to fully bridge our understanding of the mechanisms that allow an epithelial 
cancer cell to survive in circulation an eventually spread the disease, viability of these 
rare cell populations must be preserved during enrichment. 
 Researchers currently have a portfolio of technologies to meet many of their cell 
sorting needs. Critically, there is a technology gap in isolating viable, rare cancer cells in 
a rapid, highly-pure manner. Magnetic sorting excels in high-speed, low cost sorting, but 
is hampered in purity by nonspecific adsorption in antigen-positive sorts [38]. 
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Fluorescence activated cellular sorting (FACS) delivers exceptional purity but at low 
throughput and high cost [120]. Microfluidic approaches are promising, but purities for 
populations adhered to antibody coated surfaces is typically low (<50%) [34], throughput 
is limited (~10 mL or 108 cells per day) [121], and recovery of isolated cells from the 
devices has proven difficult [122].  The most common approach for sorting large 
numbers of antigen positive cells at high purity is a sequential approach where cells are 
enriched with magnetic sorting, and purity is attained with FACS [41]. Even in this 
debulked case, each antigen positive cell must pass through a FACS system, and 
throughput for high purity sorts is typically ~107 cells/day, involving time-consuming 
sterilization and gate adjustment operations. The stark contrast in magnitude between 
rates achievable with FACS and the requirements of CTC isolation illustrates a critical 
obstacle in the development of a reliable fluid biopsy. 
Here, we present Antigen Specific Lysis (ASL) technique as a fundamentally new 
approach to cellular sorting (Figure 5.1). Individual, antigen-positive cells are protected 
with a biocompatible hydrogel coating. ASL utilizes an antibody covalently conjugated to 
a photoinitiator, and upon incubation of cells in this conjugate, the initiator is localized to 
only antigen positive cells. After further exposure in a macromer solution and irradiation, 
polymer coatings are specifically formed around the targeted cells. The polymer coating 
protects the cells from a surfactant solution, while uncoated cells can be immediately 
lysed. Following lysis, the polymer coating is removed through orthogonal 
photochemistry. Different cellular activity indicators were used to evaluate viability after 
each step in ASL process. The isolate has >50% viability yield, negligible apoptotic 
activity and regulated proliferation rate. ASL purity was evaluated by utilizing GFP as 
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identity marker in a GFP-positive A549 cell line, where we detect >97% purity in the 
isolate. Specificity of ASL was corroborated by sorting a particular cell population from 
cell mixtures and further from leukocyte-enriched plasma from human blood samples. 
The feasibility and adaptability of ASL technique promises unprecedented sorting rate 
and throughput. 
5.2. Materials and Methods 
5.2.1 UV Degradable Monomer Synthesis 
A poly(ethylene glycol) diacrylate macromer (Mn ~ 3500 Da) incorporating an 
ortho-nitrobenzyl functionality (Figure 5.2) was synthesized according to a published 
protocol by Kloxin et al. Structure and purity was confirmed by H-NMR [123]. 
5.2.2 PEG-diacrylate Monomer Synthesis 
A poly(ethylene glycol) diacrylate macromer was synthesized with a similar 
molecular length as UV degradable macromers. Poly(ethylene glycol) (PEG, Mn ~3350 
Da, Sigma Aldrich) was added to the bottom of an additional funnel flask at a 10 gram 
batch size and purged with ultra-pure N2 for 10 minutes. Anhydrous dichloromethane 
(DCM, 30 mL) was added to the flask, and the PEG was allowed to dissolve under 
magnetic stirring for 5 minutes. The flask was kept in a stirred room temperature water 
bath (>500 mL) to serve as a heat sink for the exothermic reaction. For acrylation of the 
PEG macromer, a molar ratio of 1:4:4 PEG:acryloyl chloride (AC, Sigma 
Aldrich):triethylamine (TEA, Acros) was used. The calculated amount of TEA was added 
directly to the bottom of the flask under continuous stirring. The calculated amount of 
AC was mixed with 5mL of DCM and injected through a septum into the top of the 
addition funnel, and the entire apparatus was then purged with N2 for 15 minutes. The 
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AC/DCM solution was then added dropwise (~1 drop every 5 s) with the addition funnel 
under continuous N2 purge and stirring. When the entire amount of AC/DCM solution 
was added to the PEG/TEA/DCM solution, purging was stopped and the apparatus was 
sealed, covered with aluminum foil and reacted overnight. The resulting pale yellow 
mixture was then filtered through a Buchner funnel and washed with excess DCM to 
remove the bulk of the TEA salts that formed during the reaction. Next, 10-fold molar 
excess sodium carbonate was added to the solution, and the slurry was stirred vigorously 
for 1 hour. The mixture was then again passed through a Buchner filter funnel and 
washed with DCM to remove the insoluble sodium carbonate. A packed bed of alumina 
(~3 cm thick) was then prepared in a glass frit column, and the solution was passed 
through the bed and washed with DCM. The DCM was then evaporated off so that the 
solution volume was ~40 mL, and cold diethyl ether (400 mL) was added to precipitate 
the PEG diacrylate product. The mixture was kept at 4˚C for at least 1 hour to allow full 
precipitation. The white precipitate was then collected with a Buchner filter funnel and 
allowed to dry overnight in the dark. This process of dissolving in ~40 mL of DCM and 
then precipitating the PEG diacrylate product in cold ether and filtering was repeated to 
further remove any impurities. Structure and extent of acrylation (90%) were confirmed 
with H-NMR. 
5.2.3 Photopolymerization of Degradable Coatings on Cultured Jurkat Cells In 
Suspension 
Jurkat cells (ATCC) were cultured to ~60% confluency in RPMI-1640 (Cellgro) 
supplemented with 10% fetal bovine serum (FBS, Gibco) and 100U Penicillin, 10 mg/mL 
Streptomycin (Gibco). For each polymerization trial, 1.5 x 106 Jurkat cells were collected 
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in culture media. In a 15 mL conical tube, the cells were centrifuged at 300xg for 5 
minutes at 4 °C. The culture media was removed, and the cell pellet was resuspended by 
gentle vortexing in 115 μL of DPBS (Gibco) with 3% FBS and 35 μL biotinylated mouse 
anti-human CD45 (BD Biosciences), and incubated for 40 minutes at 4 °C. Following 
incubation with primary antibody, the cell suspension was rinsed twice by centrifuging at 
300xg for 5 minutes and then resuspending with cold DPBS with 3% FBS followed by 
gentle vortexing. After the final rinse, the cell pellet was resuspended in 1 mL of cold 
PBS with 3% FBS with 25 μg/mL streptavidin-eosin-5-isothiocyanate (SA-EITC), gently 
vortexed and incubated at 4 °C for 30 minutes. Streptavidin (Thermo Scientific) and 
eosin-5-isothiocyanate (Sigma Aldrich) were reacted and purified in-house by the method 
described by Hansen et al. (2007) [98],  The cell suspension was then rinsed once, as 
before, with cold PBS with 3% FBS and then once with cold DPBS. The monomer 
mixture was then prepared as follows: 25 wt% UV cleavable PEG diacrylate [123], 21 
mM triethanolamine, 35 mM 1-vinyl-2-pyrrolidinone, and 0.05 wt% nile red 20 
nanometer fluorescent nanoparticles (Fluospheres, Invitrogen) in 1x phosphate buffer. 
The solution was bubbled with humidified ultra-pure N2 for approximately 3 minutes to 
remove dissolved oxygen and reduce turbidity. The cell pellet was resuspended in 300 μL 
monomer solution, gently vortexed, and placed in pre-cooled Chip-Clip well (Whatman) 
with a standard microscopy slide (Fisherbrand). The Chip-Clip was then placed in a 
sealed clear plastic bad and purged with humidified N2 for 3 minutes. While continuing 
to purge, the reaction was initiated by turning on an LED lamp (Thor Labs) emitting 530 
nm light at 30 mW/cm2 and centering the irradiation area on the well containing the cell 
suspension. The photopolymerization was allowed to proceed for 10 minutes, at which 
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time the Chip-Clip was removed from the bag and the cell suspension was removed 
rinsed 3 times with room temperature DPBS. 
5.2.4 Photopolymerization of Degradable Coatings on Cultured A549 Cells in 
Suspension 
Before a coating experiment, A549 cells (ATCC) were cultured to ~80% 
confluency in RPMI-1640 with 10% FBS and 100U Penicillin, 10 mg mL-1 Streptomycin. 
The culture flask was then rinsed with warm PBS 1x to remove media, and then 
trypsin/EDTA solution was added for ~5 minutes to detach the adherent cells. After 
detachment, cells were washed with 1 part trypsin neutralizing solution, pelleted and 
resuspended in culture media. For each polymerization trial, 1.5 x 106 A549 cells in 1 mL 
of media were used. Throughout the protocol, a rinsing solution consisting of DPBS 1x 
(free of calcium and magnesium), 5mM EDTA, and 3% FBS was used to minimize A549 
attachment during immunolabeling and polymerization. The cells in media from culture 
were centrifuged at 300xg for 5 mins at 4 °C and resuspended in 100 μL rinsing solution 
and 1 μL of stock mouse anti-human EpCAM (BioLegend) by gentle vortexing.  The cell 
suspension was incubated in primary antibody for 40 minutes at 4 °C. At the end of the 
incubation the sample was centrifuged at 300xg for 5 mins at 4 °C and resuspended in 1 
mL rinsing solution with 5 μL stock biotinylated goat anti-mouse IgG, gently vortexed 
and incubated at 4 °C for 40 minutes. The cells were then again centrifuged as before, 
rinsed twice by centrifuging and resuspending with rinsing solution. After the final rinse, 
the cell pellet was resuspended in 1 mL of cold rinsing solution with 25 μg/mL 
streptavidin-eosin isothiocyanate (SA-EITC), gently vortexed and incubated at 4 °C for 
30 minutes. The cell suspension was then rinsed twice, as before, with cold rinsing 
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solution. The monomer mixture was then prepared as described previously for Jurkat 
coating: 25 wt% UV cleavable PEG diacrylate [123], 21 mM triethanolamine, 35 mM 1-
vinyl-2-pyrrolidinone, and 0.05 wt% nile red fluorescent nanoparticles in 1x phosphate 
buffer. The solution was bubbled with humidified ultra-pure N2 for approximately 3 
minutes to remove dissolved oxygen and reduce turbidity. The cell pellet was 
resuspended in 300 μL monomer solution, gently vortexed, and placed in a pre-cooled 
Chip-Clip well (Whatman) with a standard microscopy slide (Fisherbrand). The Chip-
Clip was then placed in a sealed clear plastic bag and purged with humidified N2 for 3 
minutes. While continuing to purge, the reaction was initiated by turning on an LED lamp 
(Thor Labs) emitting 530 nm light at 30 mW/cm2 and centering the irradiation area on the 
well containing the cell suspension. The photopolymerization was allowed to proceed for 
10 minutes, at which time the Chip-Clip was removed from the bag and the cell 
suspension was removed and rinsed 3 times with room temperature DPBS. 
5.2.5 Polymerizing Cell Mixtures 
In experiments with mixtures of Jurkat and A549 cells, each respective cell type 
was cultured and collected as previously described and then combined at varying ratios. 
The polymerization protocol used depended on the cell type targeted for isolation. 
Because A549 cells were present in these experiments, 5 mM EDTA was included in all 
rinsing solutions to prevent cell attachment.   
5.2.6 Removal of Antigen-Negative Cells by Surfactant Lysis 
Following photopolymerization and subsequent rinsing, cell mixtures were 
resuspended in 500 µL PBS 1x and gently vortexed. To the cell suspension was added 
500 µL of 10% sodium dodecyl sulfate (SDS) in PBS 1x and gently mixed by pipette to 
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get final concentration of 5% SDS in PBS 1x. The suspension was then immediately 
centrifuged at 300g for 5 minutes to collect the polymer coated, antigen-positive cells. 
The surfactant solution was removed by pipette, and the pellet was rinsed twice more 
with cold DPBS. 
5.2.7 Coating Removal by UV Degradation 
Polymer coated cells were suspended in 300 μL of 10 mM EDTA gently vortexed 
and pipetted into a Chip Clip well. A UV LED lamp emitting 365 nm light was set up to 
irradiate the entire well at 10 mW/cm2 for 15 minutes, as shown in Appendix A-1. The 
cell solution was then removed from the well, and the well was rinsed twice and 
combined with the removed solution. The cells were then pelleted by centrifugation at 
300g for 5 minutes at 4 °C, and then resuspended in PBS 1x. The cells were rinsed twice 
more in DPBS 1x similarly by pelleting and resuspending. 
5.2.8 Cell Identity Assays 
For cytometry experiments, an Accuri C6 flow cytometer was used. Gating 
between coated and uncoated cells is based on nanoparticle fluorescence (535/575 nm) 
and forward scatter. Each experiment was set to count 100,000 events and each run was 
recorded using identical measurement parameters. Each condition tested was replicated 
five times per experiment, and each experiment was repeated at least 3 times on different 
days. To support the cell identity analyses above, a cytometry experiment was designed 
to ASL sort GFP-transfected A549 cells (Cell Biolabs), where GFP signal serves as a 
strong biochemical reporter for A549 identity. GFP positive A549 and Jurkats were 
cultured in RPMI-1640 and collected as previously described above, and mixed at a ratio 
of approximately 10% GFP positive A549 into 90% Jurkats, where gating was set on FL-
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1 vs forward scatter based on single cell population controls. GFP-A549 cells were 
targeted with anti-EpCAM, and coated by photopolymerization of 25 wt% PEG-
diacrylate macromer similarly to the coating protocol detailed previously. After SDS lysis 
and rinsing with DPBS/FBS, cells were suspended in culture media and incubated 
overnight to allow recovery of GFP signal that is partially photobleached during 
photopolymerization. Cells were then resuspended in DPBS/FBS and analyzed again by 
cytometry. The experiment was repeated 3 times on different days with 1,000 events per 
replicate. 
5.2.9 Viability and Proliferation Assays 
 Cell viability was determined by MTT, calcein, caspase-3/7, and SYTOX assays. 
Measurements were taken after antibody incubations, polymerization, surfactant lysis, 
and UV degradation. After the final rinse with cold PBS 1x at each step, cells were 
centrifuged at 300g for 5 minutes and resuspended in 50 nM of calcein AM (Invitrogen) 
in PBS and incubated for 15 minutes at 4 °C. Flow cytometric analysis was then 
performed to measure calcein fluorescence. First, a threshold of fluorescence was 
generated using uncoated and cells without exposure to calcein as control samples. All 
events corresponding to uncoated cells without calcein were located at intensities below 
this threshold for both green and red fluorescence, while events corresponding to polymer 
coated cells without calcein were located at intensities below the threshold for the green 
fluorescence channel. Each experiment was set to count 100,000 events per run and each 
run was recorded using identical measurement parameters. Each condition tested was 
replicated five times and each experiment was repeated at least 3 times in different days. 
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The variation between each replicate was always less than 5% and between experiments 
less than 10% in cell mixtures. 
Cell viability after immunostaining, polymerization, lysis and polymer 
degradation was also studied with the MTT assay. After each step, 100,000 cells in 200 
µL of culture media were seeded into each well of 96-well plates.  Thiazolyl Blue 
Tetrazolium Bromide (Sigma Aldrich) was dissolved in PBS 1x at a concentration of 5 
mg/mL. Then, 20 µL of MTT solution was added into each well and incubated for 3 
hours. The absorbance was measured by means of a plate reader at 570 nm. 
To further assay viability, a flow cytometry based caspase-3/7+SYTOX reporter 
kit (Invitrogen) was used. Approximately 106 Jurkat cells were obtained from culture, 
coated with polymer via anti-CD45, exposed to SDS lysis, then to degradation conditions 
of UV light in 10 mM EDTA as described above. Apoptosis and membrane integrity 
were probed after polymerization and degradation steps by incubating samples with both 
500 nM caspase reporter reagent and 1 μM SYTOX reagent for 60 minutes at room 
temperature in the dark. For analysis, flow cytometry gating was set from Jurkat controls 
to 1,000 events per replicate. Fluorescence analysis was performed by excitation with a 
488 nm laser with a 530/30 BP filter for the caspase channel and a 675/25 nm BP filter 
for SYTOX. A dead control consisted of 70% ethanol fixed Jurkats, and an apoptotic 
control was induced with a 3 hour incubation of Jurkat cells at 37 °C with 10 μM 
camptothecin in RPMI-1640 culture media. Cell proliferation after polymer degradation 
was studied with the MTT assay. 5,000 cells in 200 µL of culture media were plated into 
each well of 96-well plate. During 5 days of co-incubation, 20 µL of MTT solution (5 
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mg/mL in PBS 1x) was added into each well of the plates and incubated for 3 h. The 
absorbance was measured by means of a plate reader at 570 nm. 
5.2.10  ɣH2AX Foci Quantitation 
A549 cells were plated on 12 mm coverslips and incubated in DMEM 10% FBS + 
1% streptomycin/penicillin + 1 % L-Gln for 16 h. The coverslips were soaked in 2 ml 
PBS in 6 cm dishes, and exposed to 10 mW/cm2, 365 nm irradiation for 10 or 20 min, 
followed by incubation in a regular medium for 30 min, 1 h, or 3 h. Cells were then fixed 
in 50% methanol followed by 100 % methanol, and then stained with anti-ɣH2AX 
(Millipore) and probed with anti-mouse IgG-Alexa Fluor 488. Cells with foci were 
counted to calculate mean %cells with foci from 10 independent observations. Foci 
formation induced by 5 minutes of 0.2 mM H2O2 and measured after 30 minutes in 
regular medium post exposure treatment is shown as a ɣH2AX positive control. 
5.3 Results and Discussion 
5.3.1 Antigen Specific Polymer Coating  
 Antigen Specific Lysis (ASL) consists of specific cellular protection by a 
temporary polymer coating and the subsequent lysis of unprotected cells (Figure 5.1). 
The formation of a polymer film requires a polymerization initiator [124], and ASL 
utilizes antibodies to localize eosin (a type II photoinitiator) on the surface of only 
antigen positive cells [97, 100, 125]. The monomer is prepared in a mixture composed by 
25 wt% UV cleavable PEG diacrylate [123], 21 mM triethanolamine, 35 mM 1-vinyl-2-
pyrrolidinone, and 0.05 wt% fluorescent nanoparticles in 1x phosphate buffer. Coatings 
are formed upon immersion in nitrogen purged monomer mix and 530 nm LED 
irradiation (30 mW/cm2) for 10 minutes, where a red fluorescent polymer coating is 
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formed on the outside of only targeted, initiator-labeled cells. When the photoinitiators 
are targeted against protein tyrosine phosphatase (CD45 antigen), protective polymer 
coatings are formed on the outside of Jurkat cells [97, 126]. Unprotected cells (Figure 
5.3.a) are lysed and killed by a 10 minute exposure to 5% SDS (Figure 5.3.b) [127], 
while we observe that cells encapsulated in fluorescent polymer coatings retain cellular 
integrity (Figure 5.3.c, 5.3.d). Cellular integrity and activity was determined by caspase-
3/7 + SYTOX assay where a cell population of 81.7 ± 8 % is detected viable (Figure 
5.4). Viability by cellular activity was determined at each step in the ASL process by 
calcein esterase activity and capspase-3/7 + SYTOX assays. Calcein esterase assays 
showed more than 80% viable Jurkat cells after polymer coating (Figure 5.3.e). The lack 
of activation of caspase-3/7 apoptotic pathways by caspase-3/7 + SYTOX assay reveal 
that after the polymer coating process, a negligible Jurkat cells population (0.2 ± 6 %) 
was in the apoptotic stage and 14.5 ± 9 % of the cells were necrotic (Figure 5.4). The 
high viability for these coating materials is to be expected given previous studies using 
similar macromers and initiation chemistry [90, 126]. These same macromers were used 
with >80% viability in tissue encapsulation studies by Kloxin et al. [123] and with >90% 
viability by Griffin et al. [128] and by DeForest et al. [129]. Additionally, the 
polymerization by a type II photoinitiation system (eosin with a tertiary amine coinitiator) 
strategy has been extensively studied by the Hubbell [60, 80] and Lin [130, 131] groups 
for pancreatic islet and pancreatic cancer tissue engineering studies. 
 This cellular protection by a targeted coating is the foundation of ASL sorting, 
where complete elimination of the untargeted population is feasible through conventional 
approaches of cell lysis. While enrichment based on the exclusion of SDS is a chemical 
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means of selection, we have also evaluated the preservation of cellular function in 
hypotonic solutions using similar coatings. Immersion of 105 uncoated Jurkat cells in 1 
mL of pure water results in a large osmotic imbalance, leading to swelling and rupture of 
the cell [132]. When Jurkat cells are coated with a PEG diacrylate polymer, the polymer 
coating preserves cell membrane integrity and enzymatic function (Figure 5.3.d, 5.3.e). 
In each mode of lysis, we have observed reductions in the numbers of uncoated cells. 
Cell exposure to 5% SDS led to an undetectable lysed population, while the water 
treatment results in a statistically insignificant (p=0.0517) number of viable cells. 
Polymer coating protection from SDS or hypotonic lysis demonstrates the potential for 
ASL to deliver 100% pure populations.  
5.3.2 Specificity of ASL 
 The limiting factor for ASL purity is the specificity of polymerization afforded by 
the antibody-targeted initiator species. To investigate the specificity of these polymer 
coatings, we isolated A549 cells from a mixed population with Jurkat cells. 
Approximately 104 A549 cells were mixed with 105 Jurkat cells. For the sake of 
adaptability, we synthesized a streptavidin-eosin conjugate that can be targeted to A549 
cells through the use of biotinylated antibodies and antibodies against epithelial cell 
adhesion molecule antigen (anti-EpCAM). After photopolymerization (as described 
above), the mixture of cells were analyzed by flow cytometry, and the two distinct 
populations are consistent with control populations of coated A549 cells and uncoated 
Jurkat cells. The fraction of each gated population (8% A549 to 90% Jurkat, Figure 
5.5.a) is consistent with the fraction of starting populations. Upon addition of 5% SDS in 
PBS to the pelleted cellular mixture, a purified population of polymer coated A549 cells 
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is obtained through centrifugation (0.3 x g for 5 minutes) and rinsing in 3% FBS in PBS. 
Flow cytometry shows >98% of the population to be consistent with coated A549 cells 
(Figure 5.5.b).  
 To demonstrate that ASL specificity is feasible for other targeted populations, we 
performed a similar experiment to isolate a minority of 104 Jurkat cells from a mixture 
with 105 A549 cells. We labeled Jurkat cells with initiator by incubation in 1:5 
biotinylated human anti-CD45 for 40 minutes in a solution of 3% FBS in 1x PBS, 
followed by incubation in 10 µg/mL streptavidin-eosin for 30 minutes. After 
photopolymerization with 530 nm light, the two distinct populations are consistent with 
initial populations of coated 9% Jurkat cells and naïve 91% A549 cells (Figure 5.5.c). 
Upon lysis with 5% SDS in PBS, ASL yielded a >96% pure Jurkat population as is 
observed by flow cytometry (Figure 5.5.d). 
 Purity was further supported by fluorescence analysis when sorting a GFP-
transfected A549 cell line. Polymer coating was performed in cell mixtures composed by 
90% Jurkat cells and 10% GFP-positive A549 cells (Figure 5.6.a). The GFP fluorescence 
signal serves as a strong biochemical reporter for A549 cell identity. GFP-positive A549 
cell population is targeted using anti-EpCAM as described above for A549 cell sorting. 
After polymerization, unprotected cells are lysed with 5% SDS. Prior to flow cytometer 
analysis of the sorted population, cells are cultured overnight in media to allow the 
recovery of GFP signal from photobleaching caused by the photopolymerization. ASL 
yields a highly pure isolated fraction consisted of 97.1 ± 2.3 % GFP-positive A549 cells, 
and only 2.9 ± 2.3 % GFP-negative cells per each 104 cell batch (Figure 5.6.b). 
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5.3.3 Release of Sorted Cells From Polymer Coating 
 Removal of the polymer coating is essential for translation of ASL as a cell 
isolation technology. We use a UV-degradable PEG-diacrylate monomer developed by 
Kloxin et al. [123] to temporally control the presence of the crosslinked polymer coating. 
Coated Jurkat cells were released from the polymer coating through 10 minute exposure 
to 10 mW/cm2, 365 nm light in PBS and 10 mM EDTA. As photobleaching and particle 
release possibilities weaken the certainty of direct observation of coating removal by 
fluorescent means, the removal of the coatings was confirmed by proliferation assays of 
the released cells and comparison to naive Jurkat cell. Released Jurkat cells proliferate at 
rates comparable to naïve Jurkat cells (Figure 5.7.a), indicating the sufficient degradation 
of the polymer coating to allow proliferation. We also evaluated the proliferation of 
released A549 cells, which are anchorage dependent. The A549 cells had a 2 day lag in 
proliferation (Figure 5.7.a). Discrepancies between the anchorage dependent A549 and 
the anchorage independent Jurkat cells suggests residual polymer may interfere with 
critical cell-substrate interactions. Observation of the cells in culture showed viable cell 
spreading and residual red fluorescent polymer remaining after 1 day (Figure 5.7.c) and 
although the fluorescent polymer can be observed still after 4 days of culturing (Figure 
5.7.d), released A549 cells recover and proliferate at rates comparable to naive A549 
cells. PEG hydrogels have been commonly used to prevent cell-substrate interactions, 
and the screening of these interactions by residual polymer highlights an opportunity for 
improvement of ASL through the more efficient removal of the polymer coating. Yield of 
viable cells throughout the ASL process is 59 ± 1.2 % as determined by MTT assay, 
(Figure 5.7.b) comparable to the viability achieved by FACS [133-135], which is 
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promising for a newly-discovered technology. Cell viability was further supported by 
caspase-3/7 + SYTOX (Figure 5.4). From the released cell population, more than the 
72.6 ± 6.8 % of the cells remained alive, 19.5 ± 5 % were necrotic cells and the apoptotic 
activity detected was negligible (0.5 ± 4 %).  
 The impact of UV light on the cell viability was studied by calcein assay and by 
DNA damage quantification. There is a small impact (<10%) of UV light in the cell 
viability after polymer degradation (Figure 5.8.a). DNA damage was quantified by 
assessing the response of histone-2AX (H2AX) phosphorylation (ɣH2AX), a marker of 
DNA double strand breaks [133-136]. ɣH2AX foci induction was monitored following 
different time interval between UV light exposure and incubation in culture media 
(Figure 5.8.b). Induction of ɣH2AX foci was negligible and not affected by the radiation 
exposure time, suggesting no DNA damage in the cells after releasing them from polymer 
coating upon UV irradiation.  
5.3.4 ASL in Spiked Blood 
 Cellular isolation from actual biological samples is often more difficult than the 
isolation of different cultured cell populations in buffers. Of these samples, blood is a 
commonly targeted tissue for cells, and has many clinically relevant applications ranging 
from progenitor cell isolation [137, 138] to cancer cell isolation [139, 140]. To support 
the generalized use of ASL for isolations of rare cell populations beyond cultured cells, 
we spiked A549 cells into the leukocyte-enriched plasma fraction harvested from 
asymptomatic human blood subjected to cell sedimentation (Figure 5.9.a).  
 The mixed population was sequentially labeled with anti-EpCAM, biotin-anti-
Mouse IgG, and streptavidin-eosin, prior to polymerization in the monomer formulation 
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with 530 nm light at 30 mW/cm2 for 10 minutes. The polymer coated A549 cells are 
distinguished from blood components by flow cytometry, constituting 16% of the 
nucleated cells in the mixture (Figure 5.9.b). After exposure to 5% SDS, around 99% of 
nucleated cells remaining correspond with A549 cells as quantified by flow cytometry 
(Figure 5.9.c).  
 The scale-up of ASL promises the rapid processing of large quantities of cells. 
ASL batch throughput is limited only by the lamp irradiation area. While our current 
experiments are performed with inexpensive LEDs using a ~40 cm2 irradiation area, there 
is a possibility of adaptation to commercially available irradiation chambers with bigger 
irradiation areas (>850 cm2). By starting with a large sample, rare populations may be 
isolated in appreciable numbers (~1010 cells per hour), allowing occult phenotypes to be 
studied beyond single cell analytical techniques. 
5.4 Conclusions 
 ASL constitutes a completely unique approach for cellular isolation. Even at this 
early stage in development, the potential is clear for a high-purity, high-viability cell 
isolation technique for both small and large batch isolations. As in the popular antibody-
coated microfluidic systems, ASL is limited to single antigen sorts at a given sensitivity. 
As such, it provides a high throughput alternative to microfluidic sorting which 
complements existing antigen-negative magnetic sorting technology for high throughput, 
high purity applications. Prior work has also shown the ease of tuning the sensitivity of 
antibody-directed polymer coating system through antibody dilution or competitive 
binding with non-labeled probes [141]. ASL’s reliance on common light sources (LEDs 
from epifluorescent microscopes) allows capital costs to be >100x cheaper than a FACS 
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system. Furthermore, all ASL processing can be performed in common disposable 
labware, eliminating the expensive and time consuming sterilization procedures used in 
most other sorting techniques. Additionally, others have shown fluorescein to be a 
reasonable alternative to eosin-based initiation, where FITC-labeled antibodies could 
potentially replace our custom eosin conjugates [141]. Further developments using 
fluorescein-antibody conjugates for polymerization initiators would logically make ASL 
even more accessible to a broad range of researchers.  
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Figure 5.1: Schematic figure of Antigen Specific Lysis. Cells are immunolabeled with 
polymerization initiators, and protective coatings are formed only on initiator labeled 
cells. Unprotected cells are lysed while coated cells remain viable. 
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Figure 5.2: Structure and photocleavage route of ortho-nitrobenzyl-PEG-diacrylate 
macromers. Adapted from Kloxin et al. (2009) [16]. 
  
84 
 
Figure 5.3: Protection of marker-positive cells through polymerization. a) Naive Jurkat 
cells. b) Uncoated Jurkat cells are lysed in <10 seconds in 5% SDS. Only sparse cellular 
debris remains in the viscous lysate. c) Polymer-coated Jurkats intact are after 10 minutes 
in 5% SDS. d) Epifluorescent image of Jurkat cells coated with a red fluorescent 
nanoparticle-loaded polymer in pure deionized water. Scale bars are 25 µm. e) Calcein 
viability assay of Jurkat cells and polymer-coated Jurkat cells after 10 minutes in 
indicated solution. Data are mean ± s.d. 
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Figure 5.4: Viability of Jurkat cells before and after polymer degradation measured by 
Caspase and SYTOX assay. Data are mean ± standard error. 
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Figure 5.5: Specific lysis of cultured cells. Representative flow cytometric analysis of 
populations before and after exposure to SDS. a) Coating targeted to EpCAM+ cells from 
an initial population of 9% Jurkat and 91% A549 after polymerization. b) Population 
from (a) after 5 minute exposure to 5% SDS. c) Coating targeted to CD45+ cells from an 
initial population of 9% A549 and 91% A549 after polymerization. d) Population from 
(c) after 5 minute exposure to 5% SDS.  
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Figure 5.6: Antigen Specific Lysis purity from a cell mixture composed by 90% Jurkat 
cells + 10% GFP-positive A549 cells. a) Flow cytometric distribution from the cell 
mixture before ASL and b) Flow cytometric data of GFP-positive cells after ASL.  
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Figure 5.7: Proliferation and viability of processed cells. a) Proliferation rates of naive 
(dashed line) or processed/released (solid line) cells. Jurkat cells (blue). A549 cells 
(grey). b) Viability of Jurkat cells at critical steps in Antigen Specific Lysis processing. 
Data are mean ± s.d. Calcein staining (green) images of released A549 cells after polymer 
degradation after: c) 1 day and d) 4 days of culturing. The presence of red fluorescence 
indicates regions of residual red fluorescent nanoparticle-loaded polymer. 
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Figure 5.8: UV irradiation effect on cell viability. a) Cell viability determined by MTT 
assay after 365 nm, 10 mW/cm2 light exposure over time. b) DNA repair activity in A549 
cells after UV irradiation (365 nm, 10 mW/cm2). Activity correlated to fraction of cells 
displaying ɣH2AX foci. X-axis indicates “[UV exposure time] => [recovery time prior to 
analysis]”. Inset provides an expanded y-axis. H2O2 condition was 5 minutes of 0.2 mM 
H2O2 and measured 30 minutes post exposure. Data are mean ± s.d. 
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Figure 5.9: Isolation of EpCAM+ cells spiked into blood. a) Overview of approach. b) 
Flow cytometric data of A549 cell spiked into erythrocyte-depleted blood after EpCAM-
specific polymerization. Dashed line indicates distinction between polymer coated A549 
cells and other blood components based on control studies of pure populations. c) Flow 
cytometric data after lysis of EpCAM- components. 
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Chapter 6: Quantitative Investigation of Surface Receptor Expression Density For 
The Isolation of Tumor Cells 
In this chapter, expression levels of common cancer markers are quantitated for 
three breast cancer and two non-small cell lung cancer lineage models. These levels are 
contrasted with that present on healthy peripheral blood mononuclear cells for 
comparison to expected background levels in a fluid biopsy setting. A key feature of this 
work is establishing a metric of markers per square micrometer. This describes an 
average marker density on the cell membrane surface, which is a critical metric for 
emerging isolation strategies. These results serve to extend expression of key tumor 
markers in a sensitive and dynamic manner beyond traditional “positive”/”negative” 
immunohistochemical staining to guide future fluid biopsy targeting strategies. The work 
presented here is adapted with minor modifications from work previously published: 
Calvin F. Cahall, Jacob L. Lilly, Edward A. Hirschowitz, Brad J. Berron. A 
Quantitative Perspective on Surface Marker Selection for the Isolation of 
Functional Tumor Cells. Breast cancer: Basic and Clinical Research. 9(Suppl 
1):1, 2015. 
6.1 Introduction 
Much effort has gone into developing fluid biopsies of patient peripheral blood 
for the monitoring of metastatic cancers. One common approach is to isolate and analyze 
tumor cells in the peripheral blood [6, 8]. Widespread clinical implementation of this 
approach has been hindered by the current choice of targeting epithelial markers known 
to be highly variable in primary tumor sites [4]. Marker-targeting isolation strategies are 
intrinsically dependent on the level of antigen expression presented on target cells.  Low 
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quantities, and more specifically low densities, of the target marker will decrease the net 
binding recognition of antibodies to a marker positive cell surface, potentially leading to 
poor discrimination between positive and negative events [4, 12]. Critically, the current 
literature poorly describes the expression of even the best known tumor markers on the 
most commonly studied tumor cell lines. Typically, the expression of a marker is 
communicated as positive or negative. At best, papers will communicate relative levels in 
terms of dim, moderate, bright, or variable. Alternatively, the level of receptor expression 
is given as moles of receptor per mass of cell lysate. Techniques that have been used to 
detect cell antigens qualitatively and quantitatively include enzyme immunoassay (EIA) 
and enzyme-linked immunosorbent assay (ELISA) [142, 143]. However, these techniques 
that quantify expression on a total mass basis are minimally useful in the development of 
viable cell sorting, as they report antigens that may be present only intracellularly and 
unavailable for targeting on an intact, viable cell [144, 145]. 
Herein, we seek to quantify the surface expression level of these critical markers 
on common cell lines. This work represents a critical step in assessing the opportunities 
and limitations of isolating functional tumor-associated cells from peripheral blood. We 
have chosen tumor cell lines, as the majority of clinical research has centered on the 
utility of finding epithelial cells in circulation. Finally, we discuss the significant 
limitations of using these in vitro cell models for CTCs in the study of rare cancer cell 
biology. 
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6.2 Materials and Methods 
6.2.1 Cell Culture 
Three breast cancer cell lines and two non-small cell lung cancer (NSCLC) cell 
lines were cultured. Breast cancer lines included MDA-MB-231 (mammary 
adenocarcinoma), MCF-7 (mammary adenocarcinoma), and T-47D (mammary ductal 
carcinoma), and NSCLC lines included A549 (alveolar adenocarcinoma) and H358 
(bronchioalveolar carcinoma). All tumor lines were cultured in RPMI-1640 growth 
medium (HyClone) supplemented with 2.05 mM L-glutamine, 10% fetal bovine serum 
(FBS, Fisherbrand), and 1% penicillin-streptomycin (Sigma Aldrich), and maintained at 
5% CO2 in air and 37 ˚C. Cells were cultured for 48 hours and were approximately 60-
80% confluent just before experimentation. Additionally, a peripheral blood control 
sample was obtained with informed consent through University of Kentucky Medical 
Center IRB protocols and processed within an hour of collection. Briefly, whole blood 
was mixed with a dextran/NaCl solution to a working concentration of 2 wt% dextran and 
0.3 wt% NaCl and was allowed to separate by 1xg sedimentation at room temperature for 
1 hour. The buffy coat containing peripheral blood mononuclear cells (PBMC) was then 
pipetted off and exposed to red blood cell lysis buffer (155mM NH4Cl, 10mM KHCO3, 
0.1mM EDTA) for 5 minutes to further remove red blood cells from the sample. The 
nucleated cells were collected by centrifugation at 300xg for 5 minutes and washed twice 
with cold 1X PBS. 
6.2.2 Cell Imaging 
Representative bright field, phase contrast images of all tumor cell lines were taken with 
a Nikon Ti-U inverted microscope. 
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6.2.3 Surface Marker Immunostaining 
Tumor cells were incubated with trypsin/EDTA (0.25%) solution for 3 minutes to 
allow for detachment, rinsed with growth medium and centrifuged. Cell concentration 
and cell diameter was determined optically with a Cellometer Automated Cell counter 
(Nexelcom). Each data replicate sample consisted of 1x105 cells in a microcentrifuge 
tube. For experimentation, a rinsing buffer of 1X PBS with 3% FBS was prepared and 
used for all rinsing steps. All materials and cell samples were kept on ice throughout the 
staining procedure. For immunolabeling, cell samples were first rinsed once with rinsing 
buffer and centrifuged (400xg, 1.5 minutes). Subsequently, samples were incubated with 
primary antibodies at ~0.5 μg in 150 μl of rinsing buffer for 40 minutes. For all cell lines, 
markers were targeted with primary monoclonal mouse IgG antibodies with 
corresponding  isotype controls that consisted of: CD326/EpCAM (IgG2b, clone 9C4, 
BioLegend, San Diego, CA), HER1/EGFR (IgG1, clone AY13, BioLegend), CD44 
(IgG1, clone BJ18, BioLegend), E-cadherin (IgG1, clone 67A4, BioLegend), 
erbB2/HER2 (IgG1, clone 24D2, BioLegend), N-cadherin (IgG1, clone8C11, 
BioLegend), alphaV-beta3 integrin (IgG1, clone 23C6, BioLegend), ICAM-1 (IgG1, 
clone HA58, eBiosciences, San Diego, CA), ER-α (IgG2a, clone F-10, Santa Cruz 
Biotechnology, Dallas, TX). Samples were then rinsed twice with rinsing buffer on ice, 
with centrifugation between rinses. Cells were then labeled with biotinylated goat anti-
mouse IgG antibody (Vector Labs, Burlingame, CA) at a 1:400 dilution in rinsing buffer 
on ice for 40 minutes. Cells were rinsed twice with rinsing buffer and incubated with 
streptavidin-phycoerythrin at ~1 μg in 200 μl on ice for 20 minutes. Samples were rinsed 
three times and resuspended in ~200 μl rinsing buffer for immediate analysis. 
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6.2.4 Flow Cytometry 
Cell sample immunofluorescence was assessed with an Accuri C6 flow 
cytometer. Samples were kept on ice, then gently vortexed before a cytometry run. For 
each replicate, 5000 cell events were collected based on initial cell culture control gating. 
Phycoerythrin fluorescence data was collected for each sample in the FL2 channel 
configured for excitation with a 488 nm laser and emission detected through a 585/40 
bandpass filter.  
6.2.5 Data Analysis 
Data is calculated as mean ± standard error of the geometric means of event 
populations (N=3) for all marker quantification assays and cell diameter calculations. 
Standard deviation within individual replicates of cytometry data is also reported. 
Quantibrite PE bead calibration was performed during cell immunofluorescence data 
collection and fluorescence calibration values are collected in channel FL2. Statistical 
analysis consisted of a two-tailed student t-test performed in Matlab to calculate p-values. 
6.3 Results and Discussion 
6.3.1 Imaging Analysis 
A summary of cell types and corresponding cell sizes is shown in Table 6.1. 
From a regression analysis relating mean forward scatter and mean Cellometer cell size 
(Figure 6.1), cell diameters of individual populations of lymphocytes, monocytes, and 
granulocytes were extrapolated. As expected, these PBMC showed diameters smaller 
than epithelial cancer cells. To estimate cell surface area, a spherical model was assumed 
for each cell. While some cell types can possess membrane folds that can alter diameter 
and surface area in certain scenarios (e.g. activation of white blood cells) [146], we posit 
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this simple model is sufficient to generally show accessible marker densities on the 
surface of the cells studied here. For morphological comparison, representative bright 
field images of tumor cell lines are shown in Figure 6.2. The basal-like breast line MDA-
MB-231 [147] show morphology quite distinct from any other investigated in the study, 
with elongated, multi-polar behavior and favoring minimal cell-cell contact consistent 
with basal subtypes. Luminal breast lines MCF-7 and T-47D [148] and NSCLC line 
H358 show morphology more consistent with an epithelial phenotype favoring extensive 
cell-cell contact and colonization. NSCLC line A549 appears to exhibit behavior 
somewhere between these extremes with less organized cell junctions. 
6.3.2 Quantitation of Marker Expression by Flow Cytometry 
The results of marker quantitation using the flow cytometric Quantibrite assay are 
presented in Figures 6.3 and 6.4, where Phycoerythrin fluorescence signal serves a 
reporter for antigen quantity. Expression data is presented here both as expression fold 
over isotype controls as well as normalized to the calculated mean surface area for each 
cell type. Because we employed an indirect immunostaining approach, some labeling 
amplification inherent in antibody binding interactions was seen. A biotin anti-EpCAM 
primary was labeled in parallel to biotin-anti-mouse secondary staining, with only a ~1.3-
fold amplification seen for secondary immunolabeling. Further, we also expect some 
amplification at the biotin/SA-PE labeling interaction. Although this may skew the 
representation of the actual number of biological copies of these surface proteins, the 
focus of our study was to provide a methodology engineering perspective on the 
maximum level of antigen affinity recognition afforded by traditional immunolabeling for 
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viable CTC isolation, where some amplification is not only acceptable but desired. 
Moreover, as all markers were tagged with identical indirect staining approaches, relative  
expression across cell lines and between markers should be consistent regardless of any 
labeling amplification. 
Overall, marker expression levels often varied drastically between cell lines with 
some correlation seen between cell morphology, behavior, and marker profiles. 
Specifically, MDA-MB-231 showed significantly decreased PE labeling density for 
EpCAM and E-cadherin compared to MCF-7, T-47D, and H358 (p-values<0.001), while 
showing higher levels of labeling density for CD44, EGFR and ICAM-1 (p-values≤0.01, 
Figure 6.4). A549 also showed decreased EpCAM and E-cadherin density (p-
values<0.001) and increased CD44 density over MCF-7, T-47D, and H358 (p-
values<0.01). EGFR and ICAM-1 expression seemed to be consistently high, resulting in 
PE label densities equal to or greater than 100 per μm2 for all cell lines except MCF-7. 
EGFR has been linked to a basal-like molecular signature [149], and elevated levels of 
EGFR and ICAM-1 have been linked to metastatic disease [150, 151]. The αV-β3 
integrin is elevated 10-fold in MDA-MB-231 cells compared to the other tumor lines 
investigated (p-values<0.001), with ~30 PE molecules per μm2. Of particular interest for 
breast cancer lines was ERα and HER2 expression because of their prominent clinical 
role in breast cancer classification, prognosis and therapy selection. The antibody chosen 
(clone F-10, Santa Cruz) targeted the c-terminus ligand binding domain. All three breast 
cancer lines showed a slight increase in ERα expression over isotype controls (p-
values<0.05, Figure 6.3.a-6.3.c), and a statistical elevation in expression over NSCLC 
lines (p-values<0.05) which showed virtually no ERα expression, with the exception of 
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MCF-7 compared to A549 (p=0.15, Figure 6.3.d, 6.3.e). HER2 expression was expressed 
at relatively high levels in all three breast cancer lines as well as NSCLC lines, resulting 
in roughly 50-100 PE molecules per μm2 (Figure 6.4).  
Our study also sought to provide background expression levels on PBMC for 
comparison, as it is ultimately a determining factor in marker selection for isolating CTCs 
from peripheral blood. Figure 6.3.f shows marker expression fold over IgG for separately 
gated lymphocyte, monocyte, and granulocyte populations. Notably, relatively elevated 
levels of both CD44 and ICAM-1 are seen. In Figure 6.4.f, the PE binding density is 
reported for PBMC, showing high non-specific noise in isotype controls, especially for 
monocytes. This immunolabeling noise can reduce the biorecognition contrast between 
the target tumor cells for capture and the majority PBMC, so here we further demonstrate 
the PE labeling density fold vs peripheral blood monocyte expression, which represent 
the most likely culprits for false-positive capture (Figure 6.5). First, MDA-MB-231 
showed drastically attenuated EpCAM (p=0.0038) and E-cadherin (p=0.90) elevation 
over monocytes due to low expression seen in Figure 6.4.a. EGFR contrast remains high 
for MDA-MB-231 and NSCLC lines (p-values<0.01). Although CD44 and ICAM-1 were 
highly expressed across all cancer lines in the study, the contrast over blood cells is 
reduced because of corresponding high expression in PBMC. MDA-MB-231 have a 
slight CD44 contrast over monocytes, and MDA-MB-231 and A549 both retain high 
contrast for ICAM-1 expression (p-values<0.01). Finally, N-cadherin and αV-β3 integrin 
expression on all five cancer lines investigated shows little to no elevation over that of 
peripheral monocytes. 
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Here, we have reported quantitative results of levels of antibody-mediated 
recognition attained for several commonly investigated markers associated with  
metastasis on both breast cancer and NSCLC lines. To our knowledge, very little 
information is reported on the numbers of marker proteins present on cancer cell 
membrane surfaces. While many fundamental biology questions can be answered with 
immunohistochemical and blotting assays that yield binned “positive” or “negative” 
information, these approaches generally fail to represent the highly dynamic and variable 
expression patterns seen for many tumor cells [31, 145, 152]. Particularly for antibody-
based cell isolation methodologies, the ability to capture a marker-presenting cell 
amongst a majority of marker-negative cells is critically dependent on the amount of 
marker proteins available on the cell surface for labeling. In this light, we propose these 
findings represent a significant step toward providing the tumor cell isolation community 
with quantitative antigenic expression information.  
Notably, our results show distinct expression signatures for basal and luminal 
breast cancer subtypes consistent with the characteristics commonly associated with each. 
Basal-like cells are often seen to be more highly invasive and de-differentiated, while 
luminal-type cells are often considered epithelial-like [148, 149]. MDA-MB-231 are 
classified as basal, whereas MCF-7 and T-47D are luminal A subtypes. We found that 
MDA-MB-231 showed elevated levels of mesenchymal and/or metastatic markers CD44, 
N-cadherin, αV-β3 integrin, ICAM-1, as well as upregulation of EGFR commonly seen 
for basal subtypes (Figure 6.3.a) [149]. Further, the basal-like MDA-MB-231 also 
showed lower expression of epithelial markers EpCAM and E-cadherin compared to 
MCF-7 and T-47D (Figure 6.3.a-6.3.c). Elevated levels of mesenchymal markers have 
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been linked to a more metastatic phenotype, as these proteins play key functional roles as 
tools for migration and invasion [18]. In the context of CTC isolation that currently is 
predominantly based on EpCAM+ sorting, these results highlight a disconnect between 
marker targeting strategy and the biologic tendencies of highly invasive cells. 
Specifically, a detection threshold of EpCAM expression exists for any antibody-based 
isolation methodology, and highly-invasive cells downregulate EpCAM and have a 
higher potential to go “unseen” as false negatives. 
A surprising result was also seen for ERα expression in comparing the basal 
(MDA-MB-231) and luminal A (MCF-7 and T-47D) subtypes in the study. All three cell 
lines showed a similar expression of HER2, which was not unexpected for basal and 
luminal A subtypes that generally do not have overexpression of HER2 [148]. However, 
we found that MDA-MB-231 cells also expressed similar surface densities of ERα 
compared to MCF-7 and T-47D. One possible explanation could be that because our 
focus was to determine antigen densities on intact tumor cell surfaces, the antibody 
chosen for ERα targeting (clone F-10, Santa Cruz Biotech) targeted the C-terminal ligand 
binding domain; however, these nuclear receptors are often trafficked 
intracellularly.[153] Therefore, these results do not account for intracellular ERα where 
differences in expression between basal and luminal A subtypes could arise. 
Our study also sought to offer some order-of-magnitude perspective on expression 
levels of surface markers CD44, N-cadherin, αV-β3 integrin and ICAM-1 implicated in 
metastatic progression [150, 154, 155], as these could potentially serve as promising new 
targets for sorting clinically relevant cells. A poorly expressed molecule may play an 
important role biologically, but would be of minimal utility as a target for live cell 
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isolation. Furthermore, a molecule may even be highly expressed, but if it is also highly 
expressed on peripheral blood cells, it would no longer serve to distinguish epithelial 
identity from the background blood cells. PBMC marker expression was normalized to 
cell size similarly to epithelial cells, and PBMC size estimates were found to be in fair 
agreement with literature [156, 157]. We found that although both N-cadherin and αV-β3 
integrin were upregulated on some lines (MDA-MB-231 and A549), their inherent 
expression density was still approximately equal to or below the expression found on 
peripheral monocytes, which consistently showed the highest background staining 
levels(Figures 6.4.f and 6.5). Additionally, while CD44 was relatively high for all cancer 
lines (Figure 6.4) it was also highly expressed in PBMC which reduced the expression 
ratio over monocytes to nearly 1 or below for all lines except MDA-MB-231 that retained 
a 7-fold ratio over monocytes (Figure 6.5). Therefore, because our results show minimal 
differences in expression of these markers over blood cells, they are not recommended 
for targeting intact tumor cells. It is worth noting though that more work is warranted in 
quantitating the extent of elevation of markers like N-cadherin shown to undergo a 
“cadherin switch” from stromal cytokine stimulation in vivo [158, 159]. This phenotypic 
transition is correlated with a more invasive cell and could conceivably potentiate N-
cadherin as a target for tumor cell isolation. ICAM-1 expression density was seen to be 
approximately 30- to 60-fold higher than monocytes for T-47D and MDA-MB-231, 
respectively (Figure 6.5). ICAM-1 is involved in cell adhesion interactions, migration, 
and has been recently been classified as a mesenchymal cell marker [160-162]. Further, 
one recent study has shown that increased populations of ICAM-1high CTCs correlated to 
poorer prognosis in hepatocellular carcinoma patients [150]. Coupled with these findings, 
102 
our results point toward ICAM-1 as a potential target for isolation of clinically relevant 
tumor cells. 
6.4 Conclusions 
We have reported surface marker densities on several model tumor cell linages to 
guide the development of isolation methodologies for live and functional CTC 
populations. The surface density of targeted markers is a critical parameter for any 
antigen-based CTC capture platform, and likely represents a key oversight that has led to 
poor performance of many previously developed technologies. Our results also indicate 
extreme variability in expression between markers and cancer cell lines, and illustrate the 
need for greater appreciation of heterogeneity at the surface marker level across different 
cancer subsets. While Figure 6.3 and Figure 6.4 are presented as mean with standard 
error of mean, Figure 6.6 also shows that the variance in immunofluorescence for cell 
events within each replicate was often considerably higher. This could be due in part to 
the inherent variability within the cultured cell population, as well as due to deviations 
from a mean Kd for each antibody used. As with any antibody based assay, the variance 
in antibody binding affinity from different suppliers should be carefully considered when 
interpreting these data as well as in designing an antibody-based isolation strategy. 
Further, cancer heterogeneity has also been widely reported for in vivo settings [152, 
163]. Cytokine signaling and tumor-stromal interactions can cause certain subsets of 
malignant cells to display drastically altered marker profiles, some resembling stem-like 
phenotypes in what is referred to as epithelial-mesenchymal transition [1]. These highly 
potent subsets have been reported to go largely unnoticed in EpCAM+ based CTC 
isolation strategies, leading many to suggest that perhaps EpCAM alone is not sufficient 
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to capture any and all CTCs [12, 164]. Our findings further support that EpCAM surface 
presentation cannot be assumed to be similar for all tumor lines, and more comprehensive 
targeting strategies that account for expression level variability is warranted. One 
possible strategy would be to use panels of antibodies to target several tumor markers to 
ensure successful capture in instances where certain markers are downregulated. For 
example, Yu et al. targeted patient-derived breast CTCs with a cocktail of EpCAM, 
EGFR, and HER2 antibodies in a microchip device approach, where subsequent 
fluorescent immunostaining of captured cells revealed they possessed highly variable and 
dynamic phenotypes with both epithelial and mesenchymal markers [31]. Building upon 
these types of robust targeting strategies will be vital for developing future generations of 
more clinically relevant fluid biopsy technologies. 
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Table 6.1: Summary of cell types analyzed in the study. Diameter and surface area 
calculations are reported as mean ± s.e.m. 
 
Cell Type Description Diameter (μm) Surface Area (μm
2
) 
MDA-MB-231 
mammary 
adenocarcinoma  
11.5 ± 0.3 415 ± 19 
MCF-7 
mammary 
adenocarcinoma 
17.1 ± 0.4 922 ± 43 
T-47D 
mammary ductal 
carcinoma 
14.5 ± 0.3 663 ± 34 
A549 alveolar adenocarcinoma 15.0 ± 0.4 710 ± 38 
H358 
bronchioalveolar 
carcinoma 
16.8 ± 0.5 890 ± 47 
Peripheral 
Lymphocytes 
Healthy PBMC 6.7 ± 0.1 142 ± 1 
Peripheral 
Monocytes 
Healthy PBMC 7.9 ± 0.1 197 ± 2 
Peripheral 
Granulocytes 
Healthy PBMC 8.2 ± 0.1 209 ± 1 
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Figure 6.1: Plot of regression analysis relating mean forward scatter vs. mean Cellometer 
cell diameter for all five cancer lines. 
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Figure 6.2: Representative bright field micrograph images of cultured breast cancer lines 
(MDA-MB-231, MCF-7, T-47D) and non-small cell lung cancer lines (A549, H358). 
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Figure 6.3: Summary of tumor marker expression on viable cells. Presented as fold over isotype controls for cancer lines and 
healthy peripheral blood mononuclear cells (PBMC) as quantified by flow cytometry analysis of a phycoerythrin reporter label. All 
data reported as mean ± s.e.m. 
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Figure 6.4: Summary of Phycoerythrin labeling density (# PE molecules per μm2 of cell surface) for various tumor marker 
targeting conditions on viable cancer line cells and healthy PBMC. All data reported as mean ± s.e.m. Corresponding antibody 
isotypes are – IgG1: EGFR, CD44, E-cadherin, HER2, N-cadherin, aVb3 integrin, ICAM-1; IgG2a: ER-alpha; IgG2b: EpCAM.  
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Figure 6.5: Summary of phycoerythrin labeling density of all cancer lines studied 
presented as fold expression over healthy monocytes from a peripheral blood sample. 
Data reported as mean ± s.e.m.  
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Figure 6.6: Summary of phycoerythrin labeling per cell for all markers and cell types. Error bars represent the standard error of 
events collected by flow cytometry. Corresponding antibody isotypes are – IgG1: EGFR, CD44, E-cadherin, HER2, N-cadherin, 
aVb3 integrin, ICAM-1; IgG2a: ER-alpha; IgG2b: EpCAM. 
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Chapter 7: The Role of Surface Receptor Density in Surface-Initiated 
Polymerizations for Cancer Cell Isolation 
In this chapter, we demonstrate the labeling density of photoinitiators is strongly 
correlated with the yield of intact cells during ASL by flow cytometry analysis. Results 
suggest ASL is fundamentally capable of delivering approximately 50-60% of targeted 
cells after isolation, which rivals competing methodologies. The gelation response during 
ASL polymerization is also investigated via protein microarray analogs on planar glass. 
Finally, a density threshold of photoinitiator labeling required for protection during lysis 
is determined for both monomer formulations. These results indicate ASL is a promising 
technology for high yield CTC isolation for rare-cell function assays and fluid biopsies. 
The chapter presented here is adapted with minor modifications from the following work 
currently in review: 
Jacob L. Lilly, Brad J. Berron. The Role of Surface Receptor Density in Surface-
Initiated Polymerizations for Cancer Cell Isolation. Langmuir, In Review. 
7.1 Introduction 
Fluid biopsies potentially offer a minimally invasive alternative to traditional 
tissue biopsies for the continual monitoring of metastatic cancer [33, 165]. Current 
established technologies for isolating circulating tumor cells (CTCs) suffer from poor 
purity, yield, and require fixatives that preclude the collection of viable cells for 
longitudinal analyses of biological function. Antigen Specific Lysis (ASL) is a rapid, 
high-purity method of cell isolation based on targeted protective coatings on antigen-
presenting cells and lysis depletion of unprotected antigen-negative cells. In ASL, 
photoinitiators are specifically labeled on cell surfaces that enable subsequent surface-
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initiated polymerization. (See Appendix A-5 for details on cell protein specificity) While 
we have shown ASL delivers viable (~90%) and highly pure (>97%) populations of 
marker-presenting cells, cell yield has yet to be fully investigated for this process. For 
CTC sorting, target cells exist in extreme rarity (~1 per 106 nucleated cells). Increasing 
isolation yield will minimize the occurrence of false negatives and potentially provide the 
key difference for an accurate diagnosis. Further, for any antigen-based isolation 
platform, successful positive capture of cells is inherently dependent on the density of 
surface markers available for targeting. For ASL, the surface density of markers dictates 
the concentration of eosin photoinitiators present at the cell surface. A distinct threshold 
eosin density has been previously reported for surface-mediated polymer amplification 
assays, below which radical generation is not sufficient for gelation [92, 125]. Therefore, 
we hypothesize a minimum density of antibody-photoinitiator binding is required to form 
complete protective coatings. 
Herein, we investigate the effect of photoinitiator loading on polymerization and 
lysis-based negative depletion of cells. (Figure 7.1) A non-small cell lung cancer line 
(A549) serves as a model CTC. To eliminate heterogeneity in surface marker clustering, 
our investigation first nonspecifically biotinylates the cell surfaces for polymer protection 
studies. This approach allows for more consistent biotin functionalization and limits the 
potential for signaling activation that targeting a specific marker might enact, which 
could influence our results. We then shift to the more clinically relevant antibody-based 
strategies, targeting either EpCAM or a panel of metastatic markers for comparison to our 
covalent labeling approach. Finally, we relate the density dependent protection to thin 
film polymerization behavior on an analogous system of biotin-functionalized protein 
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microarrays. These glass microarrays afford a controlled environment to quantitatively 
determine the gelation response to the photopolymerization conditions used in the cell 
studies. 
The impact of this study extends beyond our new lysis isolation process to the 
field of immunoprotective coatings on cells. Immunoprotection requires a complete 
polymer barrier to isolate the non-native cellular material from a host’s immune response. 
Several groups are utilizing nano- and micro-scale polymers to isolate individual cells 
from immune response [54, 166-170]. As the thickness of these materials decreases, the 
diffusive flux of oxygen and low molecular weight nutrients increases. Critically, as the 
coating thickness approaches the diffraction limit of light, it is increasingly challenging to 
visually verify the completeness of the coating. This study uses surfactant lysis as a new 
approach to cheaply and quickly verify the completeness of the coating.  
7.2. Materials and Methods 
7.2.1 Reagents and Materials 
The A549 cell line (non-small cell lung cancer) was purchased from American 
Type Culture Collection. RPMI-1640 culture media, penicillin/streptomycin (1%), and 
trypsin/EDTA (0.25%) were supplied by Gibco™. Advantage-grade fetal bovine serum 
(FBS) was purchased from Atlanta Biologicals. Lyophilized streptavidin, streptavidin-
Cy3 conjugate, biotinylated bovine serum albumin (b-BSA), sulfo-NHS-LC-biotin, 
CellTracker™-Deep Red dye, Hoechst 33342 stain, and yellow-green FluoSpheres™ 
nanoparticles (0.02μm, carboxylate-terminated, 505/515nm excitation/emission) were 
purchased through Thermo Fisher Scientific. Bovine serum albumin (BSA), Polyethylene 
glycol diacrylate (Mn~575), Polyethylene glycol (Mn~3400), monomer MEHQ dehibiting 
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columns, 1-vinyl-2-pyrrolidinone, acryloyl chloride, triethylamine, Eosin-5-
isothiocyanate (EITC), sodium dodecyl sulfate (SDS) were all supplied from Sigma 
Aldrich. Triethanolamine (TEA), dichloromethane (DCM), and diethyl ether were 
supplied by Fisher Chemical. DNase I (>500U/mg, from bovine pancreas) was supplied 
by Biomatik. Monoclonal antibodies against EpCAM (IgG2b, clone 9C4), CD44 (IgG1, 
clone BJ18), and HER1/EGFR (IgG1, clone AY13) were purchased from BioLegend, and 
anti-ICAM-1 (IgG1, clone HA58) was purchased from eBiosciences. Biotinylated goat 
anti-mouse IgG antibody was purchased from Vector Labs. Streptavidin R-phycoerythrin 
conjugate was purchased from Anaspec. The QuantiBRITE phycoerythrin (PE) 
fluorescence flow cytometry quantitation kit was supplied by BD Pharmingen. 
7.2.2 Monomer Synthesis and Preparation 
Polyethylene glycol diacrylate (Mn~575, PEGDA-575) was twice flowed by 
gravity through a dehibiting column to remove the polymerization inhibitor monomethyl 
ether hydroquinone, and stored for use protected from light at room temperature. 
Polyethylene glycol (Mn~3400) was dissolved in DCM and reacted with acryloyl chloride 
and triethylamine according a previously published protocol [171]. Monomer product 
purity (~90% acrylation yield) was confirmed by 1H-NMR and was stored at 80% (w/v) 
in water protected from light. Co-monomer 1-vinyl-2-pyrrolidinone was used as received.  
7.2.3 Photoinitiator-Protein Conjugation 
The conjugation reaction to label eosin-5-isothiocyanate to streptavidin primary 
amines was adapted from a previous protocol with only a minor protocol modification of 
reacting at pH 10 in 0.1 M carbonate/bicarbonate buffer [98]. Conjugates were purified 
115 
with a 5 mL 7 KDa MWCO Zeba desalting column and the molar ratio confirmed with 
UV-vis analysis of absorbances at 280nm and 530nm. (see Appendix A-2 and A-3) 
7.2.4 Cell Culture and Fluorescent Labeling 
A549 cells were cultured in RPMI-1640 supplemented with 10% FBS and 1% 
penicillin/streptomycin at 37˚C and 5% CO2 for approximately 48 hours. Cell flasks were 
75-90% confluent at the time of experimentation. To harvest the A549 cells, the culture 
media was removed and the cells were washed with 37˚C sterile phosphate buffered 
saline (PBS 1X). Trypsin/EDTA (0.25%) was added to each flask and incubated for 3-5 
minutes. Fresh culture media was added to the flask and gently rinsed by pipetting to 
detach cells. The cell suspension was then centrifuged at ~500g for 3 minutes and the 
supernatant discarded. The cell pellet was resuspended in fresh media and immediately 
stored on ice. To begin fluorescent labeling cell samples, cells were first centrifuged at 
500g for 1.5 minutes at 4˚C and resuspended in cold PBS by gentle vortexing. Initial cell 
counts from culture were obtained by flow cytometry using an Accuri C6 cytometer and 
adjusted to 1x106 per sample tube. Cells were rinsed in cold PBS twice more, then 
resuspended by vortexing in 0.5 μM CellTracker™-Deep Red in cold PBS and incubated 
for 30 minutes on ice. Samples were then rinsed three times with cold PBS as before. 
Experiments investigated two groups: covalently biotinylated cell samples and antibody 
immunolabeled samples.  
For covalent biotinylation, cells were incubated with 1 mM sulfo-NHS-LC-biotin 
prepared in cold PBS for 30 minutes then rinsed three times with cold PBS. Cells were 
then rinsed once more with PBS supplemented with 3% FBS in PBS (PBS/FBS) and 
incubated for 10 minutes on ice. To predictably and incrementally vary photoinitiator 
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loading while keep covalent biotinylation conditions constant, streptavidin-EITC was 
combined with unconjugated streptavidin at known and varied ratios with a total 
streptavidin concentration of 25 μg/mL. Upon contacting with cells for 30 minutes, the 
proteins competitively bound to biotin sites, allowing for photoinitiator (eosin) to be 
reliably loaded at desired levels. After rinsing twice with cold PBS, cell count was 
obtained by cytometry and adjusted to 3x105 cells per sample tube to ensure consistent 
cell density during cell photopolymerization. 
For antibody labeling of samples, cells were incubated with primary antibodies 
(anti-EpCAM or a “metastatic” cocktail of anti-CD44, anti-ICAM-1, and anti-EGFR) 
consisting of 0.5 μg of each antibody in 100 μL PBS/FBS for 40 minutes, then rinsed 
three times in PBS/FBS. Cells were then resuspended in 1:400 dilution of biotinylated 
goat anti-mouse IgG antibody in PBS/FBS for 40 minutes, and rinsed again three times 
with PBS/FBS. After the biotinylation by immunolabeling, samples were incubated with 
25 μg/mL SA-EITC for 30 minutes protected from light. After rinsing twice with cold 
PBS, cell count was obtained by cytometry and adjusted to 3x105 cells per sample tube to 
ensure consistent cell density during cell photopolymerization. A negative labeling 
control was also performed for each monomer formulation that consisted of A549 cells 
incubated with 25 μg/mL SA-EITC for 30 minutes without prior incubation with 
biotinylating agents, followed by the polymerization and lysis procedures detailed for 
biotinylated samples. 
7.2.5 Cell Suspension Photopolymerization and Lysis 
Polymerization formulations were prepared in PBS consisting of 21 mM TEA, 35 
mM VP, with 25% (w/v) of either PEGDA-575 or PEGDA-3500, and 0.05% (w/v) 
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Fluosphere nanoparticles. All formulations were adjusted to pH~7.5 with 1.2 M HCl and 
purged with humidified, ultra-pure N2 for 15 minutes just prior to combining with cells. 
Each sample was polymerized in a sterile cover glass-bottom 35 mm culture dish placed 
inside a 150 mm culture dish outfitted with purging inlet and outlet ports. (See Appendix 
Figure A-1) The entire system was purged with N2 for 5 minutes, at which point 
irradiation light was introduced while continuing to purge, consisting of 30 mW/cm2 
collimated 530 nm light (ThorLabs LED lamp) for 10 minutes. Lysing solutions were 
prepared in two parts: (1) DNase I solution of 5 mM MgCl2, 1 mM CaCl2 and 500 U 
DNase I in PBS, (2) 10% SDS in PBS. Lysing in the presence of DNase minimizes cell 
clumping due to free DNA in solution. After polymerization and rinsing, each cell pellet 
was gently resuspended in 500 μL of solution (1) and incubated for 5 minutes at room 
temperature, followed by addition of 500 μL of solution (2).  
7.2.6 Flow Cytometry and Cell Fluorescence Analysis 
Cell samples were analyzed during the isolation process just before addition of 
polymerization solution and after the lysis procedure to calculate the percent yield. To 
obtain a cell count before polymerization, each sample was redistributed evenly in 10 mL 
of cold PBS, and then 150 μL of the suspension was pipetted off for analysis. Cytometer 
fluidics were set to analyze 100 μL of the sample volume. “Positive” cell counts were 
defined from controls as FL4+ (CellTracker-Deep Red) and FSC≥2x106 (intact cell). (see 
Figure 7.2) Additionally, the FL1 channel was monitored in this gated population to 
determine the SA-EITC loading corresponding to each sample. Identical run constraints 
and gating were imposed after lysis to monitor yield. In parallel experiments, 
streptavidin-PE conjugates were also reacted with covalently biotinylated A549 
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populations at identical conditions to streptavidin-EITC binding experiments at various 
loading levels to calibrate FL2 of streptavidin-PE loaded samples vs. FL1 of SA-EITC 
loaded samples. Samples of 10,000 events were analyzed by flow cytometry and the FL2 
mean fluorescence of SA-PE tagged samples was plotted vs. FL1 of identically 
biotinylated SA-EITC samples, shown in Figure 7.3.a. BD QuantiBRITE PE quantitation 
beads were then used to quantify PE fluorescence by vortexing in 500 μL PBS and 
analyzing in the FL2 channel to calibrate PE binding on biotinylated A549 cells, as 
shown in Figure 7.3.b. The degree of substitution (DOS) of SA-PE and SA-EITC was 
also determined for fluorescent analysis. The mean DOS of SA-PE was provided by the 
manufacturer (Anaspec) to be 1.07 phycoerythrin per streptavidin. The DOS of the SA-
EITC conjugate was determined by UV-Vis analysis. Standard curves of unconjugated 
streptavidin and EITC were prepared, allowing for Equation A-2.1 to be generated that 
outputs the molar ratio of EITC to SA. The UV-vis of the conjugate used in this study is 
shown in Figure A-2, and the absorbance values at 280 nm and 530 nm were used to 
calculate a mean DOS of 4.05 eosin groups per streptavidin. Finally, an average cell 
diameter of 17 μm was determined through automated bright field image analysis with a 
Cellometer cell counter (Nexelcom) and was used to calculate average cell surface area 
of 908 μm2, assuming a perfect spherical cell geometry. Using these data with the 
fluorescence cytometry calibrations listed above, Equation 7.1 was developed to 
determine eosin molecule density from the mean FL1 obtained for each yield 
experimental trial.  
7.2.7 Cell Fluorescent Imaging 
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A549 cells were imaged after exposure to lysing conditions with a Nikon Ti-U 
inverted epifluorescent microscope. Cells were incubated with 5 μg/ml Hoechst 33342 
stain for 10 minutes, rinsed once with cold PBS and pipetted onto a coverslipped 
microscopy slide for imaging with a 20x objective. Hoechst DNA staining was imaged 
with UV excitation, followed by an overlay image of blue excitation to visualize the 
yellow-green imaging nanoparticles loaded in polymer coatings. 
7.2.8 Microarray Fabrication and Hydrogel Film Formation 
Epoxy-functionalized slides were washed with ethanol and loaded into an 
Affymetrix 417 Arrayer. Serial dilutions of bio-BSA and BSA were prepared in PBS, 
keeping the total protein concentration in solution constant at 1 mg/ml. Biotinylated-BSA 
concentration was varied to print 12 concentrations (1000, 400, 160, 64, 25.6, 10.2, 4.1, 
1.64, 0.66, 0.26, 0.1, 0 μg/ml). Each slide was printed with an array of 24 spots with each 
concentration duplicated as shown in Appendix A-4. Slides were allowed to dry 
overnight before experimentation. Each array slide was loaded into a Whatman Chip Clip 
slide incubation apparatus, and blocked for 1 hour with 1 mg/ml BSA in PBS. Slides 
were then incubated for 30 minutes in 25 μg/ml SA-EITC in 1 mg/ml BSA in PBS. 
During incubation, the slides were protected from light to prevent photobleaching during 
photoinitiator loading at biotinylated sites. Slides were then rinsed 3 times with PBS, and 
photopolymerized with either PEGDA-575 or PEGDA-3500 monomer formulations at 
identical conditions as detailed above for live cell coatings. Slides were then washed once 
with PBS, 3 times with deionized water, and allowed to dry for 1 hour. To measure 
thickness response, a Dektak 6M stylus profilometer was used with a 1 mg stylus force 
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and a scan rate of 120 μm/s. Average height of each spot was measured, with n=6 spots 
for each measurement. 
7.2.9 Cy3 Calibration of Slide Fluorescent Labeling 
Array fluorescence was measured using an Affymetrix 428 Array Scanner. 
Streptavidin-Cy3 conjugates were contacted with array slides at identical conditions as 
for SA-EITC conjugates detailed above (n=6 spots at each concentration analyzed for 
Cy3 binding). Both SA-Cy3 and SA-EITC fluorescence was then measured with 532 nm 
laser excitation, detection with a PMT with a bandpass filter centered at 570 nm, and the 
gain set at 30 db. Array spot binding density was then calculated by calibrating at 30 db 
gain with a Cy3 scanner calibration slide from Full Moon Biosystems. Calibration slides 
contain 12 replicate spots of 28 different concentrations arranged at a 2-fold dilution. By 
UV-Vis spectroscopy analysis of SA-Cy3 and SA-EITC conjugates (Figure A-2.4, 
Equation A-2.1, Figure 7.4, Equation 7.2), the ratio of EITC to Cy3 functionalization 
was calculated to be ~2.1, which allowed for photoinitiator surface density to be 
calculated for each printed array spot.  
7.3 Results and Discussion 
The overall goal of this work was to determine to effect of photoinitiator labeling 
density on the gelation response and cell protection efficiency (i.e. yield) in lysing 
conditions. A549 lung cancer cells are biotinylated either covalently or with antibody 
targeting, then coated by visible light photopolymerization. The protection afforded by 
the coating was determined by exposing the coated cells to lysing conditions and 
interrogating the remaining cells by both fluorescent microscopy and flow cytometry. In 
parallel, an analogous planar microarray system is biotinylated and exposed to identical 
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photopolymerization conditions to provide hydrogel film thickness information about our 
system by profilometry analysis. Photoinitiator binding density is quantified 
fluorometrically in both experimental scenarios for comparison.  
We first confirm the structural integrity of polymer coated cells in a 5% SDS lysis 
solution. Figure 7.5 shows an overlay of fluorescent micrograph images of A549 cells 
encapsulated with crosslinked PEGDA-3500 just after exposure to 5% SDS lysis 
solution. Here, cells were biotinylated with the “metastatic” antibody cocktail (anti-
CD44, Ant-ICAM-1, anti-EGFR). Panel (a) shows a fluorescent image of yellow-green 
fluorescent imaging nanoparticles previously shown to be physically entangled in the 
crosslinked film mesh in similar systems [97], showing visible fluorescent signal 
completely surrounding the cell perimeter. Panel (b), taken at the same stage position, is 
Hoechst 33342 DNA staining, which exhibits fluorescence confined to a smaller region 
than the polymer coating. The smaller localization of the DNA is consistent with a 
structurally-intact nuclear envelope. Frame (c) shows the blue and green channel 
overlaid, suggesting the cells have remained protected and intact and nuclear DNA 
localization has remained largely unaltered. We were unable to image any distinct 
structures in the cellular lysate of unprotected cells. Further, we have previously shown 
polymer coated cells are viable and proliferate after removal of the coating. In all, 
fluorescent imaging of the polymer supports the formation of a conformal coating, while 
nuclear staining supports the integrity of polymer coated cells in lysis conditions. 
7.3.1 Relationship Between Initiator Density and Cellular Protection  
Our seminal work in ASL work describes a binary relationship between specific 
photoinitiator labeling with antibodies and protection from surfactant lysis. On a 
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fundamental level, any antibody-based labeling is a contrast between specific and 
nonspecific labeling. As a result, our prior work implies that the specific labeling is 
sufficient to form a protective coating and nonspecific labeling is insufficient. In reality, 
the marker density of different surface receptors varies by several orders of magnitude 
within a single cell type. As such, even for a single cell type and a single marker, one 
would expect some cells to have high marker density and some to have low marker 
density. We hypothesize that this heterogeneity in marker density will translate to a 
comparable heterogeneity in photoinitiator density on the surface. In this same 
population, only a given fraction of cells will have sufficient photoinitiator density to 
completely form a protective coating on the given cell. Thus, only a fraction of the cells 
are expected to remain intact after surfactant exposure. The fraction of intact cells 
following surfactant exposure is expected to increase with an increase in the mean 
photoinitiator density for the population. In antigen labeling experiments, this equates to 
higher yields for higher surface densities of the targeted marker. 
Figure 7.6 shows the results of the flow cytometry analysis of process yield 
dependence on mean photoinitiator labeling density of each sample. The presence of an 
intact cell was defined by both size and fluorescent intensity. A549 cells were labeled 
intracellularly with CellTracker Deep Red at the outset of each experiment to enable flow 
detection with the 630 nm laser and 675/25 nm filter combination in the FL4 channel. 
The excitation-emission spectra for this dye was specifically chosen because of the 
spectral separation at higher wavelengths from the photoinitiator, imaging nanoparticles, 
and irradiation lamp used in this study to provide a distinct and reliable fluorescent 
indicator of an intact cell event. Additionally, intact A549 populations consistently show 
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forward scatter above ~2,000,000 for our instrument. Thus, a “positive” intact cell event 
was defined based on live stained A549 controls by quadrant gating FSC vs FL4 as FSC 
> 2,000,000 a.u. and FL4 > 30,000 a.u. (Figure 7.2). The yield of intact cells was 
calculated as the cell count per 1 mL after lysis divided by the cell count per 1 mL just 
before polymerization. The mean photoinitiator density (fluorophores/μm2) for each data 
point was determined by calibrating overall streptavidin-photoinitiator binding to A549 
with a QuantiBRITE fluorescence quantitation assay, and then normalizing with the 
calculated spherical model surface area. 
Figure 7.6.a shows a summary plot of A549 yield versus photoinitiator density 
for polymer coating with 25 wt% PEGDA-575. Each data point represents an 
independent isolation experiment. Covalently biotinylated samples were incrementally 
loaded by competitive binding of varied ratios of streptavidin-photoinitiator and 
unconjugated streptavidin. As expected, the yield of intact cells after lysis depletion was 
strongly and directly dependent on photoinitiator surface density. At the lowest loading 
density investigated (~1,600 eosin molecules per μm2), the yield was <1%, while at the 
highest bound of our PEGDA-575 study of above 54,000 eosin molecules per μm2 
showed nearly 50% yield of intact cells. Figure 7.6.b shows a similar summary plot of 
isolation yield dependence on photoinitiator loading for PEGDA-3500 
photopolymerization. As before, A549 cell samples were biotinylated covalently by 
succinimide-amine chemistry indiscriminately on surface proteins, then loaded with 
streptavidin eosin at incrementally varied levels by competitive binding with 
unconjugated streptavidin. At the lowest level of eosin loading of ~1,300 molecules per 
μm2, yield was again below 1%, while for the highest bound of eosin functionalization at 
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~43,000 molecules per μm2, the yield here for PEGDA-3500 coated samples was as high 
as 68%. For both monomer formulations, there is a distinct trend for a larger fraction of 
cells remaining intact when protected by a coating formed with a higher mean surface 
density of the eosin photoinitiator. This qualitatively agrees with our hypothesis that 
more cells in the population are above a threshold photoinitiator density required for 
protection.  
With a protection trend established with nonspecific biotin functionalization of 
cell surfaces, we sought to verify this trend in an antibody labeling system. In separate 
experiments, cancer cell targeting scenarios were also investigated using antibodies. We 
have previously shown that A549 exhibit significantly lower surface density of epithelial 
markers (EpCAM and E-cadherin) than stem-like markers such as CD44 and metastasis 
markers like EGFR and ICAM-1 [172]. Figure 7.6.a shows that EpCAM targeting 
resulted in low photoinitiator loading density in agreement with our previous findings of 
below 1,200 eosin molecules per μm2. The low eosin surface concentration using 
EpCAM resulted in low isolation yield near 1% for a PEGDA-575 monomer solution. 
For PEGDA-3500 in Figure 7.6.b, eosin loading was also below 1,200 molecules per 
μm2 and delivered correspondingly yield of intact cells at around 1%. The yield of intact 
cells for both monomers are in close agreement with predictions based on the covalent 
labeling studies.  
In separate experiments, A549 cell samples were also biotinylated by targeting a 
panel of markers implicated in metastasis, which included CD44, ICAM-1, and EGFR. In 
Figure 7.6.a, this antibody targeting strategy allowed for much higher surface densities 
of between 10,000 and 20,000 eosins per μm2, and resulted in higher yield of intact cells 
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of approximately 20% for the PEGDA-575. Similarly, the metastatic marker targeting 
resulted in ~10% yield of intact cells for the PEGDA-3500. The qualitative trend of 
higher yields was in fairly good agreement with the percent yield of corresponding 
covalent biotinylated samples of similar photoinitiator loading. Further, Figure 7.7 shows 
a negative control representing nonspecific labeling of streptavidin-photoinitiator without 
biotinylation by antibodies or covalent grafting. For both monomer formulations, 
photoinitiator loading densities were in the range of 100-200 eosin molecules per μm2 
and yielded <0.1% intact events, indicating that protection during lysis is predominantly 
due to the specific labeling of streptavidin-photoinitiator at biotinylated sites. 
7.3.2 Analysis of Photopolymerization Gelation Response 
Quantitative comparison of the lysis protection by PEGDA-575 and PEGDA-
3500 indicates a higher yield of intact cells for the PEGDA-3500. Specifically, a PEGDA 
575 coating from a photoinitiator density of 35,000 molecules per μm2 results in ~35% 
yield, while the same photoinitiator density provides ~60% yield using the PEGDA-3500 
monomer. To determine if this discrepancy originates in the sensitivity of polymer 
formation, we studied the polymerization of each monomer system on protein 
microarrays. Because of the inherent variability in cell geometry and morphology, direct 
measurement of nanothin film coating thickness on suspended cell substrates is 
prohibitively challenging. Protein microarrays on glass offer a reproducible platform to 
analyze these thicknesses (Figure 7.8.a-c). Photoinitiator surface densities can be tuned 
to recapitulate the range seen on cancer cell surfaces during ASL (0 to 20,000 eosin 
molecules per μm2). Figures 7.8.d and Figure 7.8.e show plots of measured profilometry 
thickness of polymerized microarrays at varied photoinitiator densities. 
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Photopolymerization conditions were identical to those used for cell suspensions for both 
PEGDA-575 and PEGDA-3500 formulations. Plot 7.8.d shows the gelation response for 
PEGDA-575 reaches average thickness of 85 nm at the high bound of the array 
experiment at approximately 17,000 eosin molecules per μm2. Plot 7.8.e shows the 
gelation response for PEGDA-3500 which exhibits a lower gel thickness response, 
reaching approximately 40 nm at the highest eosin density investigated.  
Figure 7.8 also indicates that polymer forms at photoinitiator densities of ~100 
and ~1,000 for PEGDA 575 and 3500, respectively. This observation is contrasted with 
the cell yield data, where comparable densities offers negligible protection (~1% yield, 
Figure 7.6). This underscores the requirement of a complete coating for protection 
against lysis. This has dramatic implications for the purity of ASL isolation, where cell 
with low levels of nonspecific adsorption is unlikely to protect a cell against lysis. 
Similarly, if large antibody aggregates adhere to a cell surface, it is unlikely to form a 
complete protective coating around the cell. The higher threshold of the PEGDA-3500 
over PEGDA-575 suggests the 3500 system requires a higher antigen density for 
protection over the PEGDA-575 system. The distinction between the 575 and 3500 
systems is not definitively observed in the yield data in Figure 7.6. Critically, the data in 
Figure 7.6 is an analysis based on population means, where cell-level data is obscured.  
7.3.3 Determining Photoinitiator Loading Threshold Required for Isolation 
The calculated mean photoinitiator density is not a sufficient parameter to 
determine a required photoinitiator density for the protection of a given cell. To 
determine a minimum threshold density for protection, we must further examine the 
distribution of eosin-label density for each population. If an exact threshold exists, we 
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would expect every cell of higher eosin density than the threshold to remain intact 
through the lysis. As such, we expect a population with X % of events having greater 
eosin density than the threshold to have a yield of X %. To evaluate this we calculated the 
yield of each population and drew a line on the surface density histogram where the 
fraction of events with higher eosin density than the line is equal to that sample’s yield. 
Further, we would expect this threshold to be the same for every trial. For example, if a 
hypothetical isolation run resulted in 60% yield intact cells, the histogram of eosin 
labeling for that experiment would be labeled at a density corresponding to 60% of events 
above the threshold. We then analyzed the surface density corresponding to that line for 
each population.  
Figure 7.9 shows representative “low”, “mid”, and “high” photoinitiator labeling 
examples from our study for both PEGDA-575 and PEGDA-3500 polymer formulations. 
In Figure 7.10, we plot this threshold gate for all data trials for both PEGDA-575 and 
PEGDA-3500. There is a general upward trend in threshold photoinitiator density for the 
PEGDA-575. In the PEGDA-3500 system, the calculated threshold density value is 
independent of process yield. While the mean photoinitiator density shifts drastically in 
these systems (~50 fold change), the hypothetical density threshold corresponding to the 
yield only varies by 4 fold. This suggests that the eventual yield delivered is a strong 
function of the population distribution of initiator labeling in relation to this threshold. 
Based on our cytometry labeling calibration analysis described above, these threshold 
photoinitiator densities are roughly 27,000 eosin molecules per μm2 and 21,000 eosin 
molecules per μm2 for PEGDA-575 and PEGDA-3500 formulations, respectively.  
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7.4 Conclusions 
In this work we have investigated the relationship between marker expression 
density on cancer cells and the yield of intact cells during ASL. A lung cancer cell line 
(A549) was used as a model CTC and cells were incrementally biotinylated via 
covalently functionalization and subsequent competitive binding with PI-conjugated and 
unconjugated streptavidin, which provided a predictable prototypic system to 
methodically study labeling density effects on yield. We have shown a strong, direct 
correlation between photoinitiator surface density and yield of protected, intact cells. 
Based on previous work [171], we expect these results to translate to heterogeneous cell 
suspensions and represents a critical first step in validating ASL as versatile platform for 
CTC isolation.   
Further, there was no appreciable difference between covalent eosin 
functionalization and the antibody targeting strategies examined here. Mammalian cell 
membranes are a complex, dynamic composition of cell proteins and other biomolecules 
that are distributed over the cell surface into discrete locations, often non-randomly. We 
realized caution should be taken when selecting biomarkers for photoinitiator targeting 
because some have been shown to cluster into “islands” [173], which could exaggerate 
non-uniformity in expression and lead to incomplete coating formation. Because little 
difference was seen between covalent biotinylation and the markers selected here, we 
conclude that any surface protein clustering phenomena were not significant enough to 
preclude successful isolation of the cell/antigen systems studied. 
Finally, we purposely chose to investigate an expanded photoinitiator loading 
range through covalent targeting that far exceeded conventional antibody targeting, and 
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showed elevated yield response at higher photoinitiator loading levels. These results 
suggest ASL would potentially benefit from the design and implementation of 
streptavidin-macrophotoinitiators that have been shown to direct several fold greater 
quantities of photoinitiator molecules to each site of biotin recognition and increase 
polymer amplification response [141]. Moving forward, development of such routes to 
increased gelation response to biorecognition could conceivably enable robust positive 
isolation based on targeting poorly expressed proteins that may be of high clinical 
relevance. 
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Figure 7.1: Schematic of surface polymerization approach for cancer cell isolation. 
Photoinitiator loading dictates yield of polymerized cells in surfactant lysis conditions. 
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Figure 7.2: Flow cytometry control plot of forward scatter vs. FL4 showing gating 
definition of an intact cell in upper right quadrant. 
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Figure 7.3: (a) Linear regression of FL2 vs. FL1 for calibration of SA-PE and SA-EITC 
labeling at varied biotinylation. (b) Cytometry standard curve of FL2 for R-phycoerythrin 
functionalized beads. 
 
 
Equation 7.1: Calibration equation to relate photoinitiator cell surface density to mean 
FL1 of individual cell samples.   
# 	 . .
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Figure 7.4: UV-vis absorbance spectra of streptavidin-Cy3 conjugate. 
 
 
Equation 7.2: Equation to calculate the DOS of Cy3:SA by regression analysis of UV-
vis analysis of absorbance values at 280 nm and 550 nm. 
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Figure 7.5: Fluorescent micrograph overlays of PEGDA coated A549 cells after 
exposure to 5% SDS lysing conditions. (a) Fluorescent signal from 20 nm yellow-green 
imaging nanoparticles physically entangled in polymer mesh. (b) Hoechst 33342 blue 
DNA staining. (c) Overlay of yellow-green nanoparticle and Hoechst 33342 images. 
Scale bars represent 50μm. 
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Figure 7.6: Plots of ASL isolation experiments showing yield intact yells attained after 
lysis vs. corresponding mean photoinitiator density via either covalent or antibody 
biotinylation for (a) PEGDA-575 and (b) PEGDA-3500 monomers during 
photopolymerization. 
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Figure 7.7: ASL negative control of A549 targeting. % Yield of intact cells for non-
specific SA-EITC labeling for (a) PEGDA-575 and (b) PEGDA-3500 monomer 
formulations.  
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Figure 7.8: (a) Schematic of polymer microarrays to analyze gelation response vs. 
photoinitiator density. Biotin-BSA protein arrays are printed at serial dilution, contacted 
with SA-EITC and photopolymerized with cell encapsulation conditions. Panel (b) shows 
fluorescent array scanner image showing specific SA-EITC binding and fluorescence. (c) 
Fluorescent microscopy image after photopolymerization showing fluorescent 
nanoparticle loaded polymer film formation. Scale bar represents 500 μm. Contact 
profilometry thickness analysis vs. photoinitiator surface density of (d) PEGDA-575 and 
(e) PEGDA-3500 monomer formulations. Errors bars represent standard error for n=6 
spot concentrations. 
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Figure 7.9: Photoinitiator density threshold analysis. Representative histograms for 
“low”, “mid”, and “high” photoinitiator loading trials and the FL1 intensity of the gating 
corresponding to the % yield of each individual experiment for both (a) PEGDA-575 (b) 
PEGDA-3500. 
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Figure 7.10: The threshold photoinitiator density corresponding to each individual 
isolation % yield shown for (a) PEGDA-575 and (b) PEGDA-3500 formulations. 
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Chapter 8: Conclusions and Future Perspectives 
 In this work, we explored the development of cell surface coatings formed by 
interfacial polymerization for protection during a lysis-based isolation method. This 
dissertation demonstrated several key findings for this novel technique. First in Chapter 
4, individual cells were encapsulated with complete and conformal PEG crosslinked 
coatings, and are shown to remain highly viable through this biocompatible process. 
Polymer coatings are specifically formed from photoinitiator-tagged cell surface 
receptors through polymer-based amplification. Further, these film coatings exhibit size 
selective permeability, completely excluding fluorescent dextran molecules above a 
molecular weight of approximately 10 kDa. We then further explored this coating 
technique to specifically target and sort marker-presenting cells in heterogeneous 
mixtures in Chapter 5. Notably, model CTCs were sorted with exceptional purity (~99%) 
from spiked human buffy coat by targeting the EpCAM surface marker. Designed ortho-
nitrobenzyl groups between crosslinks allows for photodegradation of positively-sorted 
cell to release pure populations for further analysis. Viability and proliferation assays 
showed these sorted and released cells are highly viable and proliferative compared to 
controls of cultured cells. While this study demonstrated ASL has great promise for high 
performance cell sorting of viable cells, we then focused on further examining marker 
availability and the feasibility of potential targeting scenarios. Chapter 6 examined the 
available densities of a panel of metastatic markers on commonly studied breast and lung 
cancer lines, revealing extreme variability between markers and cell lines. This showed 
that greater appreciation for biological heterogeneity is warranted when designing 
isolation targeting strategies, particularly for CTCs which have been shown to 
141 
downregulate epithelial markers. Finally in Chapter 7, our last study related the marker 
density for targeting to the eventual ASL process yield, and showed that targeting 
metastatic markers on A549 cells resulted in significantly higher process yield, as 
expected from the prior marker density analysis. In this work, we also determined a 
density threshold of photoinitiator functionalization on A549 for complete gelation and 
successful positive isolation that we expect to be generally applicable to other cell 
targeting scenarios.  
Uniquely, we have demonstrated high performance for this sorting technique with 
components that are inexpensive and generally commercially available.  The LED lamps 
to initiate polymerization are approximately $1000 each, and the costs for antibodies used 
in photoinitiator tagging are continuing to decrease as immunolabeling becomes more 
commonplace for virtually all biological research fields.  The processing containers are 
pre-sterilized polystyrene or polypropylene cell culture products that are disposable, 
eliminating the need for lengthy and costly cleaning as required for fluorescent sorting. 
These low costs of processing could conceivably make ASL more accessible to a broader 
range of researchers that are generally not able to use other high cost competing 
technologies.  
8.1 Future Perspectives 
The results presented in this dissertation suggest ASL is a promising technology 
for the rapid sorting of tumor cells. However, there are several barriers to development 
and clinical implementation. The following sections detail these challenges and the future 
goals of this research direction. 
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8.1.1 Correlating Marker Targeting Scenarios with Invasive Functionality of CTCs 
This work previously demonstrated the proliferative capacity and viability of cells 
after sorting. However, in the context of CTCs the most definitive assessment of 
functionality is direct measurement of invasiveness and motility. Therefore, we will 
evaluate the functionality of CTCs toward metastatic potential using a Matrigel basement 
membrane invasion assay. We expect that cells possessing the appropriate repertoire of 
migratory proteins and signaling will be able to dissolve the basement membrane 
mimicking 3D culture and will invade the farthest into the gel. The model CTCs with the 
high metastatic relevance will be generated by TGF-β stimulation, whereas tumor lines 
directly from normal epithelial culture will display lower metastatic potential. We 
hypothesize that sorting EMT stimulated model CTCs with stem cell markers will yield 
cells with the highest invasive potential in the Matrigel assay, given that the markers 
targeting allow sufficient eosin priming above the coating isolation threshold. 
Conversely, sorting tumor cells with epithelial markers that have not been stimulated 
toward a mesenchymal phenotype will yield cells with a lower invasive phenotype. All 
sorted scenarios will be compared to the parallel controls of cultured tumor lines seeded 
at matching cell densities into the Matrigel invasion wells. We expect that sorted cells to 
behave similarly to unsorted controls, in that they will proliferate and invade similarly. 
Additionally, migratory potential will also be confirmed with a wound healing scratch 
assay. As in the Matrigel assay, we expect that EMT stimulated model CTCs to migrate 
at a faster rate than non-stimulated counterparts. We again hypothesize that sorting by 
stem markers will yield populations with higher migratory potential than sorting by 
epithelial markers, and that sorted cells will migrate comparably to pre-sorted controls. 
143 
These assays will serve to both validate the metastatic functionality of CTCs sorted by 
ASL as well as further link a stem-like phenotype to higher invasive potential. We expect 
that these validations will inform the development of ASL as a more clinically relevant 
CTC isolation technology capable of delivering pure populations of biologically 
functional metastatic cells for analysis. 
8.1.2 Developing ASL for Clinical Translation 
 Several challenges must be overcome to enable the translation of ASL as a 
clinically useful fluid biopsy technology. First, because these tumor cells circulate in 
metastatic patients at extreme rarity, the process yield for antibody targeting scenarios 
must be improved. In Chapter 7, we have shown that even with targeting several markers 
that are shown to be overexpressed in the model cell line used in the study, we were only 
able to achieve approximately 25% cell yield. However, the study also showed that by 
greatly increasing the photoinitiator labeling density with covalent tagging over what is 
capable with traditional immunolabeling, process yield was improved to approximately 
50-60%. In these studies, we functionalized 4-5 eosin molecules per streptavidin; 
however, to achieve significantly higher levels of photoinitiator labeling we aim to design 
streptavidin-macrophotoinitiator conjugates that are capable of directing tens  to hundreds 
of photoinitiator molecules per biotin binding event [141]. Macrophotoinitiators will be 
synthesized by coupling an excess of eosin isothiocyanate to primary amines of 
poly(acrylamide-co-acrylic acid) macromers of varying lengths. To conjugate 
photoinitiator macromers to avidin groups, carboxyl moeities contributed by acrylic acid 
monomer units will be activated by EDC/sulfo-NHS, quenched with 2-mercaptoethanol, 
and then reacted with streptavidin. Similarly, fluorescein macrophotoinitiators will be 
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investigated for feasibility with ASL. In preliminary studies, our group has shown the 
polymerized gel thickness of fluorescein surface initiation systems can rival eosin 
systems, but the fluorescein fluorophore is more widely assimilated in the scientific 
community and is approximately 20 times cheaper per milligram. Using these types of 
macrophotoinitiators systems, we expect significantly higher levels of photoinitiator 
surface densities can be achieved that will improve process yield. 
 After process yield is improved and carefully validated with model systems 
developed in vitro, the feasibility of ASL sorting patient-derived samples can be 
examined. The key advantage of ASL over other CTC isolation methodologies is the 
potential to rapidly collect functional cells. Conceivably, this technology is uniquely 
positioned to enable the researcher to correlate cancer cell phenotype and functional 
characteristics at both the tumor primary, at metastatic lesions, as well as in circulation 
from a single patient. While this correlative study is an exciting future possibility, there 
are challenges to achieving that goal particularly due to the rarity and uncertainty of cell 
occurrences in circulation. A practical starting point is at the primary, where there are 
simply more cells for experimentation. Fresh primary tissue punch biopsies can be 
collected, then enzymatically and mechanically dispersed into a cell suspension for ASL 
processing. A preliminary study of interest at the primary would be to first separate 
different regions associated with the primary (i.e. necrotic core, invasive front, stromal 
tissue) and sort in parallel. Here, one could examine the frequency of cells that are 
obtained at each region by positively sorting with a panel of markers, but also compare 
the functional characteristics of those populations post-sorting. After the ASL system is 
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well established with primary tissue, matched primary, secondary, and peripheral blood 
samples can be examined for similarities in cell phenotype and behavior. 
 Other challenges for clinical translation center around the logistics of processing 
the sheer magnitude of cells one would see in a fluid biopsy setting. A red blood cell 
depletion step with ammonium chloride is widely used for an initial debulking step; 
however, removing that large quantity of material from the system while preserving and 
separating all nucleated cells becomes a challenge. The incorporation of EDTA and 
DNase I is expected to be beneficial in preventing large cell clumping of nucleated cells. 
Practical adaptations must also be made for material handling, as density based 
centrifugation in culture tubes may cause the unintentional removal of large proportions 
of CTCs from the sample. Further, to photopolymerize these large cell samples, larger 
collimated LED lamps must be designed that can accommodate the large irradiation areas 
needed for adequate photoinitiation.  
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Appendix 
 
A-1 Cell Photopolymerization and Degradation Experimental Set-Up 
 
 
Figure A-1.1: Photograph of purging and photopolymerization set up. Cells are 
suspended in monomer solution in recessed well of cover glass bottom 35mm dish, and 
purged with ultra-pure N2 in a 150mm clear culture dish outfitted with inlet and outlet 
ports. Irradiation light is supplied by collimated LED lamp (ThorLabs) outputting 530nm 
light. 
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Figure A-1.2: Photograph of the UV photodegradation apparatus. Collimated LED 
outputting 365 nm light with a ChipClip / FAST-slide assembly. 
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A-2 UV-Vis Analysis and Calculation of Degree of Substitution (DOS) for 
Streptavidin-eosin-isothiocyanate Conjugation 
 
Figure A-2.1: UV-Vis standard curve of streptavidin prepared in PBS. Absorbances are 
at 280 nm. 
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Figure A-2.2: UV-Vis standard curve of eosin-isothiocyanate prepared in PBS. 
Absorbances are at 530 nm. 
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Figure A-2.3: Standard curve relating concentration and UV-Vis absorbance at 280 nm 
of eosin isothiocyanate prepared in PBS. 
 
 
Equation A-2.1: Calculation of degree of substitution (DOS) of conjugation of eosin 
isothiocyanate (EITC) to streptavidin from UV-vis standard curve regression analysis. 
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Figure A-2.4: Example of UV-Vis spectra of SA-EITC conjugate showing absorbance 
peaks at 280 nm and 530 nm. 
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A-3 Study of Significant Reaction Parameters Affecting Degree of Substitution of 
Streptavidin-eosin-isothiocyanate Conjugation 
Polymerization experiments in this dissertation involve the specific labeling of 
biotinylated sites with streptavidin (SA) which is covalently conjugated with eosin 
istothiocyanate (EITC). The isothiocyanate group reacts with the primary amine of lysine 
residues at pH ~ 8 to 10. Previous studies report the use of  general reaction protocol 
which involves dissolving lyophilized streptavidin at 10 mg/ml in 0.1 M carbonate buffer 
at pH 9, and reacting with EITC at a 140:1 molar ratio (EITC:SA) for 8 to 9 hours at 4 ˚C 
in the dark [98]. This protocol yields conjugates with a calculated DOS of approximately 
2-3. We hypothesized that higher photoinitiator loading for cell labeling could be 
obtained by increasing the DOS of the EITC to SA reaction. Therefore, and investigation 
of the significant reaction parameters dictating the extent of labeling was warranted. We 
examined pH, reaction time, and the reactant molar ratio in the study, while the total 
buffer salt concentration and reaction temperature were kept constant. First, the molar 
ratio was kept constant at 140:1, while the pH was varied (9, 10, and 10.5) as well as 
reaction itme (9, 12, and 15 h). The EITC:SA ratio was calculated from UV-Vis analysis 
after conjugation of absorbance values at 280 and 530 nm. Figure A-3.1 shows the 
results of the varied pH and reaction time experiment. This figure suggests that the 
reaction time in the range examined is not a significant parameter affecting DOS. 
However, the reaction pH did significantly affect the DOS, as increasing the pH from 9 to 
10 almost doubled the DOS. The data suggests that increasing the reaction above 10 to 
10.5 does not have a significant effect on the DOS, as here the increase only yielded 
~10% increase in the DOS. Another experiment examined the reactant molar ratio as it 
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was increased above the original ratio of ~140:1 from the protocol originally reported by 
Hansen et al. (2007). Figure A-3.2 shows the results of this experiment, and indicates 
that molar ratio does increase the reaction DOS. When the molar ratio is doubled, the 
DOS increases by approximately 1.5-fold. From these studies, it was concluded that a 
reaction time of 9 hours, a reaction pH of 10, and a reactant molar ratio of 140:1 would 
be sufficiently to yield a SA-EITC conjugate for cell labeling in ASL experiments. 
  
154 
 
Figure A-3.1 The effect of reaction time and reaction pH on the DOS of EITC:SA 
conjugates. Data points are presented as mean, with error bars representing standard error 
for N=3. 
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Figure A-3.2 Effect of reactant (free EITC to SA) molar ratio on DOS at pH 9 and 10 for 
a constant reaction time of 12 hours. “Fold Molar Ratio” refers to the fold increase in 
molar ratio over the original protocol that was adapted for this work found in Hansen et 
al. (2007) [98]. Data points are presented as mean, with error bars representing standard 
error for N=3. 
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A-4 General Orientation of Printed Protein Microarrays 
 Printed protein microarrays are used in the preceding chapters to investigate the 
gelation response to varied monomer formulations and photoinitiator surface densities. A 
general layout for these microarrays is shown below in Figure A-4.1. Pre-functionalized 
epoxy microscopy slides are purchased and washed once with 100% ethanol. Slides are 
loaded into an Affymetrix 417 Array Printer, where serial dilutions of biotinylated bovine 
serum albumin (bBSA) are printed identically on each slide. As shown below, each of the 
12 concentrations are printed in duplicate on each array, with 4 replicate arrays printed on 
each slide. Figure A-4.2 shows the bBSA print concetration corresponding to the array 
spotting configuration. In all printing scenarios, the total protein concentration is kept 
constant at 1000 μg/ml, with proportions of bBSA and BSA being prepared at varied 
ratios to serially modify the eventual biotin surface density on printed microarrays. 
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Figure A-4.1 General setup of biotinylated BSA protein microarrays. Array spot color 
indicates different concentrations. 
 
 
Figure A-4.2 Concentrations of biotinylated BSA corresponding to the designed 
microarray configuration. 
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A-5: Interfacial Polymerization for Colorimetric Labeling of Protein Expression in 
Cells 
The following section is adapted with minor changes from work previously published: 
 Jacob L. Lilly, Philip R. Sheldon, Liv J. Hoversten, Gabriela Romero, Vivek 
Balasubramaniam, Brad J. Berron. Interfacial Polymerization for Colorimetric 
Labeling of Protein Expression in Cells. PLOS ONE. 9(12): e115630, 2014. 
A-5.1 Introduction 
The determination of spatial patterns of protein expression in biological samples 
is a cornerstone of modern clinical diagnostic and biological research. Protein 
identification and localization is typically achieved through incubation of the sample with 
labeled antibodies against the protein of interest. While direct labeling of the target 
antibody is sufficient for localization of abundant proteins in fluorescent imaging, 
amplification of the signal is typically required to label proteins for brightfield 
observation of samples where dilute proteins can be difficult to observe colorimetrically. 
Horseradish peroxidase (HRP) amplification is a common method for amplifying the 
label of a poorly expressed protein in cells and tissues. The basic concept uses the 
incubation of HRP enzyme coupled to antibody location, typically through biotinylated 
antibodies and HRP-avidin conjugates [174]. The specificity of the antibody binds the 
enzyme to regions expressing the protein of interest. When the sample is subsequently 
immersed in a solution of hydrogen peroxide and diaminobenzidine, the HRP rapidly 
converts the diaminobenzidine to yield an insoluble brown product. Under ideal 
conditions, the presence of the brown product is isolated to regions of expression of the 
target protein. Unfortunately, nonspecific HRP signal is common from endogenous 
159 
peroxidases naturally residing in the tissue [175]. The presence of these active enzymes 
in the sample tissue requires additional sample processing to quench their activity [176]. 
Incomplete quenching can lead to false positives or inconclusive staining. Further, fine 
localization of HRP staining is an empirical process, where over-amplification commonly 
results in significant diffusion of the signal away from the targeted protein expression. 
Polymerization based amplification (PBA) recently emerged as a signal 
amplification approach which does not suffer from diffusional loss of localization or 
endogenous signal [96, 177]. PBA uses interfacial polymerization as the basis for 
depositing a large amount of label at the site of a biological recognition event (e.g. 
antibody/antigen) [141, 178-180]. Both the presence of a polymerization initiator and 
reactive monomers are required for the formation of polymer. The PBA approach couples 
the spatial localization of the polymerization initiator to that of a specific protein 
recognition event (Figure A-5.1). Wherever the antibody recognizes the target protein, a 
polymerization initiator is immobilized. Upon addition of monomer and the appropriate 
excitation energy, a polymer coating is formed through the deposition of many monomers 
at the site of an initiation event. The process has been previously demonstrated on 
microarrays to specifically form polymer films from as few as 3 binding events per 
square micron allowing great sensitivity and specificity at antibody concentrations that 
will limit non-specific background staining [97]. PBA has limitations with respect to 
sample archival. On cells, PBA has exclusively utilized fluorescent visualization of 
polymerization events [97, 100]. While PBA has shown strong stability of fluorescent 
signal during standard imaging conditions, a colorimetric stain would be advantageous 
for long-term sample storage and archiving. 
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Here, we seek to adapt PBA to serve as a colorimetric, signal-amplification 
scheme. Our general approach, termed Polymer Dye Labeling involves the specific 
loading of the interfacial polymer with dyes. The interfacial polymer typically used in 
PBA is Polyethylene glycol diacrylate (PEG diacrylate), which has been demonstrated to 
have specific staining with common dyes [80, 124, 141, 181].  Literature shows both 
Evans Blue[80] and eosin[180] to be effective in staining PEG diacrylate polymers. In 
particular, the Sikes group has established the use of eosin stained microarrays for 
colorimetric assays of oligonucleotide and protein expression, with strong signal to noise 
[141, 180, 182]. Critically, the ability of eosin to non-specifically stain many cellular 
components present in biological samples[183] precludes its use in Polymer Dye 
Labeling to detect specific targeted cellular substrates. We seek to develop a dye system 
of comparable staining intensity to the eosin dye, but with reduced affinity for common 
cellular components in biological cells. In all, Polymer Dye Labeling is expected to draw 
from the advantages of PBA (large signal, excellent localization, and specificity of 
action) while adding colorimetric capability to allow improved sample archiving. 
Our evaluation of Polymer Dye Labeling builds on prior PBA technology [94, 96, 
97, 99, 100, 124, 178, 179, 184-186]. We first confirm the expected process of PBA 
through quantifying the deposition of initiator and polymer on control glass surfaces. We 
then examine the loading of eosin and Evans Blue dyes into these interfacial coatings 
through quantification of color change. We then extend this work to the labeling of cells 
by Polymer Dye Labeling. On a culture of human dermal fibroblast samples, we confirm 
the stability of the Polymer Dye Labeling signal over 200 days, and also demonstrate the 
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compatibility of the Polymer Dye Labeling technology with conventional mounting 
media used in sample archiving. 
A-5.2 Materials and Methods 
A-5.2.1 Materials 
Epoxy functionalized slides were purchased from CEL Associates. Biotinylated 
bovine serum albumin (bio-BSA), streptavidin, eosin-isothiocyanate, eosin-y, 
Monoclonal mouse IgG1 anti-vimentin (V9; catalogue #V6389), 10× phosphate-buffered 
saline (PBS), Triton-X 100, trypsin, hydrogen peroxide (30 wt% solution), PEG 
diacrylate (Mn = 575), triethanol amine, and 1-vinyl-2-pyrrolidinone were purchased 
from Sigma Aldrich (St Louis, MO). Monoclonal mouse IgG1 anti-NPC (MAb414) was 
purchased from Covance (Princeton, NJ; catalogue #MMS-120P). Biotinylated 
polyclonal goat IgG anti-mouse IgG (H+L; catalogue #BA-9200) and Vectashield hardset 
mounting medium was purchased from Vector Laboratories (Burlingame, CA). Bovine 
serum albumin (BSA), methanol, and ethanol (absolute) were purchased from Fisher 
Scientific (Waltham, MA). Paraformaldehyde was purchased from Electron Microscopy 
Sciences (Hatfield, PA). Streptavidin-Alexa488 conjugates were purchased from Life 
Technologies (Grand Island, NY). Rabbit antibodies against mouse pro-surfactant protein 
C was purchased from Seven Hills Bioreagents (Cincinnati, OH). Donkey antibodies 
against rabbit IgG were purchased from Invitrogen (Carlsbad, CA). 
RPMI-1640 cell culture media was purchased from Cellgro and supplemented 
with 10% fetal bovine serum (FBS, Gibco, Carlsbad, CA), 100U/mL Penicillin, 10 
mg/mL Streptomycin (Gibco) prior to use. Normal human dermal fibroblasts (#CC-2511) 
were purchased from Lonza (Basel, Switzerland). Streptavidin-eosin (SA-initiator) was 
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prepared as described previously [178]. PBSA was prepared by adding 1 mg/mL bovine 
serum albumin 1x PBS. Monomer mix was prepared immediately prior to use and 
consists of 25 wt% PEG diacrylate, 21 mM triethanolamine, 35 mM 1-vinyl-2-
pyrrolidinone, and 0.05 wt% Nile red fluorescent nanoparticles in deionized water. 
A-5.2.2 Biotin Microarray Printing 
Epoxy functionalized glass slides were rinsed with ethanol, dried under a stream 
of nitrogen, and placed on the stage of the Affymetrix (Santa Clara, CA) GMS 417 
Arrayer. BSA solutions were prepared keeping a constant 1 mg/mL concentration of BSA 
in PBS, and varying the fraction of BSA that is biotinylated . Twelve solutions were 
prepared at the following concentrations of biotinylated BSA: 1 mg/mL, 400 µg/mL, 160 
µg/mL, 64 µg/mL, 26 µg/mL, 10 µg/mL, 4 µg/mL, 1.6 µg/mL, 650ng/mL, 260 ng/mL, 
100 ng/mL, 0 ng/mL. Arrays consisted of 24 spots, where each solution was duplicated 
on each array, and four identical arrays were printed on each glass slide. Only the two 
centermost arrays were used, as the polymerization light source can only irradiate two 
arrays at a time. Slides were printed under 60% relative humidity in a single batch of 25 
slides. 
A-5.2.3 Microarray Polymerization, Staining, and Imaging 
Slides were blocked in PBSA for 10 minutes, incubated in 1.0 µg/mL SA-initiator 
in PBSA for 20 minutes, and rinsed with PBSA. These initiator-labeled arrays were then 
scanned in an Affymetrix Microarray Scanner (Model 428) using 532 nm laser excitation 
and a 551 ± 7 nm band pass emission filter. Files were exported to ImageJ for analysis of 
array spot intensity. Fluorescent data are reported as the mean and standard deviation of 
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16 measurements (two duplicates spots per array, two arrays per slide, four independent 
preparations of a single slide). 
 Slides were then immediately placed in a Chip Clip (Whatman, Little Chalfont, 
UK) with a two well FAST slide (Whatman) with 400 µL of monomer mix in each well. 
Samples were purged with humidified nitrogen in a clear plastic bag for 5 minutes. Then, 
the slide was irradiated for 20 minutes with collimated, 10 mW/cm2, 530 nm LED light 
(Thorlabs, Newton NJ, model M530L3) under a constant stream of humidified nitrogen. 
After irradiation, samples were rinsed with water. The samples were then incubated in a 1 
mg/mL solution of the indicated dye for 20 minutes. Evans Blue was prepared in PBS, 
while eosin was prepared in an aqueous solution of 50% methanol to promote solubility. 
Slides were dried under a stream of nitrogen, and imaged using an Epson Perfection 4490 
Photo flat-bed document scanner at a resolution of 2400 dpi. Only the two arrays most-
centered under the LED irradiation were analyzed owing to radial non-uniformities in the 
irradiation intensity. Greyscale values of the fractional darkness of each spot were 
collected for each spot using ImageJ. Fractional darkness is defined as 1.00 minus the 
fractional greyscale value of spot brightness. The thickness of each polymer spot was 
measured with a Dektak 6M stylus profilometer. Limit of detection is defined as the 
lowest concentration of biotinylated BSA of a different mean when compared to the 
lower concentrations with at least 95% confidence by student t-test. The saturation range 
is defined as the high concentration range of biotinylated-BSA where the mean 
measurement is not different from each other with at least 95% confidence by a student t-
test. The dynamic range is defined as the concentration range between the limit of 
detection to the saturation region. 
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A-5.2.4 Immunolabeling of Cells 
Dermal fibroblasts were cultured on 8 well chamber slides in media at 37 C in 5% 
CO2 until ~80% confluent. The cells were rinsed with cold PBS, and fixed in 4% 
paraformaldehyde in PBS for 10 minutes. Fixed cells on chamber slides were stored in 
PBS at 4 ºC for up to 30 days prior to use with no observed change in staining intensity. 
Cells were permeablized with 0.1% Triton X-100 in PBS for 5 minutes and blocked with 
PBSA for 10 minutes. Then, slides were incubated in the appropriate primary antibody at 
the appropriate dilution in PBSA (anti-NPC at 1:1,000 or anti-vimentin at a 1:5,000) for 
40 minutes and rinsed with PBSA. The cells were contacted with biotinylated antibodies 
against mouse IgG at 1:400 dilution in PBSA for 4 minutes and rinsed with PBSA. These 
samples were then ready for either Polymer Dye Labeling or control labeling with 
Alexa488. 
For Polymer Dye Labeling, the cells were incubated in a 25 µg/mL solution of 
SA-initiator in PBSA for 20 minutes and rinsed with PBS. 80 µL of monomer mix was 
added to each well, and the slides were polymerized for 20 minutes with collimated, 10 
mW/cm2, 530 nm LED light (Thorlabs model M530L3) under a constant stream of 
humidified nitrogen. After irradiation, samples were rinsed with water, and incubated in a 
1 mg/mL solution of Evans Blue dye in PBS for 20 minutes. Samples were briefly rinsed 
with PBS, and then imaged on a Nikon (Tokyo, Japan) Ti-U inverted microscope using a 
60x oil immersion objective with a Nikon DS-Ri1 12 MP cooled color CCD camera. 
For control experiments, cells labeled with biotinylated secondary antibodies were 
contacted with 1 µg/mL streptavidin-Alexa488 in PBSA for 20 minutes and were 
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immediately imaged on a Nikon Ti-U inverted microscope as before except with 
epifluorescent imaging in the FITC channel. 
Greyscale values of the fractional darkness of each spot were collected for each 
spot using ImageJ. Fractional darkness is defined as 1.00 minus the fractional greyscale 
value of spot brightness. Background (non-cell region) darkness was subtracted from 
both the signal (nucleus region) and noise (cytoplasm region). Signal to noise is defined 
by the division of the signal value by the noise value.  
A-5.3 Results and Discussion 
Our goal is to develop a colorimetric alternative to enzymatic amplification which 
is not hampered by non-specific amplification by endogenous enzymes or through 
diffusional loss of signal localization. Our approach, “Polymer Dye Labeling,” is a multi-
step process where 1) polymerization initiator is localized to the site of antigen 
expression, 2) an interfacial polymer coating is grown from the surface-grafted initiator, 
and 3) dye is loaded into the polymer. Our approach is to first study the fundamental 
relationship between initiator binding and the intensity of Polymer Dye Labeling. Then, 
we investigate the comprehensive Polymer Dye Labeling process when applied to the 
labeling of protein expression in cultured human dermal fibroblasts. 
A-5.3.1 Characterization of Recognition, Polymerization, and Dye Association 
Bio-BSA was printed into microarrays on an epoxy coated slide, and blocked with 
PBSA. Recognition of the SA-initiator with the biotin of the bio-BSA, was quantified 
through measuring the fluorescence of the eosin initiator in biotin-expressing regions. A 
solution of the SA-initiator conjugate at 1 μg/mL in PBSA was contacted with each 
microarray for 20 minutes, and excess conjugate was rinsed briefly with PBSA prior to 
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capturing a fluorescent image with a microarray scanner (Figure A-5.2.a). The 
fluorescence of each spot was measured using ImageJ, and plotted against the 
corresponding concentration of Bio-BSA in the printing solution (Figure A-5.2.b). The 
relative initiator concentration is indistinguishable from the background at printed 
solution concentrations less than 10-3 g/L of Bio-BSA (limit of detection, p=10-14). There 
is a two log fluorescent dynamic range, and saturation above 10-1 g/L of Bio-BSA 
(p=.043). Initiator binding is restricted to printed regions, and printed spots containing 
only BSA did not exhibit fluorescence greater than that of non-printed regions. The 
specificity of binding in this study is consistent with previous reports of initiator binding 
based on antibody-antigen [97, 100, 185] or Streptavidin-biotin interactions [178, 184]. 
 Interfacial polymerization is accomplished through the immersion of an initiator-
primed surface in a PEG diacrylate monomer solution. Polymerization proceeded with a 
20 minute exposure to 10 mW/cm2, 530 nm irradiation under a nitrogen atmosphere. The 
resulting arrays of polymer spots were measured by profilometry to determine the 
sensitivity and magnitude of the polymerization reaction (Figure A-5.2.c). As expected, 
polymer growth was restricted to regions of initiator-labeling, supporting the specificity 
of the polymerization process. The limit of detection was identical to that of the 
fluorescence arrays (10-3 g/L of Bio-BSA, p= .001). The dynamic range of polymer 
thickness extended to 10-1 g/L of Bio-BSA (p=.01), and was identical to that of the 
dynamic range of initiator concentration on the surface, supporting prior reports of the 
polymerization reaction being limited by the initiator concentration [141]. 
 Incubation of the PEG diacrylate hydrogels in a dye is expected to alter the color 
of the polymer. We are investigating Evans Blue as a candidate dye for strong specific 
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staining of the polymer with minimal nonspecific staining of cellular material. Arrays of 
PEG diacrylate polymer films were incubated in 1 mg/mL Evans Blue for 20 minutes, 
and upon removal, the polymer spots were darkened, while the surrounding glass slide 
remained unstained (Figure A-5.3.a). The darkness of the spots was quantified and 
plotted against the printed concentration of bio-BSA (Figure A-5.3.c). Again, the limit of 
detection was identical to that of the polymer thickness and the initiator concentration 
(10-3 g/L of Bio-BSA, p=0.0004). Critically, the dynamic range of the staining was 
negligible, and saturation range began at the next data point (4x10-3 g/L of Bio-BSA, p= 
0.008). As a result, the colorimetric response was largely binary. When compared to the 
use of 1 mg/mL eosin as the polymer dye (Figure A-5.3.b, A-5.3.d), Evans Blue has a 
greater magnitude of colorimetric labeling (p= 10-63) of the polymer stained regions but 
different levels of background staining (p= 10-5). The limit of detection (10-3 g/L of Bio-
BSA, p= 0.0008) and beginning of the saturation range (10-2 g/L of Bio-BSA, p= 0.0008) 
for eosin are similar to the Evans Blue labeling. This indicates Evans Blue is a potential 
alternative to eosin in colorimetric staining of PEG diacrylate hydrogels in microarray 
settings. The use of eosin dyes on hydrogel microarrays has already demonstrated 
effectiveness in a colorimetric detection of biological species [141], and the use of a blue 
dye may improve ease of use over the pink color associated with eosin-dyed hydrogels. 
To directly compare the effectiveness of the dye-labeling step, we related the 
darkness of each spot to the thickness of the hydrogel at that location, providing a 
relationship of how much dye is absorbed per unit thickness by the PEG diacrylate 
hydrogels. Applying a linear relationship (slope =1.78x10-4 darkness units per nm) to the 
Evans Blue data is consistent with the expected increase in spot darkness with a longer 
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path length through the dyed polymer (Figure A-5.4.a), yet this fit is statistically 
different than the data (p=.01), indicating a poor fit. A linear relationship (2.7x10-4 
darkness units per nm) is observed for the eosin-dyed polymer spots (Figure 4b), without 
a statistical difference between the data and the linear fit (p=0.06). Additionally, the eosin 
associated with the initiator is not perceptible through visual observation prior to 
immersion of the hydrogel in eosin. All darkness of the spot is attributed to the post-
polymerization dying. While the magnitude of the spot darkness is higher for the eosin 
dyed spots than the Evans Blue dyed spots, there is a comparable difference in 
nonspecific darkness on the glass slide. Here, we show the eosin labeling of the polymer 
is specific. In previous studies, greater signal to noise has been reported by others through 
the use of 20-fold higher concentrations of eosin [180]. Higher concentrations of eosin or 
Evans Blue were not used in the present study, in an effort to limit nonspecific staining in 
subsequent cell studies.  
The diameter of the dye labeled polymer spots was determined by optical 
microscopy to be 340 ± 20 µm (Figure A-5.3.a, A-5.3.b), and this value was within 
measurement error of the spot size of the original initiator labeled arrays of 350 ± 20µm 
(Figure A-5.2.a). The lack of detectible polymer overgrowth is promising for the 
localization of the polymer to the site of protein expression. 
A-5.3.2 Labeling of Protein Expression in Cells 
The transition from a controlled microarray environment to a biological substrate 
introduces additional challenges to label specificity. Every step in the amplification 
process must be specific to the region of antibody/antigen recognition. For the 
localization of the initiator, the specificity is dictated by specific binding of the antibodies 
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and the SA-initiator complex [96]. When antibodies against nuclear pore complex (NPC) 
are used on a fixed, permeabilized, and blocked dermal fibroblast, the initiator 
fluorescence is isolated to the nuclear membrane (Figure A-5.5.c). When the NPC 
primary antibodies are replaced with antibodies against vimentin, the initiator 
fluorescence is localized to vimentin, a fibrous structural component which stretches 
across the cytoplasm (Figure A-5.5.d). Control experiments using standard streptavidin-
Alexa488 instead of the SA-initiator show identical patterns of expression (Figure A-
5.5.a, A-5.5.b), supporting the appropriate protein specificity of the initiator localization. 
The signal intensity from labeling with SA-initiator (signal to noise 4.53 ± 0.36) and 
streptavidin-Alexa488 (signal to noise 4.23 ± 0.80) are fully described in Table A-5.2. 
These findings are consistent with prior work in polymerization amplification [100, 178]. 
 Upon addition of the PEG diacrylate monomer mix to the initiator-labeled cells 
and irradiation with 10 mW/cm2, 530 nm (green) light, an interfacial polymer is formed 
on only surfaces expressing the target protein. Unreacted monomer is rinsed away with 
PBS, and the polymer-labeled cells are immersed in 1 mg/ mL Evans Blue in PBS. While 
both eosin and Evans Blue are capable of specific staining in a microarray setting, the 
non-specific staining of eosin for cytoplasmic proteins and collagen precludes its use for 
Polymer Dye Labeling on most biological substrates [183]. As such, only Evans Blue 
was used in the cell staining studies. In the case of NPC labeled cells, the blue staining of 
the Polymer Dye Labeling (Figure A-5.5.e) is consistent with the fluorescent control 
NPC staining, where the nuclear membrane is labeled. Similarly, the Polymer Dye 
Labeling of vimentin is specific to these cytoskeletal components, with appropriate 
alignment of fibers towards cellular extensions (Figure A-5.5.f). Taken together, the 
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cellular labeling studies are supportive of the specificity of Polymer Dye Labeling in 
biological environments. Further, the intensity of staining is consistent with the expected 
amplification resulting from the reaction of many monomers at the site of initiation.  
In the context of biological research, colorimetric staining allows independence 
from fluorescent analysis and associated costs. Colorimetric staining is almost 
exclusively accomplished with enzymatic amplification of the label and enzymatic 
labeling has the fundamental challenge of nonspecific labeling from endogenous enzymes 
and diffusion. Importantly, our work was performed in the absence of any additional 
steps to quench endogenous enzyme activity, as the routes for nonspecific polymerization 
initiation are currently undetected. A limitation of the current embodiment of polymer 
dye labeling is the need for a photopolymerization light source. The light source utilized 
here (Thorlabs LED, <$1000 US) is significantly less expensive than a fluorescent 
microscope which requires additional filters and optics. Further, other modes of 
polymerization based amplification are based on non-light driven polymerizations [124, 
177, 186-190]. The future incorporation of ATRP or other modes of polymerization 
would further reduce the capital cost of polymer dye labeling.  
A-5.3.3 Suitability for Sample Archiving 
Signal stability is a major advantage of a colorimetric staining over a fluorescent 
approach. We challenged the stability of cells polymer dye labeled cells with storage at 
ambient conditions. Specifically, the samples were imaged immediately after Polymer 
Dye Labeling for nuclear pore complex and again after being stored in a drawer for 208 
days (Figure A-5.6). The darkness of the nucleus when stained (0.363 ± 0.088) is 
comparable to the darkness of the nucleus 208 days after the staining (0.343 ± 0.091). 
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The only observable differences between the images were a slight reorientation of the 
frame and an increase in small optical aberrations attributed to environmental 
contaminants (dust, bacteria, etc.). The storage had no significant impact on the intensity 
or localization of staining, indicating promise for the application of Polymer Dye 
Labeling to long term sample archiving.  
We also evaluated the stability of Polymer Dye Labeling signal when using a 
mounting medium. Prior studies using fluorescent PBA to label proteins has been 
exclusively executed in the absence of mounting medium, as the fluorescence is 
completely quenched in the presence of mounting media [100]. This is a significant 
limitation, as mounting medium is commonly integrated into conventional imaging and 
archiving protocols to improve image quality and to preserve signal.  
NPC expression was stained through four variants of Polymer Dye Labeling: dry 
with Evans Blue, mounted with Evans Blue, dry without Evans Blue, and mounted 
without Evans Blue. Images are presented in Figure A-5.7, while the darkness of the 
stain in these images was measured with ImageJ and compiled in Table A-5.1. For dry 
imaging of Polymer Dye Labeling, a blue nucleus is clearly observed (signal / noise ~7) 
in contrast to minimal nonspecific signal in the cytoplasm (Figure A-5.7.a). Vectashield 
hardset mounting medium was added to the sample according to manufacturer’s 
instructions, coverslipped and imaged (Figure A-5.7.b). While the overall darkness of 
the stain decreased, the signal/noise almost tripled that of the dry Polymer Dye Labeling. 
This is attributed to a large decrease in the nonspecific staining of the cytoplasm.  
The most striking change with sample mounting was the change in color of the 
Polymer Dye Labeling from blue to violet. To verify this different color of labeling is 
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attributed to the use of the Evans Blue dye, we polymerized in response to NPC with the 
omission of the Evans Blue dye (Figure A-5.7.c). This dry, undyed sample shows 
negligible signal yet did impart some contrast in the image, owing to the change in 
refractive index between the polymerized nucleus and the background. Upon addition of 
mounting medium to this sample, a slight violet tint is imparted on the interfacial 
polymer covering the nucleus (Figure A-5.7.d). The magnitude of the mounting 
medium’s contribution to the signal is low (signal/noise ~1), supporting the Evans Blue 
dye as the dominant mechanism for staining. As the dark violet color of the polymer is 
only observed when both Evans Blue and mounting medium are used, it is likely the 
change in the chemical environment of the dye is altering the absorption characteristics. 
Similar shifts in absorption peak position are commonly observed in many light-
absorbing molecules (photoinitiators [191], fluorophores [192, 193], etc.) with a change 
in solvent.  
While enzymatic amplification methods are also stable over prolonged times and 
are compatible with modern sample archiving methods, polymerization based methods 
have greater site-specificity than enzymatic amplification [100]. The present findings 
clearly address the prior limitations in archiving of polymerization amplification samples, 
delivering a plausible path forward for a new colorimetric technique with all of the 
positive attributes of both enzymatic and polymerization techniques. 
A-5.4 Conclusions 
Polymer Dye Labeling is based on interfacial polymerization which is specific to 
the site of the targeted protein, and these target-specific polymer coatings are then stained 
with Evans Blue dye. As a result, a dye-loaded polymer is isolated to regions of protein 
173 
expression. In microarray studies, the use of Evans Blue provides a comparable contrast 
to an unstained background as eosin dyes. Application of Polymer Dye Labeling to 
immunostaining of cultured cells allowed bright field observation of both the spatial 
protein expression and cell morphology. The labeling of protein expression is stable over 
several months. Prior polymerization labeling approaches were incompatible with 
mounting medium, but Polymer Dye Labeling maintains signal intensity and localization 
in common mounting media. We conclude that Polymer Dye Labeling will allow 
colorimetric visualization of the spatial localization of targets within a cell to leverage the 
highly sensitive and specific aspects of Polymerization Based Amplification. 
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Table A-5.1: Staining intensity for Polymer Dye Labeling of nuclear pore complex. 
 
Sample Signal a,c Noise b,c Signal / Noise 
 Mean Standard 
Deviation
Mean Standard 
Deviation 
Mean Standard 
Deviation 
Polymer Dye 
Labeling dry 
0.333 0.009 0.049 0.004 6.9 0.7 
Polymer Dye 
Labeling Mounted 
0.191 0.016 
 
0.010 0.003 20.9 8.2 
Polymer Dry -0.001 0.001 -0.004 0.002 0.2 0.6 
Polymer Mounted 0.016 0.006 0.005 0.014 1.2 2.3 
a - Signal is defined as the darkness of the nucleus.  
b - Noise is defined as the darkness of the cytoplasm.  
c - Values are relative increase over empty region of slide. 
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Table A-5.2: Staining intensity for immunofluorescent labeling of nuclear pore complex. 
Sample Signal a,c Noise b,c Signal / Noise 
 Mean Standard 
Deviation
Mean Standard 
Deviation 
Mean Standard 
Deviation 
Streptavidin-488 
Labeling  
0.146 0.028 0.035 0.006 4.23 0.80 
Streptavidin-eosin 
Labeling  
0.101 0.008 0.022 0.007 4.53 0.36 
a - Signal is defined as the brightness of the nucleus.  
b - Noise is defined as the brightness of the cytoplasm.  
c - Values are relative increase over empty region of slide. 
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Figure A-5.1: Polymer Dye Labeling concept at the (a) cellular level and (b) molecular 
level. A polymerization initiator is localized to site of antigen through antibody and 
biotin-streptavidin labeling. Interfacial hydrogel polymerization occurs only at regions 
labeled with initiator. The hydrogel is colorimetrically labeled through an affinity dye. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
177 
 
 
Figure A-5.2: Imaging of initiator concentration for microarray. a) Fluorescent 
microarray scanner measuring relative abundance of initiator prior to polymerization 
labeling. Scale bar = 1 mm. b) Relative initiator concentration on surface for spots printed 
from the indicated concentration of biotinylated-BSA and reacted with the SA-initiator 
complex. Measurements based on initiator fluorescence (ex/em = 525/545 nm). c) 
Thickness of spots of indicated Bio-BSA concentration. Data are mean ± standard 
deviation. n=16. 
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Figure A-5.3: Colorimetric imaging of Polymer Dye Labeling. a) Greyscale image from 
optical document scanner after Polymer Dye Labeling with Evans Blue dye. b) Greyscale 
image from optical document scanner after Polymer Dye Labeling with eosin dye. Scale 
bars = 1 mm. c) darkness of Evans Blue dyed spots of indicated Bio-BSA concentration.  
d) Darkness of eosin dyed spots of indicated Bio-BSA concentration. Data in c) and d) 
are mean ± standard deviation. n=12. 
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Figure A-5.4: Relationship between polymer spot thickness and spot darkness after 
Polymer Dye Labeling. a) Polymer Dye Labeling with Evans Blue dye. b) Polymer Dye 
Labeling with eosin dye. Each data set includes at least 6 microarrays from 3 independent 
experiments. Black squares indicate array data. Grey squares indicate mean value of non-
specific regions for each experiment. 
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Figure A-5.5: Comparison of Polymer Dye Labeling with immunofluorescent labeling in 
human dermal fibroblasts. Control fluorescent staining of nuclear pore complex (a) and 
vimentin (b) using Streptavidin-Alexa488. Initiator localization when using antibodies 
against nuclear pore complex (c) and vimentin (d). Dyed Polymer localization when 
using antibodies against nuclear pore complex (e) and vimentin (f). Scale bars are 50 µm. 
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Figure A-5.6: Labeling Stability of Polymer Dye Labeling. Polymer Dye Labeling of 
nuclear pore complex immediately after staining (a) and 208 days after staining (b). Scale 
bars are 50 µm. 
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Figure A-5.7: Compatibility of Polymer Dye Labeling with Vectashield mounting 
medium. Polymer Dye Labeling of nuclear pore complex imaged (a) dry or (b) in 
Vectashield hardset mounting medium. Polymer coated nuclei without Evans Blue dye 
imaged (c) dry or (d) in Vectashield hardset mounting medium. Scale bars are 50 µm. 
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List of Abbreviations 
 
 
 
 
AC   Acryloyl chloride 
ASL   Antigen specific lysis 
bBSA   Biotinylated bovine serum albumin 
BP   Bandpass 
BSA   Bovine serum albumin   
CK   Cytokeratin 
CTC   Circulating tumor cell 
DAPI   4',6-diamidino-2-phenylindole 
DCM   Dichloromethane 
DNA   Deoxyribonucleic acid 
DOS   Degree of substitution 
DPBS   Dulbecco’s phosphate buffered saline 
ECM   Extracellular matrix 
EDC   1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide 
EDTA   Ethylenediaminetetraacetic acid 
EGF   Epidermal growth factor 
EGFR   Epidermal growth factor receptor 
EIA   Enzyme immunoassay 
EITC   Eosin-5-isothiocyanate 
ELISA   Ezymed-linked immunosorbent assay 
EMT   Epithelial-mesenchymal transition 
EpCAM  Epithelial cell adhesion molecule 
ER-α   Estrogen receptor-α 
FACS   Fluorescence activated cell sorting 
FBS   Fetal bovine serum 
FD   Fluorescein-5-isothiocyanate labeled dextran 
FITC   Fluorescein-5-isothiocyanate  
GFP   Green fluorescent protein 
1H-NMR  Proton nuclear magnetic resonance  
HEPES  2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid 
HER1   Human epidermal growth factor receptor 1  
HER2   Human epidermal growth factor receptor 2 
HGF   Hepatocyte growth factor 
ICAM-1  Inflammatory cell adhesion molecule 1 
IgG   Immunoglobulin 
IHC   Immunohistochemical 
LAP   Lithium acylphosphinate 
LED   Light emitting diode 
MACS   Magnetic activated cell sorting 
MEHQ  Monomethyl ether hydroquinone 
MW   Molecular weight 
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MWBC  molecular weight between crosslinks 
NHS   N-hydroxysuccinimide 
NPC   Nuclear pore complex 
NSCLC  Non-small cell lung cancer 
PBA   Polymer-based amplification 
PBMC   Peripheral blood mononuclear cell 
PBS   Phosphate buffered saline 
PBSA   Phosphate buffered saline with 1 mg/ml bovine serum albumin 
PCL   Poly(caprolactone) 
PDGF   Platelet derived growth factor 
PE   Phycoerythrin 
PEG   Poly(ethylene glycol) 
PEGDA  Poly(ethylene glycol) diacrylate 
PLA   Poly(lactic acid) 
PLGA   Poly(lactic-co-glycolic acid) 
PLL   Poly(L-lysine) 
PVA   Poly(vinyl alcohol) 
SA   Streptavidin 
SDS   Sodium dodecyl sulfate 
SEM   Scanning electron microscopy 
TEA   Triethanolamine 
TEM   Transmission electron microscopy 
TGF-β   Transforming growth factor β 
UV   Ultraviolet 
VP   1-vinyl-2-pyrrolidinone 
ZEB   Zing finger E-box binding homeobox 
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